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Table  4.2 Comparison of model-derived parameters and experimental 
data for a standard model and modified model of glucose 
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56












Modifications made to base protocol for coating standard 
calcium alginate beads and subsequent results. 
 
138
Table D.2 Modifications made to base protocol for coating  




















Role of cryopreservation in tissue engineering. 
 
2
Figure 1.2 Model pancreatic substitutes studied in this thesis. A). βTC-tet 
cells encapsulated in unmodified alginate and B). Stably 




Figure 3.1 The “egg box model.” 
 
16
Figure 3.2 RGD conjugation to alginate via carbodiimide chemistry. 
 
19
Figure 3.3 Sodium periodate oxidation of alginate. 
 
20
Figure 3.4 Labeling of metabolites in the cell after introduction of U-13C 
(uniformly labeled-13C) glucose. 
 
33
Figure 3.5 Two models of mitochondrial metabolism in the beta cell that 
have been applied in the tcaCALC modeling program to 
calculate metabolic fluxes A).dual pyruvate pool model, B). a 
modified single pool model with a second non-pyruvate 
carboxylase anaplerotic substrate entrance to the TCA cycle. 
 
35
Figure 4.1 Representative 13C NMR spectrum obtained after 13C labeling 
and extraction on 6 ml of Fresh beads incubated in labeling 
medium for 6 hours. 
 
46
Figure 4.2 A). Relative multiplet peak areas of the glutamate C2 (GluC2) 
resonance during incubation in 15 mM U-13Cglucose DMEM 
for 3-15 hours. B). Representative glutamate C2 resonance 
with multiplets labeled. 
 
49
Figure 4.3 A). Relative multiplet peak areas of the glutamate C3 (GluC3) 
resonance during incubation in 15 mM U-13Cglucose DMEM 
for 3-15 hours. B). Representative glutamate C3 resonance 
with multiplets labeled. 
 
49
Figure 4.4 A). Relative multiplet peak areas of the glutamate C4 (GluC4) 
resonance during incubation in 15 mM U-13Cglucose DMEM 




Figure 4.5 A). Metabolic activity of Fresh (white bars), Frozen (light gray 
bars), and DPS-vitrified (dark gray bars) beads after medium 






Representative 13C NMR spectrum obtained after 13C labeling 
and extraction of 7 ml of Frozen beads incubated in basal 
medium for 1 hour followed by labeling medium for 6 hours. 
 
53
Figure 4.7 Representative 13C NMR spectrum obtained after 13C labeling 
and extraction of 12 ml of DPS-vitrified beads incubated in 




Figure 4.8 A). Standard model and B). a previously published modified 
model of glucose metabolism containing a second non-




Figure 4.9 Representative experimental and tcaSIM-derived simulated 
spectra from Fresh beads. 
 
55
Figure 5.1 Overall experimental procedure for 13C labeling and extraction 




Figure 5.2 A previously published modified single pyruvate pool model 




Figure 5.3 Representative isotopomer patterns from glutamate C2, C3, 
and C4 resonances from experimental spectra obtained from 
extracts of Fresh, Frozen, and DPS-vitrified encapsulated βTC-




Figure 5.4 Cryopreservation effects on metabolism of encapsulated βTC-
tet cells determined using a modified single pyruvate pool 
model applied in tcaCALC. A). Relative metabolic fluxes, B). 
Percent carbon flow into the tricarboxylic acid (TCA) cycle, 












Figure 5.5 Insulin secretion rate (ISR) measured during basal and high 
glucose 13C-labeling periods for Fresh (white bars), Frozen 






Insulin secretion rate (ISR) from encapsulated βTC-tet cells 
during small-scale glucose-stimulated insulin secretion (GSIS) 
experiment for Fresh (white bars), Frozen (gray bars), and 
DPS-vitrified groups (striped bars). 
 
75
Figure 5.7 Insulin secretion rate (ISR) from encapsulated βTC-tet cells 
during A). small–scale K+-induced depolarization experiment 
for Fresh (white bars), Frozen (gray bars), and DPS-vitrified 
groups (striped bars). B). Stimulation indices from GSIS 
(white bars) and K+-induced depolarization (gray bars) for 
Fresh, Frozen, and DPS-vitrified groups. 
 
76
Figure 6.1 Representative light microscopy images (10x) of encapsulated 
Stable C2C12 cells cultured 1 and 4 days post-encapsulation in 
RGD/RGE/no peptide alginate hydrogels. 
 
94
Figure 6.2 Metabolic activity over time for cells encapsulated in 3.5% 
RGD (white bars), RGE (light gray bars), and no peptide (dark 
gray bars) LVM alginate, and normalized to respective groups 
on Day 1. 
 
95
Figure 6.3 Cellular response to cryopreservation in adhesive (RGD, white 
bars) vs. non-adhesive (RGE, gray bars) alginate hydrogels in 
terms of A). metabolic activity-DPS-vitrified; B). metabolic 
activity-Frozen, C). insulin secretion rate (ISR)-DPS vitrified, 
and D). ISR-Frozen. 
 
96
Figure 6.4 Metabolic activity in Fresh and Cryopreserved Stable C2C12 
cells encapsulated in RGD-alginate hydrogels and cultured 




Figure 6.5 Cryopreservation effects on insulin secretory function of 
Stable C2C12 cells encapsulated in RGD-alginate hydrogels 













Figure 6.6 Effect of culture time prior to cryopreservation on Stable 
C2C12 cells encapsulated in RGD-alginate hydrogels and 
cultured for 1 or 4 days prior to cryopreservation A). metabolic 
activity-DPS vitrified, B). metabolic activity-Frozen and C). 





Representative LIVE/DEAD® images (10x) from 3-D 
projections of beads one day post-warming for Cryopreserved 
groups and respective Fresh controls for A). RGD C1, B). 
RGD C4, and C). RGE groups. 
     




Box plots displaying circularity per bead for A). Fresh RGE, 
RGD C1 and RGD C4, B). RGD C1 Fresh and Cryopreserved, 




Figure 6.9 Representative phase contrast light micrographs (4x) of 




Figure 6.10 Representative confocal microscopy images (63x) of 
actin/nuclei stained encapsulated cells in Fresh RGD and RGE 
beads at the time of cryopreservation: A)-B). RGD C1, C)-D). 
RGD C4, E)-F). RGE. 
 
105




Metabolic activity (normalized to Fresh Control) after 
vitrification of encapsulated βTC-tet cells. 
 
129
Figure A.3 ISR (normalized to Fresh Control) after vitrification of 
encapsulated βTC-tet cells. 
 
129
Figure B.1 Glutamate resonances from 13C NMR spectra obtained from 
extractions using A). metal generator probe and B). a plastic 
Omin Tip™ generator probe. 
 
130
Figure C.1 Metabolic activity of Stable C2C12 cells encapsulated in 





Stable C2C12 cells encapsulated at 1x106 cells/ml in 2% LVM 
or 2% RGD-LVM. A)., C)., and E). represent 2% unmodified 
LVM on days 1, 5, and 10, respectively. B)., D)., and F). 





Figure C.3 Metabolically active cell number measured by alamarBlue® of 
Stable C2C12 cells encapsulated in different types of RGD-
modified oxidized alginates at 1x106 cells/ml (3% alginate 
groups were encapsulated at 3x106 cells/ml) and normalized to 
Day 1 values. 
 
    133 
Figure C.4 Light microscopy pictures of Stable C2C12 cells encapsulated 
in 3% RGD-modified oxidized LVM at 3x106 cells/ml. A). 
Day 1, 10x; B). Day 3, 10x; C). Day 3, 40x; D).Day 6, 10x.   
 
    134 
Figure D.1 Flow chart summarizing approaches and results obtained after 
trying different preparations of Stable C2C12 cells 
encapsulated in partially oxidized, RGD-modified alginate 
hydrogels. 








Figure D.3 Fresh inhomogeneous calcium alginate beads after 
LIVE/DEAD® staining. 
 
    137 
Figure D.4 Fresh Stable C2C12 cells encapsulated in 3.5% oxidized RGD-
modified LVM and crosslinked in 20 mM BaCl2 in mannitol 
(inhomogeneous bead formation). 
 
138
Figure D.5 Fresh Stable C2C12 cells encapsulated in 3.5% oxidized RGD-
LVM and coated with 0.1% PLL (Standard coated beads) after 
1 and 4 days in culture. 
 
139
Figure D.6 Stable C2C12 cells encapsulated in 3.5% oxidized RGD-LVM 






Fresh inhomogeneous coated beads maintained bead integrity 
in culture but lacked spreading. Beads were coated in 0.1% 















A  Addition 
ACS  Flux through acetyl-CoA synthetase 
AGEs  Advanced glycated end products 
APA  Alginate-poly-L-lysine-alginate 
BSA                                                                                                   Bovine serum albumin 
C1                                                                                                                            Carbon 1  
CPA                                                                                                                Cryoprotectant 
D                                                                                                                                Doublet 
DMSO                                                                                                      Dimethylsulfoxide 
ECM                                                                                                      Extracellular Matrix 
EDC                                 1-Ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride 
G                                                                                                                      guluronic acid 
GluC2                                                                                                               glutamate C2   
GluC3                                                                                                               glutamate C3 
GluC4                                                                                                               glutamate C4 
GSIS                                                                            Glucose-stimulated insulin secretion 
IDD                                                                                             Insulin-dependent diabetes  
iPS                                                                                                  Induced pluripotent stem 
ISR                                                                                                        Insulin secretion rate 
KATP                                                                                                            ATP-sensitive K
+ 
KRB                                                                                                       Krebs-Ringer buffer 
LDH                                                                                                 Flux through glycolysis 
 xvii
M                                                                                                                 Mannuronic acid  
NMR                                                                                         Nuclear magnetic resonance 
PC                                                                                                        Pyruvate carboxylase   
PD                                                                                                                1,2 Propanediol 
PDH                                                                           Flux through pyruvate dehydrogenase 
PERV                                                                                     porcine endogenous retrovirus 
PK   Flux through phosphoenol-pyruvate carboxykinase/pyurvate kinase or malic enzyme 
PLL                                                                                                                  Poly-L-lysine 
Q                                                                                                                                 Quartet 
R                                                                                                                              Removal 
RT                                                                                                             Room temperature 
S                                                                                                                                  Singlet 
SNR                                                                                                       Signal-to-noise ratio 
Sulfo-NHS                                                                                 N-hydroxysulfosuccinimide 
SV40                                                                                                             Simian virus 40 
T                                                                                                                                  Triplet 
TAg                                                                                                         large tumor antigen 
TCA                                                                                                         Tricarboxylic Acid 
TEPS                                                                       Tissue engineered pancreatic substitute 
tet                                                                                                                         tetracycline 
U-13C                                                                                                  Uniformly 13C labeled     
YPC                                                                                Flux through pyruvate carboxylase 








A tissue engineered pancreatic substitute consisting of insulin-secreting cells 
encapsulated in alginate hydrogels may provide more physiologic control of blood 
glucose levels compared to current exogenous insulin therapy for patients suffering from 
insulin-dependent diabetes (IDD). For clinical translation of a pancreatic substitute, 
however, long-term storage is essential, and cryopreservation is a promising means to 
achieve this goal. The two main methods that may be employed for cryopreservation are 
conventional freezing and vitrification. Although ice formation during freezing may not 
necessarily be detrimental to single cells in suspension, it may have adverse affects on a 
3-D construct. Vitrification, or ice-free cryopreservation, is a promising alternative 
method of cryopreservation. However, potential osmotic excursions as well as 
cytotoxicity are issues associated with vitrification due to the high concentration of 
cryoprotectants used in the procedure. As both methods have their potential drawbacks, 
both must be systematically evaluated in order to determine the appropriate method of 
cryopreservation. 
It is currently unclear what cell type will be most appropriate for an encapsulated 
cell therapy for treatment of IDD, and different insulin-secreting cells may have different 
requirements for cell adhesion in 3-D.  Cell adhesion is important for various cellular 
processes, including survival, proliferation, and differentiation. In particular, 
encapsulating beta cells or islets in an adhesive environment has been shown to be 
beneficial for viability and/or function, and other cell types being explored for cell-based 
therapies for IDD treatment may also benefit from or require adhesion in 3-D. Thus, it is 
 xix
important to study the effects of cryopreservation on cells encapsulated in non-adhesive 
vs. adhesive hydrogels. In this thesis, we have focused on studying cryopreservation 
effects on two model pancreatic substitutes: murine βTC-tet insulinoma cells 
encapsulated in unmodified alginate and C2C12 cells, stably transfected to secrete 
insulin, encapsulated in partially oxidized, RGD-modified alginate. βTC-tet cells 
encapsulated in unmodified alginate were chosen as a model pancreatic substitute in a 
non-adhesive matrix, as these cells have been shown to proliferate and function in a non-
adhesive environment. Stable C2C12 cells encapsulated in RGD-alginate were chosen as 
the model pancreatic substitute in an adhesive matrix, as C2C12 cells have been well-
characterized in RGD-alginate, showing the ability to proliferate and differentiate in 3-D. 
In the first part of this thesis, we studied the effects of cryopreservation on the 
intermediary metabolism of encapsulated βTC-tet cells by 13C nuclear magnetic 
resonance (NMR) and isotopomer analysis, as well as the effects of cryopreservation on 
insulin secretory function. In order to use the 13C NMR and isotopomer analysis method, 
we first developed the appropriate parameters and procedures for 13C labeling, extraction, 
and isotopomer analysis from Fresh and Cryopreserved encapsulated βTC-tet cells. After 
the appropriate parameters and procedures were determined, relative metabolic fluxes in 
the tricarboxylic acid (TCA) cycle were measured from Fresh, Frozen and DPS-vitrified 
encapsulated cells. It was found that intermediary metabolism was maintained, as 
measured by 13C NMR and isotopomer analysis, in cryopreserved encapsulated βTC-tet 
cells. Although insulin secretory function was maintained in the Conventionally Frozen 
group, it was impaired in the DPS-vitrified group. Small-scale glucose-stimulated and 
K+-induced depolarization experiments also indicated impaired secretion from the DPS-
 xx
vitrified group, but not from the Frozen encapsulated cells. Similar stimulation indices 
between glucose-stimulated and depolarization-induced secretion tests post-warming, 
similar intracellular insulin content to Fresh controls, and impaired depolarization-
induced secretion compared to Fresh controls, indicate a possible defect in late-stage 
insulin secretion for the DPS-vitrified group. 
In the second part of this thesis, we investigated the effect of cell-matrix 
interactions on cellular response to cryopreservation by assessing metabolic activity and 
insulin secretion in Cryopreserved Stable C2C12 cells encapsulated in RGD and RGE-
alginate hydrogels up to one day post-warming. In addition, to address the longer-term 
cellular response to cryopreservation of cells encapsulated in an adhesive hydrogel 
environment, Stable C2C12 cells were encapsulated in RGD-alginate hydrogels, cultured 
for 1 or 4 days, cryopreserved, and assayed up to 3 days post-warming for insulin 
secretion and metabolic activity. As cell spreading has been associated with myoblast 
differentiation and fusion into myotubes in RGD-alginate, cell circularity in the beads 
was also measured one day post-warming. Results indicate that the presence of cell-
matrix interactions did not affect cellular response in terms of metabolic activity or 
insulin secretion up to one day post-warming. Additionally, irrespective of culture time 
pre-preservation, metabolic activity, insulin secretion rate, and cell morphology were 
maintained in Frozen, RGD-alginate encapsulated Stable C2C12 cells. Similarly, 
although there were differences immediately post-warming, overall, metabolic activity, 
insulin secretion, and cell morphology were maintained in DPS-vitrified, RGD-alginate 
encapsulated cells.  
 xxi
In conclusion, the work in this thesis presents a systematic comparison of the two 
cryopreservation methods, conventional freezing and vitrification, on the in vitro cellular 
aspects of insulin-secreting cells encapsulated in an adhesive vs. non-adhesive alginate 
environment. Results on cryopreservation effects on intermediary metabolism in 
encapsulated βTC-tet cells offer insight into the effects of cryopreservation on cellular 
bioenergetics, indicating that relative carbon flow through the TCA cycle pathways 
examined is unaffected by cryopreservation. Additionally, DPS-vitrification led to 
impaired insulin secretion from encapsulated βTC-tet cells, possibly due to a defect in 
late-stage insulin secretion. The results from Stable C2C12 cells encapsulated in RGD vs. 
RGE-alginate indicate that up to one day post-warming, cell-matrix interactions do not 
affect cellular response for these cells after vitrification or freezing. Although there are 
transient differences from the Fresh control in terms of metabolic activity and insulin for 
DPS-vitrified RGD-encapsulated Stable C2C12 cells, metabolic activity and insulin 
secretion are maintained at all time points assayed for Frozen constructs. Overall, due to 
results comparable to Fresh controls and simplicity of procedure, conventional freezing is 
appropriate for cryopreservation of βTC-tet cells encapsulated in unmodified alginate or 









 Approximately 18.8 million people in the United States have been diagnosed with 
diabetes, with approximately 5 million patients suffering from insulin-dependent diabetes 
(IDD) [1]. Both patients with Type I diabetes as well as some with Type 2 diabetes are 
insulin-dependent. Current treatments for insulin-dependent diabetes (IDD), including 
daily glucose monitoring and insulin delivery via injections or insulin pumps, do not 
provide tight glycemic control. This inability to tightly control blood glucose levels often 
leads to various secondary complications, such as kidney disease, blindness, heart 
disease, and stroke [1].  
Although the “Edmonton Protocol,” based on intrahepatic human islet 
transplantation with the use of steroid-free immunosuppression, is a promising approach 
to the treatment of IDD, the shortage of donor islets and the need for life-long 
immunosuppression prevent the wide-spread application of this treatment [2]. A tissue 
engineered pancreatic substitute (TEPS) based on microencapsulation of xenogeneic 
islets or other insulin-secreting cells in an immunoprotective barrier has the potential to 
provide more physiologic and less invasive blood glucose control than exogenous 
insulin-based treatments for IDD, while potentially relaxing the limitations due to tissue 
availability and immunosuppression [3]. 
Long-term storage is essential for clinical realization of a tissue engineered 
pancreatic substitute, and cryopreservation is the most promising means to achieve this 
goal (Figure 1.1). The two main methods that may be employed for cryopreservation are 
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conventional freezing and vitrification. Conventional freezing leads to the formation of 
extracellular ice, which although not necessarily detrimental to cells in suspension, can be 
damaging to natural tissues as well as 3-D tissue engineered constructs [4, 5]. During 
vitrification, however, a glass is formed instead of ice, thereby preventing damage 
associated with ice formation. However, vitrification can be damaging to the cells in a 
construct due to cytotoxicity and potential osmotic excursions that may occur due to the 
high concentration of cryoprotectants used in the procedure [5, 6]. As conventional 
freezing and vitrification have their associated drawbacks, both cryopreservation methods 
must be evaluated in order to determine the optimal cryopreservation method for a 
pancreatic substitute. 
 
Figure 1.1 Role of cryopreservation in tissue engineering  Adapted from Life in  the 
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It is currently unclear what cell type will be most appropriate for an encapsulated 
cell therapy for treatment of IDD, and indeed different types of insulin-secreting cells 
may exhibit quite different requirements for cell adhesion in 3-D.  Although pancreatic 
substitutes often consist of cells encapsulated in unmodified alginate hydrogels [8, 9], 
studies have suggested that pancreatic substitutes may benefit from an adhesive 3-D 
environment [10-12]. For anchorage-dependent cells, adhesion to the matrix is important 
for various cellular processes, including cell signaling, differentiation, and proliferation 
[13]. The added complexity of cell-matrix interactions between cells and the matrix may 
affect the outcome of the cryopreservation procedure, as compared with cells that are 
essentially suspended within a hydrogel matrix, as evidence in the cryopreservation 
literature indicates that adhesion has affects cryopreservation outcome [14-17]. Thus, in 
order to gain a fundamental understanding of the effects of cryopreservation on systems 
of encapsulated insulin-secreting cells as a whole, it is important to study the effects of 
cryopreservation on both cells encapsulated in an adhesive hydrogel matrix as well as 
cells encapsulated in a non-adhesive hydrogel matrix. Two model pancreatic substitutes 
that can be used to study this are βTC-tet cells encapsulated in unmodified alginate and 
C2C12 cells, stably transfected to secrete insulin, encapsulated in adhesive alginate 
(Figure 1.2). Murine insulinoma βTC-tet cells were used as the model pancreatic 
substitute in a non-adhesive environment, as they have been shown to proliferate and 
function well in a non-adhesive alginate system [18, 19]. On the other hand, C2C12 cells 
have been well-characterized in an adhesive (RGD-alginate) based system, and have been 
shown to proliferate and differentiate in this 3-D adhesive environment [20]. Thus, 
C2C12 cells, stably transfected to secrete insulin [21] and encapsulated in partially 
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oxidized, RGD-modified alginate, were studied as the model pancreatic substitute in a 3-
D adhesive alginate system. Hence, the overall goal of this thesis was to investigate 
cryopreservation effects on model pancreatic substitutes consisting of cells encapsulated 
in non-adhesive and adhesive 3-D alginate hydrogels. 
To address this overall goal, the first specific aim is to evaluate the effects of 
cryopreservation on intermediary metabolism and secretory function in βTC-tet cells 
encapsulated in unmodified alginate. As cryopreservation effects on cell viability  and 
function in encapsulated beta cells [22, 23]  have already been evaluated, and recent 
studies have indicated impairment in insulin secretion post-warming from encapsulated 
islets [24, 25] and beta cells [22], it is important to understand how fundamental aspects 
of glucose-stimulated insulin secretion, such as intermediary metabolism, are affected by 
cryopreservation. The hypothesis of this aim is that cryopreservation produces a 
significant change in the intermediary metabolism of encapsulated, insulin-secreting cells 
that survive the cryopreservation procedure. 
  The second specific aim of this thesis is to examine the effects of 
cryopreservation on cell survival and function in recombinant C2C12 cells encapsulated 
in adhesive alginate. Previous literature has suggested adhesion affects cell response to 
cryopreservation in various ways [16, 17, 26, 27], with some studies indicating an 
increased likelihood of cryoinjury due to adhesion [26, 27], and others indicating benefits 
to cryopreservation of attached cells compared to cells cryopreserved in suspension [17] 
or in non-adhesive matrices [16]. For example, adhesion has been shown to increase the 
likelihood of intracellular ice formation for cells cryopreserved while attached in 2-D 
compared to cells cryopreserved in suspension [26, 27]. However, studies have also 
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indicated benefits to adhesion in 3-D in terms of increased viability compared to cells 
cryopreserved in suspension or in a non-adhesive matrix [16]. Thus, although perhaps 
conflicting with respect to cryopreservation outcome, evidence in the literature points to 
adhesion affecting cryopreservation response. The hypothesis of this aim is that the 
presence of cell-matrix interactions between insulin-secreting cells and the matrix will 
affect cellular response to cryopreservation in terms of cell survival and function.  
 
Figure 1.2 Model pancreatic substitutes studied in this thesis. A). βTC-tet cells 
encapsulated in unmodified alginate and B). Stably transfected C2C12 cells encapsulated 
in RGD-modified oxidized alginate.  
 
 
An important first step in setting up a vitrification protocol for encapsulated cells 
is choosing the appropriate cryoprotectant solution for vitrification. In order to determine 
the appropriate cryoprotectant solution for vitrification of encapsulated βTC-tet cells, pre-
developed cryoprotectant cocktails were added and removed from encapsulated βTC-tet 
cells. A previously developed math model was used to develop addition/removal 
protocols for the solutions [28]. The results of the cryoprotectant addition/removal study 
as well as initial vitrification studies are found in APPENDIX A. 
Cryopreservation is critical for clinical translation of a TEPS, but recent studies 

















warming [22, 24, 25]. Although decreased cell viability may be an important factor in 
this reduced secretion, the state of the viable cells may also be impaired. In terms of cell 
function, however, previous studies on cryopreserved pancreatic substitutes have only 
examined insulin secretion post-warming [25, 29, 30]. Investigating fundamental 
processes in glucose-stimulated insulin secretion is important for gaining an in-depth 
understanding of the sublethal effects of cryopreservation on encapsulated beta cells or 
islets, as well as understanding possible cryopreservation-induced secretion defects. 
Studying intermediary metabolism is particularly important, as it is key to glucose-
stimulated insulin secretion in beta cells [31-33]. One powerful method that has been 
employed to study intermediary metabolism in beta cells is 13C nuclear magnetic 
resonance (NMR) and isotopomer analysis [34-36]. However, various parameters or 
procedures must be determined or optimized prior to using the 13C NMR and isotopomer 
analysis method on the particular cells or tissue of interest. CHAPTER 4 addresses these 
issues, describing the development and optimization of parameters for 13C labeling, 
extraction, and NMR isotopomer analysis for both Fresh and Cryopreserved encapsulated 
cells. In particular, the development of the perchloric acid extraction procedure, 
determination of isotopomer steady state, test of incubation medium on cryopreserved 
encapsulated cells, as well as determination of the appropriate model of glucose 
metabolism to use with tcaCALC are discussed. Using the optimized parameters and 
procedures developed in CHAPTER 4, the effects of cryopreservation on intermediary 
metabolism in encapsulated βTC-tet cells were investigated and are discussed in 
CHAPTER 5. In addition, insulin secretory response to both glucose stimulation and K+-
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induced depolarization after cryopreservation were studied and discussed in CHAPTER 
5.  
Although cryopreservation effects on viability and/or function of cells 
encapsulated in non-adhesive hydrogels have been studied [24, 25, 30, 37-44], not many 
studies have focused on similar effects on cells encapsulated in adhesive hydrogels [16, 
45-47]. Studying cellular response after cryopreservation in an adhesive environment is 
especially important with respect to a TEPS, as studies have indicated the importance of 
adhesion in 3-D for encapsulated beta cells or islets [10-12]. Additionally, as different 
cell types, such as genetically engineered non-beta cells [48] and stem cells [48, 49] are 
being investigated for cell-based therapies for IDD, such cells may have different 
requirements for anchorage dependence in 3-D. The few studies on cells encapsulated in 
adhesive hydrogels have examined cryopreservation response after either conventional 
freezing [16, 45] or vitrification [50, 51], and have not compared the two. In CHAPTER 
6 of this thesis, Stable C2C12 cells encapsulated in RGD and RGE-alginate hydrogels 
were cryopreserved and directly compared up to one day post-warming in order to 
investigate the effect of cell-matrix interactions on cryopreservation response in terms of 
metabolic activity and insulin secretion. Additionally, to address the longer-term response 
post-warming of Stable C2C12 cells encapsulated in an adhesive 3-D environment, 
Stable C2C12 cells were encapsulated in RGD-alginate hydrogels, cultured either 1 or 4 
days post-encapsulation, cryopreserved, and assessed up to 3 days post-warming. As 
myoblast spreading in partially oxidized, RGD-modified hydrogels has been associated 
with myoblast differentiation and fusion into myotubes [20], and myoblast differentiation 
would be optimal for a pancreatic substitute prior to in vivo implantation, cell circularity 
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in beads was also assessed after cryopreservation. Additionally, intermediary metabolism 
was not studied from cryopreserved encapsulated Stable C2C12 cells as these cells do not 
possess the tight glucose stimulus-secretion coupling, of which intermediary metabolism 
is a  key component, that is present in beta cells. 
 Finally, the conclusions and future directions from these studies are discussed in 
























 This thesis presents a systematic comparison of the in vitro effects of the two 
main cryopreservation methods that may be applied when preserving a tissue engineered  
construct. This is significant as cryopreservation studies in the literature often vary 
between cryopreservation method used, type of cell or construct cryopreserved, and 
method of analysis to evaluate cell function. Thus, it is often difficult to gain a 
fundamental understanding of the effects of different cryopreservation treatments on a 
particular system.  
Specifically, work in this thesis investigates the effects of both conventional 
freezing and vitrification on different cellular aspects of pancreatic substitutes consisting 
of insulin-secreting cells encapsulated in adhesive and non-adhesive alginate matrices.  
With respect to a pancreatic substitute consisting of βTC-tet cells encapsulated in alginate 
hydrogels, our findings offer new insight into the effects of the two cryopreservation 
methods on cellular bioenergetics, with respect to TCA cycle pathways that have been 
shown to be key to insulin secretion [34-36]. Specifically, work in this thesis offers 
insight into understanding components of the insulin secretory pathway that are 
maintained after cryopreservation as well as those that should be investigated further to 
better understand compromised secretion from encapsulated beta cells post-warming. 
This work is novel, as past studies have examined viability and/or insulin secretion post-
warming in cryopreserved pancreatic substitutes [24, 25, 29, 30, 37, 52, 53] but none 
have evaluated fundamental aspects of glucose-stimulated insulin secretion in the 
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remaining viable cells, which are critical for proper construct function post-warming. In a 
broader sense, this work is significant as it offers insight into the effects of different 
cryopreservation procedures (i.e. conventional freezing vs. vitrification) on detailed 
cellular bioenergetics in a cryopreserved tissue engineered construct, for which 
information is current lacking in the scientific literature. By elucidating metabolic 
pathways that are affected by cryopreservation, and how they relate to cell function, 
cryopreservation protocols can be tailored to better maintain cell function in constructs 
post-warming. 
With respect to a pancreatic substitute containing insulin-secreting cells in an 
adhesive matrix, this work is novel, as there exist no reported studies on the effects of 
both vitrification and freezing on cells encapsulated in a 3-D adhesive alginate 
environment. In addition, the studies in this thesis are unique as they address the effects 
of cell-matrix interactions on cryopreservation response by encapsulating stably 
transfected, insulin-secreting myoblasts in adhesive, RGD-alginate vs. cells encapsulated 
in non-adhesive, RGE-alginate, which has also not been studied previously using both 
cryopreservation methods. Also, no studies have addressed the longer-term cellular 
response to both methods of cryopreservation in an adhesive alginate hydrogel 
environment up to a few days post-warming. This particular work is significant, as it 
adds to the fundamental knowledge of the effects of different cryopreservation methods 
on cell viability and function in an adhesive hydrogel environment, which is particularly 
important as more studies in the literature are utilizing biomimetic hydrogels with the 
addition of adhesive motifs. Overall, studying the effects of cryopreservation on cells 
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with the added complexity of adhesion in 3-D provides a means to examine how 






3.1        Diabetes 
3.1.1    Type I and Type II Diabetes 
Diabetes mellitus is a serious disease that results in elevated blood glucose levels. 
According to the Centers for Disease Control and Prevention, approximately 18.8 million 
people in the United States have been diagnosed with diabetes, with  approximately 5-
10% of diagnosed adults suffering from Type 1 diabetes [54].  Patients with Type I 
diabetes as well as some with Type 2 diabetes are insulin-dependent. Type 1 diabetes is 
caused by an autoimmune attack which destroys the insulin-producing beta cells of the 
islets of Langerhans in the pancreas. Type II diabetes is characterized by insulin 
resistance and a reduction in insulin production by beta cells in the pancreas. Although 
Type II diabetes can be initially controlled with proper diet and exercise [55] as well as 
by taking oral medications, some patients do become insulin-dependent over time. 
 
3.1.2    Secondary Complications of Diabetes 
Current treatments for insulin-dependent diabetes (IDD), including daily glucose 
monitoring and insulin delivery via daily injections or insulin pumps, do not provide tight 
glycemic control. This inability to tightly control blood glucose levels often leads to 
various secondary complications, such as kidney disease, blindness, heart disease, and 
stroke [54]. The secondary complications associated with diabetes are often caused by 
chronic hyperglycemia that can lead to tissue damage [56]. Specifically, microvascular 
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complications are one of the major causes of morbidity and mortality in patients with 
IDD [57]. One of the mechanisms of vascular damage is proposed to be through the 
production of advanced glycated end products (AGEs), which form due to reducing 
sugars binding to amine groups on proteins, lipids, or nucleic acids. Since advanced 
glycation of molecules occurs over a prolonged period of time, proteins with a low 
turnover rate, such as extracellular matrix molecules, are quite susceptible to advanced 
glycation [56]. In particular, collagen and elastin in blood vessels become increasingly 
cross-linked due to AGE formation, leading to an increase in blood vessel stiffness [58, 
59]. This change in blood vessel compliance can lead to vascular dysfunction [60].  
 
3.1.3    Current Treatments for Diabetes 
3.1.3.1 Exogenous Insulin Therapy 
Exogenous insulin therapy involves monitoring blood glucose levels daily with 
insulin delivery via either insulin injections or pumps. Insulin pumps are currently used 
by approximately 20-25% of patients in the United States that suffer from Type 1 
Diabetes [61], with studies indicating better and less variable control of blood glucose 
levels compared to daily insulin injections [62, 63]. However, insulin pumps can be 
cumbersome and lead to possible infections at the insertion site in the skin [64]. Another 
major disadvantage of current insulin pumps is that they operate on an “open-loop” 
system, where there is no automatic feedback control to deliver the appropriate amount of 
insulin based on monitoring of real-time blood glucose levels.  
The Diabetes Control and Complications Trial indicated that intensive insulin 
therapy via injections or pumps can delay the onset and progression of secondary 
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complications associated with diabetes [57]. However, intensive insulin therapy was 
found to increase the likelihood of hypoglycemic episodes in patients [57]. Although 
intense exogenous insulin therapy may reduce the progression of secondary 
complications of diabetes, it does not necessarily lead to their prevention. Thus, a more 
physiologic treatment is desired to better control blood glucose levels. 
 
3.1.3.2 Whole Pancreas and Islet Transplantation 
Current clinical cell-based therapies provide more physiologic glycemic control 
compared to exogenous insulin therapy. Whole pancreas transplantation leads to the 
reduction or elimination of the progression of secondary complications, and decrease in 
hypoglycemic episodes compared to exogenous insulin therapy [65]. However, issues 
persist with the requirement of immunosuppression, greater surgical complications 
compared with other organ transplant procedures [65], and increased risk of cardiac 
morbidity [66]. Islet transplantation represents a less invasive endocrine cell therapy 
compared to whole pancreas transplantation, and has been associated with less severe 
complications compared to whole pancreas transplantation [67]. Researchers at the 
University of Alberta at Edmonton found that hepatic portal vein transplantation of islets 
in combination with a glucocorticoid-free immunosuppressive regime led to insulin 
independence in all patients that received treatment [68]. However, after five years only 
10% of patients remained insulin-independent [69], and issues remain with islet survival 




3.2      Tissue Engineered Pancreatic Substitutes 
Tissue engineered pancreatic substitutes have the potential to provide more 
physiologic and less invasive blood glucose control than current treatments for IDD [3, 
70]. Additionally, tissue engineering approaches have the potential to overcome the 
limitations of the Edmonton protocol in terms of islet availability by using non-human 
tissue and immune rejection by encapsulation. Various tissue-engineered pancreatic 
substitutes have been studied, with most involving encapsulation of pancreatic beta cells 
or islets in an immunoprotective barrier. Microencapsulation of cells in particular is 
advantageous because it creates constructs with a high surface-to-volume ratio and thus 
good mass transfer properties [71-73].  In addition, microcapsules are often only a few 
hundred microns to 1 mm in diameter, and thus easier to handle as well as implant in vivo 
[72]. 
One of the most common encapsulation systems consists of encapsulating cells in 
calcium alginate-poly-L-lysine-alginate (APA) beads [74]. Encapsulating cells in a 
hydrogel with a semi-permeable membrane may reduce the need for immunosuppressive 
therapy [73].The poly-L-lysine layer serves as a semipermeable membrane to prevent the 
entry of large molecules, such as antibodies, while allowing for the diffusion of nutrients 
and metabolites such as glucose and insulin [75].  In diabetic small animal studies, 
implantation of islets [75-78] or beta cells [79, 80] encapsulated in APA beads has led to 
restoration of normoglycemia.  However, the poly-L-lysine layer may contribute to fibrotic 
overgrowth [81, 82] and an increase in cytokine expression [81-83] upon implantation of 
APA beads in vivo. Thus, studies of alginate encapsulation systems without the use of the 
poly-L-lysine layer have also been conducted. In particular, alginate-only beads crosslinked 
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with barium ions and containing islets have also been used to successfully treat the diabetic 
state in animal models [84-87].  
 
3.3        Alginate 
   3.3.1    Alginate Material Properties 
Hydrogels are ideal for cell encapsulation, as they are hydrophilic and have 
minimal protein adsorption and cell adhesion, leading to greater biocompatibility. In 
addition, they are permeable to nutrients and metabolites [71]. Alginates are the most 
often used hydrogels for cell encapsulation, as they are readily available, gel easily, and 
are biocompatible [74]. Alginates are natural polysaccharides derived from seaweed or 
bacteria and consist of block copolymers of 1-4-linked β-D mannuronic acid (M) and α-
L-guluronic acid (G) in the form of M, G or MG blocks [88]. Divalent cations, such as 
Ca2+, Ba2+ and Sr2+, bind to the G residues via ionic interactions to crosslink the alginate 
in a 3-D conformation described by the “egg box model” (Figure 3.1). In this model, the 
chains of guluronic acid residues represent the corrugated cardboard in an egg box, and 
the divalent cations represent the eggs in the box [89].  
 
Alginate chain Divalent cation
 
Figure 3.1 The “egg box model.” Adapted from Grant et al. [89] 
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Alginate gels high in guluronic acid content tend to form gels with higher 
mechanical strength, porosity, and greater resistance to shrinking or swelling [88]. In 
addition, the alginate gel strength increases with the length of the G blocks and the 
concentration of the alginate [90]. 
The chemical composition (i.e. ratio of guluronic to mannuronic acid) of the 
alginate itself can affect the growth and functional characteristics of the cells 
encapsulated within it. βTC3 cells encapsulated in high mannuronic acid alginate have 
been shown to have greater proliferative capacity than cells encapsulated in high 
guluronic acid alginate. Specifically, βTC3 cells encapsulated in APA beads using high G 
alginate were shown to have an initial decline in growth, metabolic, and secretory 
activities, which reversed and started to increase after a few weeks in culture [91, 92]. 
Cells encapsulated in high M alginate, however, showed an increase in these properties 
from the beginning of the culture period [91, 92]. This has been attributed to a weaker 
alginate gel network in the lower G alginates [92].  Interestingly, βTC3 cells encapsulated 
in high G alginate without the poly-L-lysine layer did not experience any decline in 
growth unless regular CaCl2 washes were performed to maintain the integrity of the 
calcium alginate crosslinking [93]. This discrepancy between APA beads and alginate-
only beads may be due to the poly-L-lysine layer serving as a barrier to slow down the 
diffusion of calcium ions from the alginate, thus maintaining the integrity of the alginate 





3.3.2    RGD-Alginate 
Although alginates are widely used in encapsulation, they lack intrinsic cell-
binding motifs. Even though some cell types are able to function in unmodified alginate 
hydrogels, other cells may require adhesion for better survival and proliferation [95]. In 
the context of a tissue engineered pancreatic substitute, it has been shown that some cell 
types benefit from adhesion to their matrix for cell survival and function [11, 12, 96]. 
Specifically, when cultured in PEG hydrogels with extracellular matrix (ECM) molecules 
such as collagen, fibrinogen, or laminin, encapsulated MIN6 cells exhibited higher 
viability than cells encapsulated in hydrogels without ECM proteins. Culturing in 
hydrogels containing collagen Type IV or laminin  in particular resulted in higher insulin 
secretion compared to culturing in hydrogels with other ECM molecules or no ECM 
molecules [11]. Similarly, murine islets encapsulated in PEG hydrogels containing 
collagen type IV, laminin, or the laminin peptide IKVAV exhibited higher insulin 
secretion compared to islets encapsulated in gels without any additional ECM proteins or 
peptides, respectively [10]. MIN6 cells were shown to better maintain viability, exhibit a 
lower level of apoptosis, and secrete more insulin when encapsulated in laminin-peptide 
(i.e. IKLLI and IKVAV) functionalized as opposed to unmodified PEG hydrogels [12].  
One way to allow for cell adhesion in an alginate matrix is to chemically modify 
the alginate chains with adhesive motifs. In particular, alginates have been covalently 
modified with the arginine-glycine-aspartic acid (RGD) peptide using aqueous 
carbodiimide chemistry to promote cell adhesion [97-102]. In this procedure, an amide 
bond is formed between the N-terminal amine on the RGD peptide and the carboxyl 
group on the uronate residue in the alginate chain (Figure 3.2) [98]. Hydrogels containing 
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the RGD adhesive peptide motif in particular have been used for encapsulation of a 
variety of cell types, including myoblasts [20, 103], bone marrow stromal cells [101], 
pre-osteoblasts [103], and human embryonic stem cells [104]. The RGD peptide, 
originally discovered in fibronectin [105], and found in other extracellular matrix (ECM) 
molecules, including vitronectin and laminin, has been widely used as an adhesive motif 
for cells [106]. Integrins containing the α4, α5, α8, αIIb, and αv subunits bind to the RGD 
sequence in ECM molecules [107]. In particular, the C2C12 murine myoblast cell line 
has been well characterized in RGD-alginate, displaying the ability to survive, proliferate, 
and differentiate on 2-D [99]  as well as in 3-D hydrogel systems [20].  
 
 
Figure 3.2 RGD conjugation to alginate via carbodiimide chemistry. Adapted from [98, 
108]. The 1-Ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride (EDC) forms 
an O-acylisourea intermediate which is stabilized by N-hydroxysulfosuccinimide (sulfo-
NHS). An amide bond is then formed between the N-terminal amine on the RGD peptide 




3.3.3    Oxidized Alginate 
Controlling the mechanical environment of encapsulated cells in alginate is 
important, as cellular behavior, such as proliferation and differentiation, can change with 
different mechanical properties of the 3-D environment [100, 109]. Specifically, a weaker 
and and/or degradable gel may be desirable for the spreading of adherent cells in 3-D, as 
they are more likely to migrate or spread if they have less resistance from the matrix 
[110]. Spread cells in hydrogels also mimic the tissue environment found in vivo. 
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However, since alginate is a natural polymer, the ability to fine tune its mechanical 
properties is limited. In addition, alginate hydrogels naturally degrade by a slow and 
poorly controlled process, occurring via loss of divalent cations to chelating compounds 
such as lactate and phosphate [88]. Degradable alginates created via sodium periodate 
oxidation can address the above issues by creating weaker alginate gels with more 
controlled degradation kinetics compared to native alginates. In these oxidized alginates, 
the carbon-carbon bond of the cis-diol group on the uronate residue is cleaved, converting 
the chair conformation to an open-chain adduct, with the formation of aldehyde groups at 
the oxidized carbon residues (Figure 3.3) [111]. The aldehyde groups then react with the 
hydroxyl groups on the two adjacent uronate residues to spontaneously form a six-
membered hemiacetal ring [112].The open adduct formation allows for new rotation 
around 3 bonds (between carbon 4 (C4), C5, the original ring-oxygen atom, and C1 of the 
oxidized residue) [113]. This creates bonds that are susceptible to hydrolysis. The open-
chain adduct can no longer participate well in crosslinking with divalent cations, so the 
extent of crosslinking in the oxidized alginates is lower compared to non-oxidized 
alginates. These weaker alginate gels also degrade over time, with the rate of degradation 
being controlled by percent oxidation of the alginate [111, 114] as well as pH and 
temperature [114, 115] .  
 
Figure 3.3 Sodium periodate oxidation of alginate. Figure adapted from [111]. During 
the oxidation procedure, the cis-diol group on the uronate residue is cleaved to form an 
open-chain adduct. The resulting alginate is susceptible to hydrolysis. 
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Oxidized alginates have been used in a variety of applications, including tissue 
engineering and delivery of growth factors [114, 116, 117]. With respect to cell delivery 
and tissue engineering, the oxidized alginate serves as a carrier to keep the cells in place 
while allowing for natural production of extracellular matrix and tissue formation from 
the encapsulated cells with degradation of the alginate hydrogel over time [114, 116]. In 
particular, oxidized alginates were first reported to be used to deliver encapsulated 
chondrocytes in vivo, and were shown to degrade in vivo with concurrent replacement of 
the alginate matrix with cell-derived matrix to help promote cartilage formation [114].  
Additionally, oxidized alginates have been used as cell carriers to deliver human adipose 
stem cells in vivo to help promote new adipose tissue formation [116]. With respect to 
growth factor delivery, oxidized alginate gels have been used to successfully release 
VEGF in a hind limb ischemia model to promote angiogenesis [117].  
 
3.4       Cell Sources for Pancreatic Substitutes 
3.4.1    Islets 
Although human islets represent an appropriate cell source for an encapsulated 
cell therapy, donor islet supply is limited. Thus, studies have looked into using 
xenogeneic islets, in particular porcine islets, as a cell source for treatment of IDD [48]. 
Porcine islets are advantageous as porcine insulin is similar to human insulin, and high 
yields of porcine islets can be obtained after isolation [48]. Indeed, studies have 
successfully shown reversal of hyperglycemia by implantation of encapsulated adult 
porcine islets in diabetic mouse models [118, 119]. Although reversal of diabetes in 
monkeys after implantation of porcine islets encapsulated in alginate-poly-L-lysine was 
reported [120], these results have not been reported to be reproduced. Additionally, 
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concerns persist regarding transfer of porcine endogenous retrovirus (PERV) from 
porcine islets to humans, as PERV has been shown to infect human cells in vitro as well 
as mouse tissue in vivo [121]. However, a study with transplantation of porcine fetal islets 
into diabetic patients detected no PERV infection in any patient up to 4-7 years post-
transplant [122].   
 
3.4.2 Stem Cells  
Although beta-like cells derived from the differentiation of  embryonic stem cells 
represent a promising, renewable beta cell source, issues still exist with differentiation of 
embryonic stem cells towards a true beta cell phenotype [49]. In particular, for human 
embryonic stem cell differentiation, studies have indicated that the resulting cells lack 
glucose-responsiveness in vitro [123, 124], with in vivo culture required to produce 
glucose-responsive cells [124]. Additionally, concerns arise over the possibility of tumor 
formation after implantation of embryonic stem cells [125]. Studies examining the use of 
induced pluripotent stem (iPS) cells to create insulin-secreting cells are forthcoming, but 
have resulted in questionable findings [49, 126], and low efficiency of differentiation of 
iPS cells into pancreatic beta cells [127]. Studies are also investigating differentiation of 
pancreatic progenitor cells as well as other adult stem cells such as bone-marrow derived  
mesenchymal stem cells into pancreatic beta cells [125]. Overall, although studies with 
stem cells differentiated towards a beta cell phenotype are forthcoming, issues still 
remain with determining the appropriate conditions for and creating cells that exhibit the 




3.4.3    Transdifferentiation of Non-Beta Cells  
Another area that has been examined for cell-based therapy for IDD is the 
transdifferentiation of non-beta cells into beta-like insulin-producing cells. Specifically, 
liver cells have been transdifferentiated towards a beta cell phenotype [128, 129]. In 
particular, Sapir et al. [128] transduced human and fetal liver cells with the PDX-1 gene 
and were able to obtain cells that were glucose responsive as well as had the ability to 
reverse hyperglycemia when implanted in diabetic mice, although blood glucose levels 
were higher than in healthy mice. This may have been caused by only a fraction of the 
implanted cells actually containing proinsulin [128]. Similarly, Zalzman et al. [129] were 
able to restore noromoglycemia in diabetic mice by implanting liver cells that had been 
incubated in serum-free medium with growth factors in order to differentiate cells into a 
more beta cell-like phenotype. However the cells had an insulin content of only 60% that 
of human pancreatic islets [129]. Thus, work still remains on obtaining transdifferentiated 
cells that exhibit beta cell-like phenotypes. 
 
3.4.4    Cell Lines 
 
3.4.4.1 Beta Cell lines 
A promising alternative cell source for a pancreatic substitute, especially for use 
with animal models of diabetes, is cultured beta cells that have been immortalized via 
oncogene expression [130]. Using these cell lines allows for large amounts of cells to be 
grown in culture prior to incorporation into a construct and in vitro or in vivo study [130]. 
Human beta cell lines, however, generally tend to lose their differentiated function over 
time due to loss of expression of transcription factors for the insulin gene[130]. Mouse 
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beta cell lines are better to use for long-term culture because they retain telomerase 
activity and differentiated functions longer than human beta cell lines [130].  
In order for a cell line to possibly be used in vivo, it is important that its growth be 
regulated so as to not form tumors once implanted. Although the βTC3 mouse insulinoma 
cell line has been used for various studies on a bioartificial pancreas [91-93, 131-136], its 
potential use in vivo is limited as its growth cannot be regulated [137]. The βTC-tet 
murine insulinoma line, derived from tumors of double transgenic C3HeB/FeJ mice, has 
been genetically engineered to express the simian virus 40 (SV40) large tumor antigen 
(TAg) oncoprotein under the control of the bacterial tetracycline (tet) operon. These cells 
have been genetically engineered to respond to the “tet off’ system, whereby proliferation 
is stopped in the presence of tetracycline [138]. This growth arrest is reversible, as 
removal of tetracycline leads to continuation of proliferation. Encapsulated βTC-tet cells 
have also shown growth regulation in vitro [139] and in vivo [79] in the presence of 
tetracycline. 
 
3.4.4.2 Myoblast Cell Lines 
Autologous, non-beta cells offer an option for cell sourcing without the issue of 
immune rejection, as with allogeneic or xenogeneic cells. This would entail removing 
cells from the patient and genetically engineering them ex vivo before re-implantation, or 
delivering the gene in vivo. Various non-beta cells have been genetically engineered to 
express insulin, including hepatocytes [140, 141], intestinal endocrine cells [142-144], 
myoblasts [21, 145-147], and adipocytes [148]. Although studies with primary cells may 
be more appropriate than cell lines in terms of mimicking a potential autologous cell 
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therapy, cell lines can still be used to gain important fundamental information from in 
vitro as well as in vivo studies with animal models.  
In particular, myoblasts are promising to use, as they can proliferate in culture and 
also exit the cell cycle to terminally differentiate and form myotubes [149].  This is 
important in the context of a tissue engineered construct, as differentiation of myoblasts 
into myotubes would prevent excessive, uncontrolled cell growth in vivo. Unfortunately, 
since myoblasts are non-neuroendocrine cells, they lack the prohormone convertases 
PC1/3 and PC2, and cannot process proinsulin to insulin [147]. However, by genetically 
engineering the proinsulin at the A-chain C-peptide and B-chain C-peptide junctions with 
furin-cleavable basic sequences, the proinsulin can be processed in these cells to insulin 
via the constitutive pathway of secretion by the ubiquitous protease furin [150]. One cell 
line in particular, the murine C2C12 adult skeletal muscle myoblast cell line, has been 
successfully genetically engineered to secrete furin-cleavable insulin [21, 145, 146].  
Although insulin-secreting C2C12 cells have been genetically engineered further 
to exhibit tetracycline-controlled [146] and differentiation-dependent [145] insulin 
production, increasing  the level of insulin secretion/accumulation is still desirable. In 
order to produce a more stable form of insulin [151] that accumulates to a greater extent 
[150], primary myoblasts [147] and C2C12 cells [21] have been genetically engineered 
with furin-cleavable B10 mutated human insulin. Insulin with the histidine-to-aspartic 
acid mutation at the tenth position in the B chain has also been shown to be more active 
than native insulin and has a higher affinity for the insulin receptor [152]. Specifically, 
when transfected with a furin-cleavable B10 human proinsulin construct vs. a furin-
cleavable human proinsulin construct alone, primary rat myoblasts transfected with the 
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former were shown to secrete more proinsulin [147]. Additionally, encapsulated 
myoblasts, genetically engineered to constitutively secrete insulin, would likely serve as a 
basal source of insulin for patients with IDD.  
 Based on the characteristics described above, βTC-tet cells and C2C12 cells, 
stably transfected to secrete insulin in our laboratory [21], were chosen to address the 
objectives in this thesis.   
3.5      Cryopreservation 
3.5.1    Cryoprotectants 
One of the first uses  of cryoprotectants during cryopreservation was described by 
Polge et al., who discovered the benefit of using glycerol in cryopreserving fowl sperm 
[153]. Cryoprotectant (CPAs) are used to decrease the concentration of water inside the 
cell, thereby reducing the likelihood of intracellular ice formation. There are two main 
types of cryoprotectants: permeating and non-permeating. Permeating cryoprotectants 
can enter the cell and include dimethylsulfoxide (DMSO), ethylene glycerol, and 1,2-
propanediol [154]. In addition to reducing the concentration of intracellular water, 
permeating cryoprotectants are also important in decreasing the intracellular 
concentration of solutes, reducing the likelihood of cell injury due to solution effects 
(discussed below). Non-permeating cryoprotectants cannot enter the cell, and include 
sugars such as trehalose and polyvinyl pyrollidone [154]. Non-permeating 
cryoprotectants are important osmotic buffers that prevent the cell from swelling, 
especially during cryoprotectant removal post-thaw [155].  Additionally, trehalose in 
particular is thought to stabilize plasma membranes during cryopreservation of cells 
[156]. 
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3.5.2    Conventional Freezing 
Conventional freezing has been used to successfully cryopreserve cells in 
suspension with high recovery post-thaw [155, 157]. Important variables in conventional 
freezing include the concentration of the cryoprotectant, temperature of CPA addition, 
rate of cooling and warming, as well as the temperature of CPA removal [155]. There are 
two major modes of cell freezing injury during slow freezing that can be described by the 
two factor hypothesis [158]. According to this hypothesis of cell damage, cooling cells at 
too high of a cooling rate leads to intracellular ice formation, which can damage the 
intracellular components of the cell [159]. On the other hand, if cells are cooled too 
slowly, damage by “solution effects” occurs whereby the cell may become dehydrated or 
damaged by the high concentration of intra and extracellular electrolytes. The optimal 
slow cooling rate is dependent on cell type, and is represented by an inverted “U” curve, 
where cooling too fast or too slow leads to low cell viability post-thaw. If conventional 
freezing is done properly, ice will form only in the extracellular milieu with the 
intracellular environment forming a vitreous state [160]. Rapid thawing (e.g. 200oC/min) 
is usually used with slow freezing processes to prevent the growth of any intracellular 
nuclei that may have formed during the cooling process and to prevent a large extent of 
recrystallization of extracellular ice [157]. 
 Although extracellular ice is not damaging to cells in suspension, it can be 
damaging to more complex systems, such as tissues. Ice formation can damage the 3-D 
architecture of the tissue and is thought to be the most serious obstacle when 
cryopreserving more complex multicellular systems [155]. Specifically, conventional 
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freezing has been shown to be unsuccessful for the cryopreservation of various tissues 
such as blood vessels, corneas, and cartilage due to ice formation [161].  
 
3.5.3    Vitrification 
Since ice formation may damage tissue engineered constructs, an alternative “ice-
free” method of cryopreservation is desirable. Vitrification has shown promise in 
preserving various tissue engineered constructs, including encapsulated hepatocytes [51], 
tissue engineered blood vessels [162], and tissue engineered pancreatic substitutes [24, 
29, 30]. Vitrification is the process by which a glassy state is formed when a liquid 
becomes too viscous to flow and becomes a solid without crystallization, or ice 
formation. As the temperature in the system is lowered, molecular motion decreases, 
translational and rotational molecular motion are stopped, and the system is trapped in a 
high energy state [160]. Two important issues related to the cryoprotectants used in the 
vitrification process include the cytotoxicity and potential osmotic excursions that may 
occur due to the high concentration of CPAs necessary to vitrify [5, 6] (usually above 5.5 
M). In addition, osmotic excursions caused by the high concentration of CPAs used can 
be reduced by using multi-step addition and removal protocols [28] as well as osmotic 
buffers to reduce cell swelling [155]. Recently, a model for CPA addition/removal at 
concentrations relevant for vitrification has been developed for beta cells in order to 
reduce osmotic excursions [28]. Temperature is also important when dealing with CPAs, 
as cytotoxicity decreases as the temperature is reduced [155, 163, 164].  
All liquids have the potential to vitrify, given that they are cooled sufficiently 
quickly and that the sample volume is low [165]. The critical cooling rate is defined as 
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the rate of cooling at which the volume fraction in the sample  that is crystallized is less 
than 10-6 [166]. A solution will vitrify if it is cooled at or above its critical cooling rate. 
Once vitrified, the solution exhibits structural properties of a liquid and mechanical 
properties of a solid. The temperature at which this liquid to glass transition occurs is 
known as the glass transition temperature or Tg [165]. During warming, however, if the 
warming rate is not fast enough, existing crystals may grow or new ice nucleation may 
occur. This transition from a glassy to a crystalline state is known as devitrification and 
the growth of existing ice nuclei  is called recrystallization [160]. Thus, the critical 
warming rate, above which ice formation will not occur during the warming process, is 
also very crucial to a successful vitrification procedure. Although it may be possible to 
vitrify tissue systems, achieving the warming rates necessary to avoid ice formation upon 
warming has been quite challenging [160].  
 
3.5.4    Cryopreservation of Microencapsulated Insulin-Secreting Cells 
Studies examining cryopreservation of encapsulated islets or beta cells vary based 
on cryopreservation method used, species, and type of encapsulation matrix. Currently, 
no studies in the literature have examined cryopreservation of encapsulated insulin-
secreting cells other than encapsulated beta cells or islets.  A few studies in particular 
have examined cryopreservation effects on encapsulated beta cell lines [22, 39]. 
Mukherjee et al. reported impaired viability and insulin secretory function after 
conventional freezing of APA encapsulated murine βTC3 cells, with freezing-associated 
damage to the alginate matrix [22]. Another study examining cryopreservation of sodium 
cellulose-sulfate encapsulated hamster HIT-T15 cells found that freezing constructs using 
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a solution containing 1 M glycerol resulted in little cell loss post-warming with recovery 
over a week post-warming [39].  
With respect to cryopreservation of alginate-encapsulated islets, studies have 
examined conventional freezing of encapsulated rat [37, 52, 167], porcine [53], and 
canine islets [168]. In particular, a study examining freezing of APA encapsulated rat 
islets, found that glucose-stimulated insulin secretion in Frozen constructs was similar 
post-warming to Fresh controls, and in vivo transplantation of Cryopreserved 
encapsulated islets successfully restored normoglycemia in all implanted diabetic mice 
for up to 90 days [37]. The study found similar insulin secretion function in vitro and in 
vivo using two methods of conventional freezing: 1). cooling from 4oC to -70oC in an 
isopropyl alcohol bath, followed by plunging into liquid nitrogen [169], and 2). Rajotte’s 
protocol [170], cooling from 4oC to -45oC at 0.2oC/min with ice nucleation at -7.5oC [37].    
However, another study by the same group examining the effects of conventional 
freezing on APA encapsulated porcine islets, found that the two conventional freezing 
methods gave different results in terms of insulin secretory function post-warming [53], 
indicating species-specific responses to freezing of alginate-encapsulated islets. Rajotte’s 
protocol worked best for encapsulated porcine islets compared to using linear cooling 
with an isopropyl alcohol bath; however, only 70% of islet batches were glucose 
responsive post-warming, and after transplantation into diabetic mice, only 60% of mice 
became normoglycemic for 90 days [53]. A more recent study of cryopreservation of rat 
islets encapsulated in barium alginate hydrogels reported success in maintaining glucose-
stimulated insulin secretion post-warming and 80% graft function after transplantation 
into diabetic rats for up to 4 weeks [38]. A longer-term follow-up study with 
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Cryopreserved barium-alginate encapsulated rat islets found maintenance of 
normoglycemia in diabetic rats for greater than 360 days post- transplantation, with 
studies still ongoing [167]. With respect to Cryopreserved encapsulated canine islets, 
Rajotte et al. [168] found that transplantation resulted in restoration of normoglycemia in 
diabetic nude mice. 
Studies by Iwata’s group have explored cryopreservation of hamster islets 
encapsulated in agarose [24, 25].  An in vitro study reported a 45% decrease in insulin 
secretion, with respect to non-preserved controls, after both freezing and vitrification of 
agarose-encapsulated rat islets, with capsule damage after freezing [25]. A follow-up in 
vivo study with vitrified encapsulated islets indicated impairment in insulin secretion 
post-warming, with a requirement of twice the number of Vitrified encapsulated islets to 
maintain normoglycemia for a similar time period to non-preserved controls in addition 
to the use of immunosuppression [24].  
 
3.6       Glucose-Stimulated Insulin Secretion (GSIS) and Mitochondrial Metabolism 
In the consensus model for GSIS, an increase in extracellular glucose 
concentration leads to an increase in glucose consumption, which results in an increase in 
the ATP/ADP ratio, closure of ATP-sensitive K+ (KATP)
 channels, plasma membrane 
depolarization, opening of voltage-gated Ca2+ channels,  increase in intracellular Ca2+, 
and exocytosis of insulin [171-173]. Although this pathway, sometimes referred to as the 
KATP channel-dependent or ‘triggering’ pathway, is widely accepted, it does not explain 
all aspects of GSIS, and evidence has indicated that a KATP channel-independent  or 
“amplifying” pathway is also important [172, 174-176] .  In order to better understand the 
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amplifying pathway of secretion, some studies have focused on the roles of metabolic 
coupling factors generated from the mitochondria on GSIS [32]. Indeed, it has been 
shown that mitochondrial metabolism is important not only for ATP generation, but also 
for the generation of metabolites via anaplerotic pathways for stimulus-secretion coupling 
in the beta cell [33, 177].  Overall, as intermediary metabolism is critical in GSIS, it is 
important to study it after cryopreservation of a pancreatic substitute.  
 
3.7          13C NMR and Isotopomer Analysis 
13C nuclear magnetic resonance (NMR) is a powerful tool to study metabolism. It 
is advantageous for studying metabolism as multiple labeled metabolites can be seen in 
one spectrum, and more information can be gained than with 14C radioisotopic techniques 
[178, 179]. Since the natural abundance of 13C is only 1.1%, it can be introduced into the 
cell as an isotopic tracer, with its path being traced by the labeling patterns found in 




















Figure 3.4 Labeling of metabolites in the cell after introduction of U-13C (uniformly 
labeled-13C) glucose. Metabolites in red have high enough intracellular concentrations to 
be detected by NMR. PC (pyruvate carboxylase); PDH (pyruvate dehydrogenase); ALT 
(alanine aminotransferase) (Adapted from Papas et al.[180]). 
 
  13C NMR and isotopomer analysis have been used to study specific metabolic 
fluxes in the tricarboxylic acid (TCA) cycle [35, 36, 178, 181-185]. The labeled molecule 
analyzed is often glutamate, as it is found in relatively high concentrations in the cell and 
is considered to be in fast exchange with the TCA cycle intermediate α-ketoglutarate 
[179, 186]. The presence of 13C-13C spin-spin coupling between adjacently labeled 
carbons in the glutamate molecule allows for the detection of isotope isomers, called 
isotopomers, in the NMR spectrum [178]. In terms of glutamate labeling, C4 and C5 are 
derived from acetyl-CoA, and C1, C2, and C3 are derived from oxaloacetate from each 
turn of the TCA cycle. Relative areas of the isotopomer patterns of glutamate in the 13C 
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spectrum are analyzed with the tcaCALC modeling program to obtain relative metabolic 
fluxes through specific TCA cycle pathways [179].  
Although early studies using 13C NMR and isotopomer analysis often centered on 
metabolism in the perfused heart [181, 184, 185], more recently, one of the main focuses 
of 13C NMR and isotopomer analysis has been studying glucose metabolism in beta cells 
[35, 36, 182, 183]. Recent studies utilizing 13C NMR and isotopomer analysis have 
specifically highlighted the importance of mitochondrial metabolism in GSIS, by 
correlating certain metabolic fluxes with insulin secretion using specific models in the 
tcaCALC modeling program  [32, 35, 36, 182, 187]. In particular, one study using the 
INS-1 cell line described the dual-pyruvate pool model (Figure 3.5A), where there were 
two independent pyruvate pools present in the cell that did not mix and that pyruvate 
cycling correlated with glucose responsiveness more than oxidation of pyruvate to acetyl-
CoA [182]. Another study examining the role of anaplerotic substrates in the TCA cycle 
of INS-1 cells also found a strong correlation between insulin secretion and flux through 
pyruvate carboxylase (PC), with the addition of anaplerotic substrates leading to an 
increase in pyruvate carboxylase flux [35]. However, more recently, in a study looking at 
four different beta cell lines (INS-1, R7T1, βTC3, and βTC-tet) it has been suggested that 
a modified single pyruvate pool model of mitochondrial metabolism with a second non-
PC anaplerotic entrance (Figure 3.5B) may be more appropriate and better reflect the 
bioenergetics of the beta cell [36, 187]. In particular, a modified single pyruvate pool 
model was used to show that encapsulation of beta cells leads to a decrease in flux 
through glycolysis and pyruvate carboxylase with an increase in flux through a second 
non-PC anaplerotic entrance [183].  These 13C NMR studies form a basis for evaluating 
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the effects of different cryopreservation methods on the intermediary metabolism of 
insulin-secreting cells. 
Figure 3.5 Two models of mitochondrial metabolism in the beta cell that have been 
applied in the tcaCALC modeling program to calculate metabolic fluxes, adapted from 
Simpson et al. [36]. A).a dual pyruvate pool model, B). a modified single pool model 























































DEVELOPMENT OF OPTIMIZED PARAMETERS AND 
PROCEDURES FOR 13C LABELING, EXTRACTION, AND 
ISOTOPOMER ANALYSIS OF FRESH AND CRYOPRESERVED 
ENCAPSULATED βTC-TET CELLS 
 
4.1       Introduction 
13C NMR and isotopomer analysis is a powerful method that can be used to 
measure relative carbon flow into the tricarboxylic acid (TCA) cycle by using metabolic 
models to analyze isotopomer patterns in the 13C NMR spectrum [179, 188, 189]. In 
particular, this method has been applied in as diverse situations as investigating substrate 
selection in the heart [181] and preferred metabolic pathways in the pancreatic beta cell 
[34-36]. Applying the method of 13C NMR and isotopomer analysis to cultured cells or 
tissues, however, involves various key steps, including choosing and/or designing an 
appropriate metabolite extraction procedure that leads to sufficient signal-to-noise ratio 
(SNR) in the NMR spectrum; determining isotopomer steady state [179, 188]; and 
determining the appropriate model of metabolism to use to interpret the 13C NMR-
derived data [187]. In particular, obtaining sufficient SNR in 13C NMR spectra derived 
from cellular extracts can be challenging, as the 13C nucleus is inherently insensitive 
[188, 190]. Therefore, a carefully designed procedure is necessary and must be followed 
closely to reproducibly obtain sufficient SNR. This chapter details the development of the 
methodology for 13C NMR and isotopomer analysis for Fresh and Cryopreserved 
encapsulated βTC-tet cells. First, important steps in the extraction procedure itself are 
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discussed, followed by the determination of isotopomer steady state from Fresh 
encapsulated cells, and verification of maintenance of metabolic activity after incubation 
in basal and high glucose medium for both Fresh and Cryopreserved cells. 13C NMR 
spectra were also obtained from Frozen and DPS-vitrified beads to ensure sufficient SNR 
was obtainable with the parameters used. Finally, two models of glucose metabolism are 
compared in order to determine the appropriate model to use with tcaCALC to determine 
relative metabolic fluxes. 
 
4.2       Materials and Methods 
4.2.1    Cell Culture and Encapsulation  
 All chemicals and reagents were obtained from Sigma (St. Louis, MO) unless 
otherwise noted.  βTC-tet cells were obtained from the laboratory of Dr. Shimon Efrat 
(Albert Einstein College of Medicine, Bronx, NY) [191].  Cells were cultured as 
monolayers in T-175 flasks in fully supplemented, 25 mM glucose DMEM, referred to as 
complete DMEM, containing 4 mM L-glutamine, supplemented with 10% (v/v) FBS 
(Gemini Bioproducts, West Sacramento, CA, USA), 1% (v/v) penicillin (10,000 U/ml)-
streptomycin (10,000 μg/ml) (Mediatech, Manassas, VA), and 1% L-glutamine 
(Mediatech). Medium was changed every 2-3 days, and cultures were split at ratios of 1:5 
to 1:7 when confluent. Cells were cultured in a humidified incubator at 37oC with 5% 
CO2/95% air. 
  At the time of encapsulation, cells were detached from monolayers using 0.25% 
trypsin (Mediatech) and resuspended in 2% PRONOVA Ultrapure LVM alginate (FMC 
Biopolymer, Philadelphia, PA) in order to achieve an encapsulation density of 7x107 
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cells/ml. Cells were encapsulated using an electrostatic bead generator (Nisco 
Engineering AG, Zurich, Switzerland), with alginate cross linked in a 1.1% (w/v) CaCl2 
bath , as described previously [30],  but without the poly-L-lysine and alginate coating 
process.  This high cell density was used in order to obtain good SNR in the NMR 
spectrum. Beads formed were approximately 500-600 μm in diameter and were incubated 
overnight on a platform rocker (Stovall, Greensboro, NC) in complete DMEM prior to 
performing experiments. 
 
4.2.2    Vitrification  
Encapsulated βTC-tet cells were vitrified using the cryoprotectant (CPA) cocktail 
DPS, containing 3 M dimethylsulfoxide (DMSO), 3 M 1,2 propanediol (PD), and 0.5 M 
Sucrose (Fisher Chemical, Fisher Scientific, Pittsburgh, PA). For the CPA addition 
procedure, CPAs were added to beads on ice in a stepwise fashion according to the 
protocol in Table 4.1.  This protocol was developed with the aid of a  mathematical 
model that minimized cell osmotic excursions while ensuring CPA equilibration at each 
step [192].  One ml of beads was placed in a 100 µm cell strainer (BD Biosciences, 
Bedford, MA) and sequentially transferred through CPA solutions of increasing 
concentration (Table 4.1) at 4oC in a six-well plate (BD Biosciences).  After CPA 
addition, the beads in each strainer plus CPA (total volume 1.5 ml) were transferred to 
each of 3 pre-siliconized 20 ml borosilicate glass scintillation vials (Fisherbrand/Fisher 
Scientific), and 700 µl of isopentane (EMD Chemicals, Gibbstown, NJ, USA) was added 
on top of the CPA/bead mixture in each vial.  Vials were transferred to a pre-chilled rack 
and the rack was placed in an isopentane bath in a mechanical freezer (Sanyo North 
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America, San Diego, CA) set at -135oC for fast cooling to ~ -100oC (~64oC/min). The 
rack was then transferred to a shelf in the freezer for slow cooling (~2oC/min) to -130oC. 
During cooling, temperature was tracked with a thermocouple in a dummy sample 
containing only CPA and isopentane. After overnight storage in the freezer, one ml of 
beads was warmed at a time by agitating vials in a room temperature 30% (v/v) DMSO 
bath.  CPAs were then removed stepwise at room temperature in a similar fashion as CPA 
addition (Table 4.1).  After CPA removal, beads were aliquoted out for immediate assay 
for the medium incubation test.  
For obtaining 13C NMR spectra from Vitrified encapsulated cells, vitrification 
was performed 13 separate times. Beads were warmed 1 ml at a time, and incubated at 
37oC until all beads were warmed. A volume of 12 ml beads was then aliquoted out for 
the extraction experiments. Details on the scale-up procedure are also described in 
CHAPTER 5. 
Table 4.1 Cryoprotectant addition/removal protocol for DPS vitrification. A: addition; R: 
removal; RT: room temperature (22oC); PD: 1,2 propanediol 
Step DMSO (M) PD (M) Sucrose (M) Time (min) Temperature 
(oC) 
A1 1 1 0.15 2 4 
A2 2 2 0.3 2 4 
A3 3 3 0.5 2 4 
R1 2.25 2.25 0.3 2 RT 
R2 1.5 1.5 0.2 2 RT 
R3 0.75 0.75 0.1 2 RT 
R4 0 0 0 4 RT  
 
4.2.3   Conventional Freezing 
For freezing for the medium incubation test, complete DMEM at 4oC, containing 
10% (v/v) DMSO, was added to 1 ml of beads. Beads were incubated in this solution for 
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10 minutes, and then transferred to 2.0 ml cryogenic vials (Corning Inc., Corning, NY) 
and placed in a Mr. Frosty isopropyl alcohol bath (Nalgene/Thermo Fisher Scientific, 
Rochester, NY) in a -80oC freezer (VWR International Inc., Radnor, PA) for 1.5 hours. 
Subsequently, vials were plunged into liquid nitrogen.  After overnight storage, 1 ml of 
beads at a time was warmed rapidly by agitating vials in a 37oC water bath until no ice 
was visible in the vials.  Beads were next placed in complete DMEM at 37oC for 10 
minutes.  After a subsequent wash with complete DMEM, beads were aliquoted out for 
immediate assay. 
For obtaining 13C NMR spectra from Frozen encapsulated cells, beads were 
frozen 8 times in 1 ml batches. Beads were warmed 1 ml at a time, and incubated at 37oC 
until all beads were warmed. A volume of 7 ml of beads was then aliquoted out for the 
extraction experiments. Details on the scale-up are also described in CHAPTER 5. 
 
4.2.4   13C Labeling and Extraction of Fresh Encapsulated βTC-tet Cells for   
the Isotopomer Steady-State Study 
13C labeling and extraction were performed one day post-encapsulation on a 
volume of 6 ml of Fresh beads (approximately 200x106 cells). This bead volume was 
used because it gave sufficient SNR in NMR spectra (Figure 4.1). Beads were washed 4 
times with glucose and glutamine-free basal DMEM supplemented with 1.31 g/l BSA 
(Sigma). Next, beads were incubated in the same type of medium at a 1:10 bead: medium 
volume ratio for 1 hour at 37oC. Beads were subsequently washed once with basal 
medium and once with labeling medium, containing 15 mM uniformly labeled 13C (U-
13C) glucose (Cambridge Isotope Laboratories, Andover, MA) in glucose-free DMEM 
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(pH 7.4) plus 10% (v/v) FBS (Gemini), 1% (v/v) L-glutamine (Mediatech), and 1% (v/v) 
penicillin-streptomycin (Mediatech). Next, beads were incubated in the same type of 
medium, at a 1:10 bead: medium volume ratio, for 3-15 hours. Subsequently, perchloric 
acid extraction was performed based on the protocol in Simpson et al. [183], with 
modifications. The extraction procedure was performed on ice with ice-cold reagents. 
Beads were washed with glucose-free and glutamine-free DMEM and alginate was 
dissolved in 110 mM sodium citrate (Fisher Chemical/Fisher Scientific).  Cells were 
pelleted at 200xg at 4oC for 10 minutes, and the pellet was washed with 0.85% (w/v) 
NaCl.  Cells were then extracted twice in 0.5 M perchloric acid using an Omni GLH 
homogenizer (Omni International, Marietta, GA) with an Omni Tip™ plastic generator 
probe (for hard tissues) to prevent paramagnetic ion contamination.  Supernatants were 
pooled and neutralized with 0.01-5 M KOH to pH 7.0 using an InLab® Cool (Metler 
Toledo, Columbus, OH) low temperature pH electrode. This solution was then 
centrifuged at 10,000xg to remove precipitated salts and Chelex-100® resin (2g/10 ml 
extract volume) was added to the supernatant to remove paramagnetic ions.  After stirring 
the solution containing Chelex resin for one hour on ice, the resin was removed by 
filtration through Whatman Grade 540 quantitative ashless filter paper (Whatman Inc., 
Piscataway, NJ) in a Nalgene® polysulfone filter holder (Thermo Fisher Scientific). 
Subsequently, the resin was chased with ultrapure water. The pH of the filtrate was 
adjusted to approximately 7.4 with 0.01-1 M HCl.  The final extract was placed in 50 ml 
centrifuge tubes (with 15-20 ml extract per tube), covered with two lab wipes, and frozen 
at -80oC. The frozen extract was placed in a lyophilizer (Labconco Corporation, Kansas 
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City, MO) for two days prior to reconstitution. Special care was taken to avoid contact 
with metal whenever possible, to reduce potential paramagnetic ion contamination. 
 
4.2.5     13C Extract Reconstitution and NMR Spectroscopy 
 After lyophilization, dried extracts were transferred from 50 ml centrifuge tubes 
to 2.0 ml microcentrifuge tubes with plastic disposable spatulas (VWR) and reconstituted 
in 200 μl of 99.99% D2O. Subsequently the extract was spun at 18,300xg at room 
temperature for 10 minutes. The supernatant was removed after centrifugation, 
transferred to a new 1.7 ml microcentrifuge tube, and placed on ice for 30 minutes to 
precipitate out KClO4 salts.  The extract was then centrifuged at 18,000xg for 10 minutes 
at 0oC to pellet out additional precipitated salts.  The supernatant was then removed, 
transferred to a new 1.7 ml microcentrifuge tube, and allowed to warm to room 
temperature.  Subsequently, an NMR long tip transfer pipette (Wilmad-LabGlass, 
Vineland, NJ) was used to transfer the sample to a 5 mm symmetrical NMR microtube 
(Shigemi Inc., Allison Park, PA) that was magnetic susceptibility-matched to D2O. The 
glass insert was then placed into the tube in such a way as to prevent air bubbles in the 
sample. NMR data were acquired with a 5 mm broadband probe in an 11.7 T vertical 
bore Bruker DRX 500 magnet with an Avance Console (Bruker, Billerica, MA) with 
previously described parameters [36, 183].  
 New and re-used NMR tubes were thoroughly cleaned prior to use to help reduce 
potential paramagnetic ion contamination. All reagents, except for ethanol, were 0.2 µm 
filtered prior to use to remove possible particulates. New NMR tubes and inserts were 
soaked overnight in 10 mM EDTA in ultrapure water, and subsequently rinsed 
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thoroughly with ultrapure water. Additional rinses in 1M HCl as well as ultrapure water 
were also performed. Re-used NMR tubes and inserts were first rinsed with ultrapure 
water, followed by 1M HCl and ultrapure water rinses prior to overnight incubation in 10 
mM EDTA. Tubes and inserts were finally rinsed with ultrapure water and 100% ethanol 
and air dried overnight on an NMR tube rack. 
 
4.2.6   13C NMR Spectra Analysis and tcaCALC Modeling 
 13C NMR spectra were processed using NUTS NMR software (Acorn NMR, 
Fremont, CA).  Prior to relative peak area determination, a 1 Hz line broadening factor 
and polynomial baseline correction were applied to all spectra. Peaks were referenced to 
the lactate C3 peak at 21.0 ppm.  Relative multiplet peak areas of isotopomer patterns of 
glutamate C2, C3, and C4 were determined using a line-fitting routine in NUTS as 
described previously [36]. Subsequently, relative multiplet peak areas were analyzed 
using the tcaCALC modeling program in order to determine relative metabolic fluxes 
[179, 181, 188]. In order to get a visual representation of how well the models 
represented the experimental data, tcaCALC-derived metabolic fluxes were input to 
tcaSIM to generate simulated spectra. In addition, %C3/C4 error [36, 183, 187]  as well 
as residual sum of square values [183] were determined to examine how well model-
derived results fit the experimental data. 
 
4.2.7    Medium Incubation Test  
 Fresh and Cryopreserved beads were split into two subgroups, and subsequently 
exposed to two different medium incubation schemes. Under “condition 1,” a 0.1 ml 
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volume of beads from each treatment (Fresh, Frozen, Vitrified) was incubated in 
complete DMEM for 6 hours. Subsequently, beads were washed 3 times with 1 ml of 
complete DMEM, followed by exposure to complete DMEM for 6 hours. Under 
“condition 2,” a 0.1 ml volume of beads from each group was incubated in 0 mM glucose 
DMEM + 1.31 g/l BSA for one hour. Subsequently, beads were washed 3 times with 1 ml 
of 0 mM glucose DMEM + 1.31 g/l BSA. Next, beads were exposed to 15 mM glucose 
DMEM, supplemented with 10% FBS (Gemini Bioproducts, West Sacramento, CA), 1% 
P/S, and 1% L-glutamine for 6 hours. This last solution is henceforth referred to as “15 
mM FS.”  
 
4.2.8    Metabolic Activity of Beads after Medium Incubation Test 
 After the medium incubation test, beads from Fresh, Frozen, and DPS-vitrified 
groups were transferred to 12-well plates and incubated with 1 ml complete DMEM and 
100 µl of alamarBlue® stock solution (Life Technologies, Carlsbad, CA) for 1.5 hours at 
37oC. Subsequently, three 100 µl aliquots from each sample were placed into separate 
wells of a black 96-well microplate (Nalgene/Nunc) and fluorescence was read using a 
SpectraMax Gemini plate reader (Molecular Devices, Sunnyvale, CA) with excitation 
and emission wavelengths of 544 and 590 nm, respectively.  
 
4.2.9    Statistical Analysis 
 Data are presented as mean ± standard deviation. Statistics were performed using 
either a one-way ANOVA using the General Linear Model or a two-tailed t-test in 
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Minitab (Minitab Inc., State College, PA). Pairwise comparisons were performed using 
Tukey’s test. Values of p<0.05 were considered statistically significant. 
 
 
4.3       Results and Discussion 
4.3.1    Summary of Important Conditions for Perchloric Acid Extraction of  
            Encapsulated Cells and Reconstitution of Extracts  
Perchloric acid extraction was used to extract metabolites from encapsulated cells, 
as in a previous study with encapsulated βTC3 cells [183]. Important additional 
modifications were made in order to ensure good signal-to-noise ratio (SNR) in the NMR 
spectrum. First, as opposed to extraction of metabolites form intact beads, beads were 
solubilized and cells pelleted to get better SNR. For the homogenization procedure, a 
special OmniTip™ plastic probe (Omni International) was used in order to reduce 
potential paramagnetic ion contamination. A special low temperature InLab® Cool pH 
electrode (Metler Toledo, Columbus, OH) was used to measure the pH of samples at 4oC.  
With respect to reconstitution of the metabolite extract, in order to increase the 
concentration of metabolites in the reconstituted sample, a volume of only 200 µl of D2O 
was added to the lyophilized extract. After addition of D2O, multiple centrifugations and 
incubation on ice were used to help precipitate out salts to reduce sample conductivity 
and help increase SNR [193]. In addition, a symmetrical NMR microtube and glass insert 
(Shigemi NMR), magnetic susceptibility matched to D2O, were used to allow for a small 
sample volume without a decrease in spectral resolution. This was used as an alternative  
to using a standard 5 mm NMR tube which would normally require larger volumes of 
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around 500-600 µl of sample. All NMR tubes were soaked in 10 mM EDTA overnight 
and rinsed in ultrapure water prior to use in order to help remove potential paramagnetic 
ions. In general, extra precaution was taken during extraction and reconstitution 
procedures to avoid contact with metal to minimize potential paramagnetic ion 
contamination. Using this extraction and reconstitution method, NMR spectra with SNR 
sufficient for isotopomer analysis were obtained. A representative 13C NMR spectrum 
obtained from an extraction of Fresh beads is shown in Figure 4.1. 
Additionally, methanol/chloroform dual-phase extractions [194] were attempted 
on pelleted cells from solubilized beads to see if 31P NMR spectra could also be obtained 
from extracts to assess ATP/ADP levels in the sample. However, this extraction method 
was found to be undesirable as a viscous supernatant was present even after several 
washes, possibly due to the presence of remaining alginate. 
 
Figure 4.1 Representative 13C NMR spectrum obtained after 13C labeling and extraction 





4.3.2    Isotopomer Steady State Study  
Establishing isotopomer steady state, where isotopomer patterns are not changing 
with time, is especially important for determining relative metabolic fluxes using the 
modeling program tcaCALC [179, 188]. With respect to 13C NMR and isotopomer 
analysis studies examining metabolic fluxes in relation to insulin secretion in beta cells 
[34-36], when switching to the labeling medium, cells are exposed to the labeled 
substrate (i.e. 13C-glucose) as well as possibly different concentrations of nutrients in 
medium. Thus, it is important to ensure that enough time has been given after 
introduction of 13C-enriched substrates to cells to allow for the number of turns of the 
TCA cycle necessary for the replacement of endogenous 12C-labeled metabolites with 
13C-labeled metabolites as well as to ensure that metabolism and isotopomer patterns are 
not changing with time. However, as the previously mentioned studies are often 
performed in batch culture systems, where there is not continuous replenishment of the 
external medium, it is important to not wait an extended period of time after addition of 
the labeling medium in order to prevent the associated changes in metabolism that may 
occur due to changes in metabolite concentrations in the incubation medium over time. 
Thus, performing a study where the relative multiplet peak areas of the glutamate 
resonances of interest, specifically glutamate carbons C2, C3, and C4, are examined over 
time is necessary.  
 Fresh beads were incubated in medium containing 15 mM U-13C glucose for 3-15 
hours. The glutamate carbon resonances analyzed included the following types of 
multiplets: doublet (D), triplet (T), quartet (Q), and singlet (S). As indicated in Figure 
4.2A, for glutamate C2 (GluC2), the relative peak areas did not change with time, except 
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for C2Q, which was higher at the 12 hour time point compared to the 3 hour time point 
(p<0.05). For glutamate C3 (GluC3) (Figure 4.3A), the relative multiplet peak areas 
changed with time, with an overall increase in the C3 triplet and a decrease in the singlet 
peak. There was no difference between relative peak areas from 3 to 6 or 6 to 9 hours 
except for the GluC3 triplet, which was greater at 6 hours than at 3 hours (p<0.05). For 
glutamate C4 (GluC4) (Figure 4.4A), there was an overall decrease in the D45 resonance 
and an increase in the C4Q with time. No difference was found between the 6 and 9 hour 
time points or 3 and 6 hour time points for glutamate C4.  
Overall, for most of the multiplets, there was no difference in relative multiplet 
peak areas between 3 and 6 and 6 and 9 hours. Therefore, although the isotopomer 
patterns overall changed with time, around the 6 hour timeframe, most of the multiplet 
peak areas remained constant. Thus, a “pseudo” isotopomer steady state was 
approximated at the 6 hour period. The precise reason for the continued changes in 
isotopomer patterns is unclear; however, one possibility is that this is caused by changes 
in the concentration of nutrients and metabolites in the medium as a result of cellular 
metabolic activity. Avoiding these changes, for example, by implementing a single-pass 
perfusion system, is not desirable due to the high cost of the labeled glucose necessary for 
the duration of the experiment. Additionally, the changes in isotopomer patterns present 
in the batch culture system used here do not preclude the use of the analysis, especially as 
most patterns were not changing around the chosen incubation time frame. 
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Figure 4.2 A). Relative multiplet peak areas of the glutamate C2 (GluC2) resonance 
during incubation in 15 mM U-13Cglucose DMEM for 3-15 hours. The quartet (Q) 
multiplet is represented by the blue line, doublet 23 (D23) by the green line, doublet 12 
(D12) by the orange line, and the singlet (S) by the purple line. B). Representative 
glutamate C2 resonance with multiplets labeled. *indicates p<0.05 compared to 3 hour 
time point. n=3 for 3-12 hours and n=1 for 15 hours.  
 
Figure 4.3 A). Relative multiplet peak areas of the glutamate C3 (GluC3) resonance 
during incubation in 15 mM U-13Cglucose DMEM for 3-15 hours. The singlet (S) 
multiplet is  represented by the purple line, doublet (D) by the green line, and the triplet 
(T) by the red line. B). Representative glutamate C3 resonance with multiplets labeled. 
*p<0.05 compared to 3 hour time point, #p<0.05 compared to 6 hour time point, ^p<0.05 
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Figure 4.4 A). Relative multiplet peak areas of the glutamate C4 (GluC4) resonance 
during incubation in 15 mM U-13Cglucose DMEM for 3-15 hours. The singlet (S) 
multiplet is represented by the purple line, doublet 45 (D45) by the green line, quartet (Q) 
by the blue line, and doublet 34 (D34) by the orange line. B). Representative GluC4 
resonance with multiplets labeled. *p<0.05 compared to the 3 hour time point, #p<0.05 
compared to 6 hour time point. n=3 for 3-12 hour incubations and n=1 for 15 hour 
incubation 
 
4.3.3    Medium Incubation Test 
After establishing the appropriate incubation time in the labeling medium from 
the isotopomer steady state study, it was necessary to ensure that metabolic activity was 
maintained in the Cryopreserved beads after the basal and labeling medium incubation 
scheme imposed upon the encapsulated cells. For 13C NMR and isotopomer analysis 
studies specifically looking at metabolism in βTC cell lines, the cells are exposed to 
glucose-free and serum-free solutions prior to high glucose exposure to mimic glucose-
stimulated insulin secretion conditions [36, 183]. Although this incubation scheme is 
likely not a concern for Fresh encapsulated cells, the additional stress of nutrient 
deprivation immediately post-warming may have adverse effects on the Cryopreserved 










































beads in glucose and serum-free medium followed by incubation in fully supplemented 
15 mM glucose DMEM did not lead to a significant decrease in metabolic activity 
compared to incubation in complete DMEM post-warming. This test was also important 
in evaluating the approximate bead volume necessary to obtain sufficient SNR in the 
NMR spectra from the Cryopreserved groups, based on the 6 ml volume used for Fresh 
beads.  
As indicated by Figure 4.5, there was no difference in metabolic activity (when 
normalized to the Fresh group cultured in complete DMEM) between the Frozen 
“condition 1” and Frozen “condition 2” groups or the DPS-vitrified “condition 1” and 
DPS-vitrified “condition 2” groups (p>0.05). It was therefore determined that the basal 
and labeling incubation scheme applied did not affect the metabolic activity of the cells in 
the DPS-vitrified or Frozen beads compared to Cryopreserved beads incubated in 
complete DMEM for the same period. Thus, the incubation scheme was deemed 
appropriate for use with DPS-vitrified and Frozen beads for subsequent 13C labeling and 
extraction experiments. In addition, the metabolic activity in the DPS-vitrified beads 
under incubation condition 2 was approximately 50-60% that of the Fresh control 
cultured under the same conditions. Thus, as a volume of 6 ml of Fresh beads was 
deemed sufficient to obtain a good SNR in the NMR spectra, a 12 ml bead volume of 
DPS-vitrified beads was chosen for the 13C labeling and extraction experiments. 
Similarly, as the metabolic activity of the Frozen beads was approximately 90-100% that 
of the Fresh group under the same incubation condition, a 7 ml volume of Frozen beads 
was chosen for the subsequent 13C labeling and extraction experiments. Although the 
chosen bead volume for the DPS-vitrified and Frozen beads was such to allow for a 
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similar metabolic activity compared to the Fresh control, it is important to note that 
isotopomer analysis is cell-number independent. 
 
Figure 4.5 A). Metabolic activity of Fresh (white bars), Frozen (light gray bars), and 
DPS-vitrified (dark gray bars) beads after medium incubation test. B).Medium incubation 
scheme used in current experiment. Beads cultured under “condition 1” were exposed to 
fully supplemented, 25 mM glucose DMEM (complete DMEM) for one hour, followed 
by another 6 hours in complete DMEM. Beads cultured under “condition 2” were 
incubated in 0 mM glucose DMEM + 1.31 g/l BSA for one hour followed by a six-hour 
incubation in fully supplemented, 15 mM glucose DMEM (15 mM FS). Metabolic 
activity was assessed with alamarBlue®. *indicates p<0.05 compared to Fresh within 
same incubation condition, #indicates p<0.05 compared to Frozen within same medium 
incubation condition, ^indicates p<0.05 compared to incubation in complete DMEM 
within same cryopreservation treatment group. n=3 
 
 
4.3.4  13C NMR Spectra From Frozen and DPS-Vitrified Encapsulated βTC-tet Cells 
 
            As the appropriate extraction procedure and isotopomer steady state period were 
determined for Fresh beads, and the medium incubation scheme deemed appropriate for 
the Cryopreserved groups, it was important to ensure that good quality 13C NMR spectra 
could be obtained from the Frozen and DPS-vitrified beads. As indicated in Figures 4.6 
and 4.7, high quality 13C NMR spectra were obtained for both groups.  The scale-up 
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Figure 4.6 Representative 13C NMR spectrum obtained after 13C labeling and extraction 
of 7 ml of Frozen beads incubated in basal medium for 1 hour followed by labeling 
medium for 6 hours. 
 
 
Figure 4.7 Representative 13C NMR spectrum obtained after 13C labeling and extraction 
of 12 ml of DPS-vitrified beads incubated in basal medium for 1 hour followed by 









4.3.5    Determination of Appropriate Model of Glucose Metabolism for Use with  
            tcaCALC 
Choosing the appropriate model of glucose metabolism to use with tcaCALC is 
important, as different models used on the same experimental data can lead to different 
results in relative metabolic fluxes [187]. Thus, it was important in the current study to 
ensure that the model chosen represented the experimental data well. Two models of 
glucose metabolism, a “standard” model (Figure 4.8A) as well as a previously published 
modified model (Figure 4.8B), referred to as the “modified” model, containing a second 
non-pyruvate carboxylase (PC) entrance to the TCA cycle [36, 183, 187], were compared 
with NMR-derived data in order to determine which model better represented the 
experimental data. The modified model has been used previously with encapsulated 
βTC3 cells [183] as well as βTC-tet cells cultured in monolayers [36]. For this, 
tcaCALC-derived data were input into tcaSIM, a companion program to tcaCALC, to 
obtain simulated spectra to assess how well the models visually represented the 
experimental data. In terms of simulated spectra, the modified model better represented 
the experimental data, which was especially evident when examining the C4 quartets, 
which were overestimated by the standard model (Figure 4.9). To more quantitatively 
compare the two models with the experimental data, the percent C3/C4 error as well as 
the residual sum of square values between model-predicted values and experimental data 
were evaluated. As indicated in Table 4.2, the modified model had lower percent C3/C4 
error and residual sum of square values (p<0.05) than the standard model, indicating 
again that the modified model better represented the experimental data. The modified 
model also fit experimental data from DPS-vitrified and Frozen bead spectra better than 
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the standard model (data not shown). Thus, the modified single pyruvate pool model was 
chosen to use with tcaCALC to determine relative metabolic fluxes for the subsequent 
studies.
 
Figure 4.8 A). Standard model and B). a previously published modified model of glucose 
metabolism containing a second non-pyruvate carboxylase entrance to the TCA cycle 
applied in tcaCALC [36]. Adapted from Simpson et al [36]. The tcaCALC fluxes 
represented above are PK (phosphoenol-pyruvate carboxykinase/pyurvate kinase or malic 
enzyme); LDH (glycolysis); PDH (pyruvate dehydrogenase); YPC (pyruvate 
carboxylase); ACS (acetyl-CoA synthetase); and YS (non-pyruvate carboxylase 
anaplerosis). 
 
Figure 4.9 Representative experimental and tcaSIM-derived simulated spectra from 
Fresh beads. Simulated spectra were obtained by inputing tcaCALC-derived metabolic 


















































Table 4.2 Comparison of model-derived parameters and experimental data for a standard 
model and modified model of glucose metabolism from Fresh encapsulated βTC-tet cells. 
* p<0.05 compared to standard model. n=3 
  Standard Modified 
%C3/C4 Error 71.79 ± 17.90 3.21 ± 3.46* 
Sum of Squares 0.2112 ± 0.0590 0.0064 ± 0.0038* 
 
4.4       Conclusions 
In this study, we established parameters and procedures necessary for 13C NMR 
and isotopomer analysis from Fresh and Cryopreserved encapsulated βTC-tet cells. This 
involved a) establishing an extraction protocol that allowed for sufficient SNR in the 
NMR spectrum from Fresh and Cryopreserved encapsulated βTC-tet cells; b) determining 
the appropriate incubation time in the high glucose labeling medium to achieve 
isotopomer steady state; c) verifying that metabolic activity of Cryopreserved 
encapsulated cells did not decrease when incubated according to the necessary incubation 
scheme; and d) determining the appropriate model of glucose metabolism to use in 
interpreting the 13C-NMR-derived isotopomer data. Relative metabolic fluxes obtained 
using the optimized parameters and procedures developed in this chapter from Fresh and 









CRYOPRESERVATION EFFECTS ON INTERMEDIARY 
METABOLISM IN A PANCREATIC SUBSTITUTE: A 13C 




Cryopreservation is important for clinical translation of tissue engineered 
constructs. With respect to a pancreatic substitute, encapsulated islets or beta cells have 
been widely studied for the treatment of insulin-dependent diabetes mellitus.  Besides cell 
viability loss, cryopreservation may affect the function of the remaining viable cells in a 
pancreatic substitute by altering fundamental processes in glucose-stimulated insulin 
secretion, such as pathways associated with intermediary metabolism, potentially leading 
to insulin secretion defects.  In this study, we used 13C nuclear magnetic resonance 
(NMR) spectroscopy and isotopomer analysis to determine the effects of conventional 
freezing and ice-free cryopreservation (vitrification) on carbon flow through tricarboxylic 
acid (TCA) cycle-associated pathways in encapsulated murine insulinoma TC-tet cells; 
the secretory function of the encapsulated cells post-preservation was also evaluated.  
Specifically, calcium alginate-encapsulated TC-tet cells were frozen or vitrified with a 
cryoprotectant cocktail.  Beads were warmed and 13C labeling and extraction performed.  
Insulin secretion rates were determined during basal and labeling periods and during 




Adapted from Ahmad et al., Cryopreservation Effects on Intermediary Metabolism in a 
Pancreatic Substitute: A 13C Nuclear Magnetic Resonance Study. Tissue Engineering (Accepted) 
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small-scale glucose stimulation and K+-induced depolarization.  Relative metabolic 
fluxes were determined from 13C NMR spectra using a modified single pyruvate pool 
model with the tcaCALC modeling program.  Treatments were compared to non-
preserved controls.  Results showed that relative carbon flow through TCA cycle-
associated pathways was not affected by conventional freezing or vitrification.  However, 
vitrification, but not freezing, led to impaired insulin secretion on a per viable cell basis.  
The reduced secretion from the vitrified group occurred irrespective of scale and was 
present whether secretion was stimulated by glucose or K+-induced depolarization, 
indicating that it might be due to a defect in late-stage secretion events.   
 
5.2 Introduction 
Encapsulated islets or beta cells have been studied extensively as tissue-
engineered pancreatic substitutes, as they may provide more physiologic control of blood 
glucose levels compared to exogenous insulin therapy [79, 131, 195-202].  For future 
clinical translation, long-term storage of encapsulated cells for off-the-shelf availability is 
essential, and cryopreservation is a promising means towards achieving this objective.  
The two main methods of cryopreservation, vitrification, or ice-free cryopreservation, 
and conventional freezing, have both been studied in preserving encapsulated islets [24, 
25, 37, 38, 40] or beta cells [30, 39].  Vitrification is promising since it may maintain 
biomaterial integrity better than conventional freezing, as indicated in previous studies 
with encapsulated islets [25] and insulinoma cells [30].  
  In terms of construct function post-preservation, recent studies have indicated that 
insulin secretion is often impaired after cryopreservation, specifically after conventional 
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freezing of encapsulated insulinoma cells [30] and conventional freezing [25] or 
vitrification [24, 25] of encapsulated islets.  Although a reduction in cell viability may be 
an important component of this decreased secretion, the function of the remaining viable 
cells may also be compromised.  Thus, an understanding of cryopreservation effects on 
fundamental aspects of beta cell function is critical for elucidating cryopreservation-
induced secretion anomalies; however, no studies have addressed the quality of the 
remaining viable cells in cryopreserved encapsulated islets or beta cells, besides their 
ability to secrete insulin [24, 25, 30, 37, 38, 40].  Evaluating intermediary metabolism 
after cryopreservation is especially important, as it is key to glucose-stimulated insulin 
secretion (GSIS) in beta cells [31-33, 171], and cryopreservation has been shown to 
affect aspects of intermediary metabolism in other systems [203, 204].  Recently, 13C 
nuclear magnetic resonance (NMR) spectroscopy and isotopomer analysis were used to 
study mitochondrial metabolism in GSIS, by correlating certain metabolic fluxes with 
insulin secretion using specific models applied in the tcaCALC modeling program [32, 
34, 36, 183, 187, 205].  Since the natural abundance of 13C is only 1.1%, it can be 
introduced into cells as an isotopic tracer, with its path being followed by the labeling 
patterns found in enriched metabolites [178].  Adjacently labeled 13C carbons lead to the 
formation of isotopomer patterns, and analysis of steady-state glutamate isotopomer 
patterns with models of metabolism can estimate relative carbon flow through 
tricarboxylic acid (TCA) cycle-associated pathways, thus allowing for a quantitative 
assessment of intermediary metabolism [179].  
In this work, we applied 13C NMR and isotopomer analysis to elucidate the 
intermediary metabolism of calcium alginate-encapsulated murine insulinoma TC-tet 
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cells post-cryopreservation by conventional freezing and vitrification.  The secretory 
function of the encapsulated cells was also characterized.  Cell-derived 13C-glutamate 
isotopomers were analyzed using a previously published model of glucose metabolism 
[36, 183, 187] with tcaCALC to determine relative metabolic fluxes through TCA cycle-
associated pathways, and the corresponding insulin secretion was measured post-
preservation.  To gain further insight into effects on secretion, the latter was measured in 
response to both glucose and high K+ exposure. The ramifications of our findings towards 
identifying specific cellular processes affected by cryopreservation are discussed. 
 
5.3 Materials and Methods 
5.3.1    Cell Culture and Encapsulation 
             
All chemicals were from Sigma (St. Louis, MO) unless otherwise noted.  The 
βTC-tet cell line was obtained from S. Efrat (Albert Einstein College of Medicine, Bronx, 
NY).[191]  Cells were cultured as monolayers in DMEM (pH 7.4) containing 25 mM 
glucose and  4 mM L-glutamine, supplemented with 10% (v/v) fetal bovine serum (FBS) 
(Gemini Bioproducts, West Sacramento, CA), 1% (v/v) penicillin (10,000 U/ml)-
streptomycin (10,000 μg/ml) (Mediatech, Manassas, VA), and 1% L-glutamine 
(Mediatech) to a final concentration of 6 mM.   This medium is henceforth referred to as 
complete DMEM.  Cells were cultured in a humidified incubator at 37oC with 5% 
CO2/95% air, and used between passages 37 and 42. 
 Cells were detached from monolayers using 0.25% trypsin (Mediatech) and 
encapsulated at 7x107 cells/ml alginate in 2% PRONOVA ultrapure LVM sodium 
alginate (FMC Biopolymer, Philadelphia, PA), with droplets crosslinked in 1.1% (w/v) 
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CaCl2, as described previously [30] but without poly-L-lysine coating.  Beads were 500-
600 μm in diameter and were incubated overnight on a platform rocker (Stovall, 
Greensboro, NC) in complete DMEM. All salt solutions used in the encapsulation and 
subsequent procedures were adjusted to 300 mOsm to ensure isotonicity. 
 
5.3.2    Vitrification 
Cryopreservation was performed one day post-encapsulation.  Beads were 
vitrified using the cryoprotectant (CPA) cocktail DPS comprised of 3 M 
dimethylsulfoxide (DMSO), 3 M 1,2 propanediol (PD), and 0.5 M sucrose (Fisher 
Chemical, Fisher Scientific, Pittsburgh, PA) in a modified version of the EuroCollins 
carrier solution. The EuroCollins component of the CPA solution contained 34.95 g/l 
glucose, 0.84 g/l NaHCO3 (Fisher Chemical), 1.12 g/l KCl, and 1.68 g/l NaCl.  Initial 
studies indicated that a volume of 6 ml Fresh beads was adequate to obtain sufficient 
signal-to-noise ratio in the 13C NMR spectra.  As vitrified/warmed beads had a minimum 
metabolically active cell number of 50% that of fresh beads, a 13 ml bead volume was 
vitrified to obtain a sufficient signal-to-noise ratio.  Although similar metabolically active 
cell numbers were used for all groups to obtain sufficient signal-to-noise ratios, at 
isotopomeric steady state, isotopomer analysis is cell-number independent.  CPAs were 
added to beads on ice stepwise according to the protocol in Table 5.1.  This protocol was 
developed using a mathematical model that minimized cell osmotic excursions while 
ensuring CPA equilibration at each step [192].  One ml of beads was placed in a 100 µm 
cell strainer (BD Biosciences, Bedford, MA) and sequentially transferred through CPA 
solutions of increasing concentration (Table 5.1) at 4oC in a six-well plate (BD 
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Biosciences).  Following CPA addition, beads plus CPA were transferred to 20 ml glass 
scintillation vials (Fisherbrand/Fisher Scientific), and isopentane (EMD Chemicals, 
Gibbstown, NJ) was added on top of the CPA/bead mixture.  Vials were transferred to a 
rack and the rack placed in an isopentane bath in a mechanical freezer (Sanyo North 
America, San Diego, CA) set at -135oC for fast cooling to approximately -100oC at a rate 
of ~64oC/min.  Vials were then transferred to a shelf in the freezer for slow cooling at 
~2oC/min to -130oC, after which they were transferred to freezer storage boxes.  During 
cooling, temperature was tracked with a thermocouple in a sample containing only CPA 
and isopentane.  For each 13C extraction, vitrification was performed on 1 ml bead 
aliquots 13 separate times.  Vials were kept in the freezer overnight, and the next day 1 
ml of beads was warmed at a time by agitating vials in a room temperature 30% (v/v) 
DMSO bath.  Vitrification in each vial was verified by visual observation after cooling 
and immediately prior to warming [206]. Additionally, no crystallization/devitrification 
was visible upon warming. CPAs were then removed stepwise at room temperature in a 
similar fashion as CPA addition (Table 5.1).  After CPA removal, beads were incubated 
in complete DMEM at 37oC until all 13 ml of beads were warmed and CPA removed.  
Beads were then combined and a 12 ml volume withdrawn for labeling and extraction.  




5.3.3    Conventional Freezing 
Beads were frozen in complete DMEM containing 10% (v/v) DMSO.  After 
incubation in this solution at 4oC for 10 minutes, beads were transferred to 2.0 ml 
cryogenic vials (Corning Inc., Corning, NY) and placed in a Mr. Frosty isopropyl alcohol 
bath (Nalgene/Thermo Fisher Scientific, Rochester, NY) in a -80oC freezer (VWR 
International Inc., Radnor, PA) for 1.5 hours, followed by plunging into liquid nitrogen.  
As previous studies indicated a minimum metabolically active cell number of 
approximately 90% that of Fresh beads post-warming, 8 ml of beads were frozen (in 1 ml 
batches) to obtain a sufficient signal-to-noise ratio in the NMR spectra.  After overnight 
storage, 1 ml of beads at a time was warmed rapidly by agitating vials in a 37oC water 
bath until no ice was visible.  Beads were next placed in complete DMEM at 37oC for 10 
minutes.  After a subsequent wash with complete DMEM, beads were incubated in 
complete DMEM at 37oC until all batches were warmed.  Beads were then combined and 
a 7 ml volume withdrawn for labeling and extraction. 
 
5.3.4  13C Labeling and Perchloric Acid Extraction of Encapsulated Cells 
Figure 5.1 shows the experimental procedure for 13C labeling and extraction.  13C 
labeling and extraction was performed one day post-encapsulation for Fresh and two days 
post-encapsulation for cryopreserved beads.  A 6 ml bead volume was used for the Fresh 
control.  After washing beads 4 times with basal medium consisting of glutamine-free 
and glucose-free DMEM supplemented with 1.31 g/l bovine serum albumin (BSA) 
(Sigma) at pH 7.4, beads were incubated in the same type of medium for 1 hour at 37oC.  
Beads were subsequently washed once with basal medium and once with labeling 
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medium, containing 15 mM uniformly labeled 13C glucose (Cambridge Isotope 
Laboratories, Andover, MA) in glucose-free DMEM (pH 7.4) plus 10% (v/v) FBS 
(Gemini), 1% (v/v) L-glutamine (Mediatech), and 1% (v/v) penicillin-streptomycin 
(Mediatech), and incubated in the same type of medium for 6 hours.  This labeling period 
was determined in a previous isotopomeric steady-state study (data not shown). 
Subsequently, perchloric acid extraction was performed based on the protocol in Simpson 
et al. [183], with modifications.  Beads were washed with glucose-free and glutamine-
free DMEM and alginate was dissolved in 110 mM sodium citrate (Fisher 
Chemical/Fisher Scientific).  Cells were pelleted at 200xg at 4oC for 10 minutes, and the 
pellet was washed with 0.85% (w/v) NaCl.  Cells were then extracted twice in 0.5 M 
perchloric acid using an Omni GLH homogenizer (Omni International, Marietta, GA) 
with an Omni Tip™ plastic generator probe to prevent paramagnetic ion contamination.  
Supernatants were pooled and neutralized with 0.01-5 M KOH.  This solution was then 
centrifuged at 10,000xg to remove precipitated salts and Chelex-100® resin (Sigma) was 
added to the supernatant to remove paramagnetic ions.  After stirring the solution 
containing chelex resin for one hour on ice, the resin was removed by filtration through 
ashless filter paper (Whatman Inc., Piscataway, NJ) in a Nalgene® polysulfone filter 
holder (Thermo Fisher Scientific).  Subsequently, the resin was chased with ultrapure 
water.  The pH of the filtrate was adjusted to approximately 7.4 with 0.01-1 M HCl.  The 
final extract was frozen at -80oC and subsequently placed in a lyophilizer (Labconco 
Corporation, Kansas City, MO) for two days prior to reconstitution. 
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Figure 5.1 Overall experimental procedure for 13C labeling and extraction experiments of 
Fresh and Cryopreserved encapsulated βTC-tet cells.    
 
5.3.5  13C Extract Reconstitution and NMR Spectroscopy 
 Lyophilized extracts were reconstituted in 200 μl of 99.99% D2O and 
subsequently spun at 18,300xg at room temperature for 10 minutes.  The supernatant was 
placed on ice for 30 minutes to precipitate out KClO4 salts prior to being centrifuged at 
18,000xg for 10 minutes at 0oC to pellet out additional precipitated salts.  The supernatant 
was allowed to warm to room temperature before being placed in a 5 mm symmetrical 
NMR microtube (Shigemi Inc., Allison Park, PA) that was magnetic susceptibility-
matched to D2O.  NMR data were acquired with a 5 mm broadband probe in an 11.7 T 
vertical bore Bruker DRX 500 magnet with an Avance Console (Bruker, Billerica, MA) 
with previously described parameters [36, 183].  
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5.3.6 13C NMR Spectra Analysis and tcaCALC Modeling 
13C NMR spectra were processed using NUTS NMR software (Acorn NMR, 
Fremont, CA).  A 1 Hz line broadening factor and polynomial baseline correction were 
applied to spectra prior to relative peak area determination.  Peaks were referenced to the 
lactate C3 peak at 21.0 ppm.  Relative multiplet peak areas of isotopomer patterns of 
glutamate C2, C3, and C4 were determined using a line-fitting routine in NUTS as 
described previously [36].  Relative multiplet peak areas were input into tcaCALC [179, 
181, 207] to determine metabolic fluxes relative to the flux through citrate synthase, 
defined as 1.  
 To determine the appropriate model of glucose metabolism to use with tcaCALC, 
%C3/C4 error [36, 183, 187] and the residual sum of squares [183] were determined for a 
standard model of metabolism and a previously published modified single pyruvate pool 
model containing a second non-pyruvate carboxylase anaplerotic entrance to the TCA 
cycle [36, 183, 187].  Parameters examined in tcaCALC included relative fluxes through 
glycolysis (LDH), pyruvate dehydrogenase (PDH), pyruvate carboxylase (YPC), 
phosphoenolpyruvate carboxykinase/pyruvate kinase or malic enzyme (PK), acetyl-CoA 
synthetase (ACS), non-pyruvate carboxylase anaplerosis (YS), and the average relative 
flux of pyruvate carboxylase and pyruvate kinase-pyruvate cycling [(YPC+PK)/2] [34, 
205].  To ensure local minima were not reached during modeling, convergence to the 
same output was confirmed using multiple initial parameter estimates, and simulated 
spectra were generated based on the tcaCALC output using tcaSIM.  Conditions of 
complete scrambling between oxaloacetate and fumarate and no conserved orientation 
transfer between succinyl-CoA and malate were assumed.  Relative metabolic fluxes 
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were converted to percent carbon entry into the TCA cycle from different metabolic 
pathways relative to the total carbon entry into the TCA cycle, defined as follows: 
Total carbon entry to the TCA cycle = PDH + ACS + YS + YPC                             (Eq. 1) 
Similarly, relative fluxes were converted to percent carbon entering and leaving the 
pyruvate pool using the following equations: 
Total carbon flow into the pyruvate pool = PK + LDH                                              (Eq. 2) 
Total carbon flow out of the pyruvate pool = PDH + YPC                                        (Eq. 3) 
 
5.3.7    Insulin Secretion during 13C Labeling and Extraction Experiments 
The average insulin secretion rate (ISR), calculated as (total insulin accumulation 
up to a given time point)/(time of incubation), was measured during basal and labeling 
periods and normalized to the viable cell number determined at the end of the six-hour 
labeling period. Medium samples were taken at the following times, where t=0 hour 
represents the beginning of the basal incubation period: 0 hour, 1 hour, 1.5 hours, 4 
hours, and 7 hours (end of labeling period).  
 
5.3.8 Small-Scale Glucose-Stimulated Insulin Secretion Experiment 
 Fresh, Frozen, and DPS-vitrified beads were exposed to the same basal and high 
glucose incubation conditions as during the 13C labeling and extraction experiments, 
except on a smaller scale, with 0.3 ml beads per group in duplicate wells.  At this scale, 
cryopreservation was performed in a single batch, as opposed to the multiple batches 
used in the scaled-up experiments.  Stimulation index was determined by dividing the 
high glucose ISR measured during the initial 0.5 hours by the basal ISR.  Medium 
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samples were removed at the same time points as the scaled-up 13C experiments for later 
assay of insulin, and the viable cell number was measured at the end of the experiment.  
 
5.3.9 K+ Depolarization Experiment 
 Fresh, Frozen, and DPS vitrified beads were exposed to high K+ to induce insulin 
secretion by membrane depolarization using a protocol adapted from Fleischer et al.[208]    
Cryopreservation was performed on a small scale in a single batch.  Briefly, 0.3 ml of 
encapsulated cells from each group in duplicate wells were exposed for 1 hour to HEPES 
buffered Krebs-Ringer buffer (KRB) containing 4.7 mM KCl (pH 7.4) supplemented 
with 1.31 g/l BSA (basal incubation), followed by 1 hour in HEPES buffered KRB 
containing 47 mM KCl (pH 7.4) also supplemented with 1.31 g/l BSA (high K+ 
incubation).  The NaCl concentration in the high K+ KRB was reduced to maintain 
isotonicity.  Medium samples were taken at the beginning and end of the basal 
incubation, and at the beginning, 0.5 hours, and end of the high K+ incubation period.  
Samples were stored at -80oC for later assay for insulin.  At the end of the basal period, 
beads from a parallel well containing 0.2 ml beads were solubilized, and cells were 
pelleted and extracted to measure intracellular insulin.  Intracellular and secreted insulin 
was normalized to the viable cell number measured at the end of the experiment. 
 
5.3.10 Assays 
 Insulin concentrations in medium samples were determined using a mouse insulin 
ELISA kit (Mercodia, Uppsala, Sweden) according to manufacturer’s instructions.  
Absorbance was read at 450 nm on a SpectraMax Plus microplate reader (Molecular 
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Devices, Sunnyvale, CA). Intracellular insulin was extracted using a mammalian cell 
lysis kit (Sigma).  Viable cell numbers were measured by solubilizing beads with sodium 
citrate and using trypan blue dye exclusion. 
 
5.3.11 Statistical Analysis 
Data are reported as mean ± standard deviation.  Values were obtained from three 
independent experiments (n=3).  Statistical analyses were performed with a two-tailed t-
test or a one-way ANOVA using the General Linear Model in Minitab® (Minitab Inc., 
State College, PA).  Multiple pairwise comparisons were performed using Tukey’s post-
hoc analysis.  Values of p<0.05 were considered to be statistically significant. 
 
5.4 Results 
5.4.1 Metabolic Fluxes from Fresh and Cryopreserved  Encapsulated Cells  
Metabolic fluxes were determined using a modified single pyruvate pool model 
[36, 183, 187] (Figure 5.2), as it was shown to have lower %C3/C4 error and lower 
residual sum of square values compared to a standard model of metabolism without a 
second non-pyuruvate carboxylase anaplerotic entrance to the TCA cycle (data not 
shown).   
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Figure 5.2 A previously published modified single pyruvate pool model of glucose 
metabolism applied in tcaCALC to determine metabolic fluxes. Figure adapted from 
Simpson et al. [36]  The tcaCALC fluxes represented above are PK (phosphoenol-
pyruvate carboxykinase/pyurvate kinase or malic enzyme); LDH (glycolysis); PDH 
(pyruvate dehydrogenase); YPC (pyruvate carboxylase); ACS (acetyl-CoA synthetase); 
and YS (non-pyruvate carboxylase anaplerosis).  
 
 
The similarity of the simulated and experimental glutamate spectra (Figure 5.3) 
indicates that the metabolic model and parameters used provided a good representation of 
experimental results.  As indicated in Figure 5.4A, there were no differences in the raw 
relative metabolic fluxes among the different treatment groups and the Fresh, non-
cryopreserved control group (p>0.05).  Figure 5.4B indicates that when converting raw 
metabolic flux data into percent carbon flow into the TCA cycle, there were also no 
differences among groups for any of the pathways examined (p>0.05).  Percent carbon 
entry via non-pyruvate carboxylase anaplerosis, pyruvate carboxylase anaplerosis, and 
pyruvate dehydrogenase was similar among groups, with 28-36% of carbon entry via 
each pathway.  In addition, there was negligible entry to the TCA cycle via the acetyl-
CoA synthetase pathway, with less than 1% entry in all groups.  To gain a snapshot of 
metabolism upstream of the TCA cycle, flow into and out of the pyruvate pool was also 
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examined.  Figure 5.4C shows that no differences among the treatments and the Fresh 
non-cryopreserved group were identified.  More pyruvate entered the pyruvate pool 
through malic enzyme or phosphoenolpyruvate carboxykinase/pyruvate kinase than 
through glycolysis for all groups (p<0.05). 
Figure 5.3 Representative isotopomer patterns from glutamate C2, C3, and C4 
resonances from experimental spectra obtained from extracts of Fresh, Frozen, and DPS-
vitrified encapsulated βTC-tet cells and simulated spectra obtained from tcaSIM based on 
tcaCALC output.  A modified single pyruvate pool model was used to determine the 
tcaCALC output. The different multiplet components are represented by Q (quartet), D 












Figure 5.4 Cryopreservation effects on metabolism of encapsulated βTC-tet cells 
determined using a modified single pyruvate pool model applied in tcaCALC. A). 
Relative metabolic fluxes, B). Percent carbon flow into the tricarboxylic acid (TCA) 
cycle, C). Percent carbon flow into and out of the pyruvate pool.  Data obtained from 
Fresh (white bars), Frozen (gray bars), and DPS-vitrified (striped bars) groups. Data are 




5.4.2 Insulin Secretion during 13C Labeling and Extraction Studies 
Figure 5.5 shows that on a per viable cell basis, there was no difference in insulin 
secretion rate (ISR) between Fresh and Frozen groups during the basal period and at all 
time points assayed in the high glucose labeling period.  However, ISR per viable cell 
was significantly lower for the DPS group compared to the Fresh or Frozen groups at all 





Figure 5.5 Insulin secretion rate (ISR) measured during basal and high glucose 13C-
labeling periods for Fresh (white bars), Frozen (gray bars), and DPS-vitrified 
encapsulated βTC-tet cells (striped bars). *indicates statistical significance (p<0.05). Data 
are presented as mean ± standard deviation. n=3 
 
 
5.4.3 Insulin Secretion during Small-Scale GSIS Experiment 
To investigate if the decreased ISR from the DPS group was due to the required 
scale-up of the vitrification process for the extraction procedure, insulin secretion was 
also tested on a smaller scale.  Insulin secretion during the smaller scale GSIS experiment 
resulted in trends similar to those seen in the large-scale extraction experiments (Figure 
5.6A).  Specifically, there was no difference in ISR per viable cell among the three 
groups during the basal period and between the Fresh and Frozen groups during the high 
glucose period.  At the 4 and 7 hour time points during the high glucose period, however, 
ISR was lower for DPS compared to Fresh and Frozen groups.  
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Figure 5.6 Insulin secretion rate (ISR) from encapsulated βTC-tet cells during small-
scale glucose-stimulated insulin secretion (GSIS) experiment for Fresh (white bars), 
Frozen (gray bars), and DPS-vitrified groups (striped bars). *indicates statistical 




5.4.4 Insulin Secretion during K+-Induced Depolarization  
To investigate if the depolarization/exocytosis response was affected by 
vitrification with DPS, encapsulated cells were exposed to a high extracellular [KCl].  As 
indicated in Figure 5.7A, ISR measured during exposure to 47 mM KCl was much lower 
for DPS compared to the Fresh group at both the 1.5 and 2 hour time points (p<0.05), and 
there was no difference between the Fresh and Frozen groups.  In addition, there was no 
difference in ISR between the Fresh and DPS groups during the basal period.   For the 
Fresh and Frozen groups, the stimulation index with high K+ was higher than that with 
glucose (Figure 5.7B).  However, there was no difference between the two indices for the 
DPS group.  Importantly, there were no differences in intracellular insulin content 
measured at the end of the basal period among the three groups, with 23.79 ± 3.53, 24.85 
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± 5.75, and 19.09 ± 3.39 pmol/105 viable cells for Fresh, Frozen, and DPS vitrified 





Figure 5.7 Insulin secretion rate (ISR) from encapsulated βTC-tet cells during A). small 
–scale K+-induced depolarization experiment for Fresh (white bars), Frozen (gray bars), 
and DPS-vitrified groups (striped bars). B). Stimulation indices from GSIS (white bars) 
and K+-induced depolarization (gray bars) for Fresh, Frozen, and DPS-vitrified groups. 





 Cryopreservation is important for clinical translation of pancreatic substitutes, but 
recent studies have often shown impaired insulin secretion post-cryopreservation in 
encapsulated islets or insulinoma cells [24, 25, 30]. Although an overall reduction in 
viable cell number is likely a significant contributor to the impaired secretion, 
cryopreservation stresses may also affect the function of the remaining viable cells.  In 
this study, we applied 13C NMR and isotopomer analysis to evaluate the effects of two 
cryopreservation methods on the intermediary metabolism of encapsulated TC-tet cells 
and examined secretory function both after glucose and non-nutrient secretagogue 
stimulation.  Using a modified, single pyruvate pool model of metabolism [36, 183, 187], 
we found that relative carbon flow through the TCA cycle-associated pathways examined 
was not significantly affected by either conventional freezing or vitrification.  
Furthermore, insulin secretion per viable cell was not affected by conventional freezing.  
However, the glucose-stimulated and depolarization-induced insulin secretion responses 
were significantly compromised by vitrification.   
 It is well established that intermediary metabolism is a crucial component in the 
glucose-stimulated insulin secretion response in beta cells [31-33, 171].  Understanding 
how metabolic pathways are affected by cryopreservation is important in better 
evaluating impaired insulin secretion and in designing optimal cryopreservation 
protocols.  Specifically, the use of 13C NMR and isotopomer analysis allows for a 
comprehensive view of mitochondrial metabolism [178], by examining carbon flow 
through various metabolic pathways at once, which has not been done previously for 
cryopreserved encapsulated islets or beta cells.  Although this method alone does not 
 78
determine absolute metabolic fluxes, it does allow for the evaluation of relative metabolic 
fluxes and preferred metabolic pathways, which have shown significant correlations with 
insulin secretion [34, 36]. 
Reports in the literature are conflicting with respect to secretory function after 
cryopreservation in encapsulated islets [24, 25, 37, 38, 40] or beta cells [30] and also vary 
with species, type of cryopreservation method, and insulin secretion protocol used.  
Additionally, few studies have directly compared conventional freezing to vitrification 
[25, 30].  Studies on cryopreservation of encapsulated hamster islets have indicated 
impaired insulin secretion from Vitrified [24, 25] and Frozen [25] constructs in vitro, 
with freezing leading to capsule breakage.  On the other hand, Vitrified encapsulated 
TC3 cells reportedly exhibited similar insulin secretion to nontreated controls, although 
Frozen encapsulated cells exhibited lower secretion [30].   However, the particular cell 
line, freezing protocol, and vitrification solutions used were different than those used in 
the current study. 
Although secretion from the Frozen group appeared slightly elevated compared to 
Fresh in the large-scale 13C NMR experiments, the increase was not statistically 
significant.  More importantly, insulin secretory function was significantly lower in the 
DPS vitrified group relative to Fresh (Figure 5.5).  This decreased secretion is likely not 
due to the large-scale of the 13C experiments, as a similar trend was observed in the 
small-scale secretion study (Figure 5.6). 
Although studies using 13C NMR and isotopomer analysis typically do not show 
correlations between all metabolic fluxes and insulin secretion, the significant decrease in 
insulin secretion in the DPS group without any corresponding changes in metabolic 
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fluxes is noteworthy and unprecedented.  This maintenance of carbon flow through TCA 
cycle pathways suggests that insulin secretion may be compromised downstream of the 
TCA cycle in the DPS-vitrified group.  
 Various steps downstream of the TCA cycle may be potentially affected by DPS-
vitrification, with one possible area being depolarization/exocytosis. In particular, studies 
have examined the K+-induced depolarization responses from various cryopreserved cells 
and tissues [209-211]. One study on cryopreservation of boar spermatozoa indicated 
impaired response to depolarization after high K+ exposure in Frozen cells, where the rise 
in intracellular calcium was three times lower compared to that in Fresh cells [209]. 
Additionally, studies on Conventionally Frozen blood vessels have indicated impairment 
in contractility response after exposure to high K+ compared to unfrozen controls [210, 
211]. Specifically, the reduced contractility response from Frozen human internal 
mammary arteries has been associated with enhanced basal intracellular calcium 
concentration in smooth muscle cells post-warming due to possible enhancement in 
calcium flux through voltage-gated calcium channels and activation of protein kinase C 
after cryopreservation [210]. A subsequent study, also indicating impairment in 
contractility response after freezing, suggests that freezing-induced membrane 
depolarization and activation of the Rho/Rho kinase pathway are important factors in the 
increased basal intracellular calcium concentration after Conventional Freezing of human 
saphenous veins [211]. With respect to Vitrified blood vessels, Song et al. examined the 
effects of drug agonist-induced contractility in Vitrified and Frozen rabbit veins, and 
found similar responses to most agonists from Vitrified veins relative to Fresh controls 
[212]. Overall, studies have reported on the effects of freezing on K+ induced 
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depolarization response from Frozen cells [209] or tissues [210, 211], but the effects of 
vitrification on K+ induced depolarization responses remain less known. 
It has been previously shown that TC-tet cells stimulated by high K+ had a 
higher fold induction in insulin secretion compared to cells stimulated by glucose [208].  
Similarly, in our study, significantly higher stimulation indices were found for high K+ 
stimulation compared to high glucose stimulation for the Fresh and Frozen groups, but 
not the DPS group.  The blunted insulin secretion from the DPS group after high K+ 
exposure and the similar stimulation indices between high K+ and high glucose exposure 
for DPS may indicate a defect in depolarization/exocytosis.  Importantly, this is 
corroborated by the similar intracellular insulin content among the three groups at the end 
of the basal period, which indicates that the lower induced secretion from the DPS group 
was not due to insufficient intracellular insulin.  Although the reason for the reduced 
secretion is unclear, defects in the membrane depolarization mechanism itself or in 
subsequent steps, such as the opening of voltage-gated calcium channels and the rise in 
intracellular calcium, are possibilities.  
 
5.6 Conclusions 
 Using 13C NMR and isotopomer analysis, we found that intermediary metabolism 
was maintained in encapsulated TC-tet cells cryopreserved by either vitrification or 
conventional freezing.  Additionally, insulin secretion was maintained post-warming in 
Conventionally Frozen constructs.  Although vitrification may be advantageous due to 
better maintenance of biomaterial integrity in some systems, our study indicates 
compromised insulin secretion, possibly due to defects in late-stage secretion events.  
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Overall, our results offer new insight into understanding insulin secretion pathways that 
are maintained after cryopreservation as well as those that should be investigated further 




CRYOPRESERVATION EFFECTS ON RECOMBINANT 
MYOBLASTS ENCAPSULATED IN ADHESIVE ALGINATE 
HYDROGELS 
 
6.1      Abstract 
Cryopreservation is critical for long-term storage of microencapsulated cells. 
Although many studies have examined cryopreservation of cells encapsulated in non-
adhesive hydrogels, as bio-functionalized hydrogels, such as those with adhesive motifs, 
are increasingly being used, it is important to understand how the additional complexity 
of 3-D adhesion affects cryopreservation outcome. Indeed, evidence suggests that 
adhesion plays an important role in cell response to cryopreservation. With respect to a 
pancreatic substitute, studies have indicated benefits with adhesion in 3-D. Thus, the 
main objectives of this study were 1). to assess the effect of cell-matrix interactions on 
cryopreservation response in terms of metabolic activity and insulin secretion from 
encapsulated, stably transfected murine C2C12 myoblasts and 2). to determine the 
longer-term cryopreservation response of the cells encapsulated in a 3-D adhesive 
hydrogel matrix. Materials/Methods: To determine the effect of cell-matrix interactions 
on Cryopreserved encapsulated cell response, stably transfected C2C12 cells, 
encapsulated in partially oxidized RGE and RGD-alginate hydrogels, were compared and 
assessed for metabolic activity and insulin secretion after freezing and vitrification. To 
assess the longer-term response of cells encapsulated in RGD-alginate hydrogels, 
encapsulated cells were cultured either 1 or 4 days post-encapsulation, cryopreserved, 
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and assessed up to 3 days post-warming for metabolic activity and insulin secretion. Cell 
morphology was assessed one day post-warming via circularity measurements. Results: 
Cells encapsulated in RGE or RGD-modified alginate responded similarly after 
vitrification and conventional freezing in terms of metabolic activity and insulin secretion 
up to one day post-warming. Frozen RGD-alginate encapsulated cells responded 
similarly to Fresh controls in terms of metabolic activity and insulin secretion over 3 days 
post-warming. However, DPS-vitrified beads exhibited lower metabolic activity one day 
post-warming. Cell circularity was also similar between Fresh and Cryopreserved groups. 
Conclusions: The presence of cell-matrix interactions did not affect cell response to 
cryopreservation in terms of metabolic activity and insulin secretion up to one day post-
warming. In spite of initial differences in metabolic activity and insulin secretion rate 
relative to Fresh controls for the DPS-vitrified group, overall, conventional freezing and 
DPS-vitrification maintain metabolic activity, insulin secretion rate, and cell morphology 
for Stable C2C12 cells encapsulated in partially oxidized, RGD-alginate hydrogels.   
 
6.2      Introduction 
Cryopreservation is critical for long-term storage of tissue engineered constructs 
[4, 5, 213, 214]. The two main methods of cryopreservation are conventional freezing 
and vitrification (ice-free cryopreservation). Although extracellular ice formation is not 
necessarily detrimental to single cells in suspension, ice formation during freezing 
presents a significant challenge in cryopreserving multicellular systems and tissues [4, 5]. 
Thus, vitrification, or ice-free cryopreservation, has been investigated for preservation of 
various natural tissues [5, 215, 216] as well as tissue engineered constructs [24, 25, 30, 
 84
50, 51, 162, 214]. However, vitrification may potentially lead to cell osmotic excursions 
as well as cytotoxicity due to the high concentration of cryoprotectants used in the 
procedure [5, 6]. Thus, it is important to study both vitrification and freezing methods in 
order to determine the best method of preservation for a given 3-D construct.  
Cell microencapsulation within 3-D hydrogels has been widely studied for various 
tissue engineered constructs, with alginate commonly being used as the encapsulation 
polymer [74, 217, 218]. With respect to cryopreservation of encapsulated cells, most 
studies have examined cellular response in non-adhesive hydrogel systems [24, 25, 30, 
37-44]. However, to better control cell fate in 3-D, bio-functionalized hydrogels are 
increasingly being studied, with additions of bioactive motifs to help control cellular 
processes such as cell adhesion [219, 220]. Adhesion in 3-D is especially important, as 
cell-matrix interactions have been shown to be important for cell survival, proliferation, 
and differentiation among other cell processes [221].  
With respect to a pancreatic substitute, unmodified alginate has been commonly 
used for cell encapsulation [8, 71]. However, as various cells types are being explored for 
use in cell-based therapies for insulin-dependent diabetes [48], different degrees of 
anchorage dependence may become necessary upon their encapsulation in a 3-D hydrogel 
environment. In addition, recent evidence suggests that cell-matrix interactions in 3-D are 
beneficial for encapsulated beta cells or islets [11, 12, 96]. Thus, adhesive hydrogels may 
be advantageous for certain pancreatic substitutes. In particular, alginate polymer chains 
have been coupled with the ubiquitous tripeptide RGD [222], in order to promote cell 
adhesion in 3-D [20, 101, 223]. Specifically, the C2C12 myoblast cell line has been well 
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characterized in RGD-alginate, displaying the ability to survive, proliferate, and 
differentiate on 2-D [99]  as well as in 3-D hydrogel systems [20].  
It is critical to study the viability and function of cells in an adhesive environment 
post-cryopreservation, as previous studies suggest that adhesion plays an important role 
in cell response to cryopreservation. Indeed, literature reports indicate that cells in 
suspension respond differently to cryopreservation than cells attached to a substrate [14, 
15, 17, 224]. In addition, encapsulation underneath or within adhesive matrices has been 
suggested to improve cryopreservation response for certain cells compared to cells in 
suspension [16, 17, 225]. However, cryopreservation studies on cells in 3-D adhesive 
hydrogels have generally focused on either the effects of conventional freezing [16, 45] 
or vitrification [50, 51] and rarely compare or decouple the separate effects of 
encapsulation and adhesion [16]. Additionally, no study has directly examined 
cryopreservation response to both vitrification and freezing in 3-D adhesive vs. non-
adhesive hydrogel matrices.  
In this study, we used a model pancreatic substitute consisting of C2C12 cells, 
stably transfected to secrete insulin, encapsulated in partially oxidized, RGD-modified 
alginate hydrogels. To address the issue of the effects of cell-matrix interactions on 
cellular response to both vitrification and conventional freezing, we compared metabolic 
activity and insulin secretion up to one day post-warming for Cryopreserved Stable 
C2C12 cells encapsulated in RGD and RGE-modified, partially oxidized alginate 
hydrogels. As previous studies have indicated benefits of longer-term culture of 
encapsulated cells pre-preservation [17, 225], we cryopreserved beads 1 and 4 days after 
encapsulation, and assessed metabolic activity and insulin secretion up to 3 days post-
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warming. Cell morphology after cryopreservation was also quantified and compared to 
that of Fresh controls, as cell spreading has been associated with myoblast differentiation 
and fusion to form myotubes in RGD-alginate hydrogels [20].  
 
6.3   Materials and Methods 
6.3.1 Alginate Modification 
All chemicals were obtained from Sigma (St. Louis, MO), unless otherwise 
indicated. Alginate was partially oxidized with sodium periodate based on previously 
published protocols [20, 111, 226]. Briefly, 1% (w/v) Pronova UP LVM alginate (FMC 
Biopolymer, Philadelphia, PA) was dissolved in ultrapure water. Subsequently, sodium 
periodate (Acros Organics, Geel, Belgium) was added to the alginate solution at 21.6 
mg/g alginate [20] and stirred in the dark at room temperature for 19 hours. 
Subsequently, a two-fold molar excess, compared to the sodium periodate used, of 
ethylene glycol was added to the alginate solution to quench the oxidation reaction and 
stirred for an additional 2 hours [226]. Alginate was then placed in 2000 MWCO dialysis 
cassettes (Thermo Fisher Scientific, Waltham, MA) and dialyzed against ultrapure water 
for 3 days prior to lyophilization.  
Partially oxidized alginate was subsequently reconstituted and conjugated with 
either GGGGRGDSP [20]  or GGGGRGESP peptides (Biomatik Corporation, 
Wilmington, DE) at 10mg/g alginate using aqueous carbodiimide chemistry [98, 99]. The 
incorporation efficiency of the RGD peptide into the alginate matrix was previously 
described [98].  Briefly, 1% (w/v) partially oxidized alginate was dissolved in 0.1 M 
MES buffer with 0.3 M NaCl (pH 6.5) for four hours at room temperature. Subsequently, 
1-Ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride (EDC) (Thermo Fisher 
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Scientific) and N-hydroxysulfosuccinimide (sulfo-NHS) (Thermo Fisher Scientific) were 
dissolved in MES buffer immediately prior to the reaction and added to the alginate to 
obtain a 2:1 molar ratio. The alginate solution was then allowed to react for 5 minutes 
prior to addition of the respective peptides [101]. The resulting solution was continuously 
mixed at room temperature for 20 hours prior to being transferred to 3500 MWCO 
dialysis cassettes (Thermo Fisher Scientific) for three-day dialysis against ultrapure water 
to remove unbound peptide and reactants. The peptide-modified, partially oxidized 
alginate was subsequently lyophilized.  
 
6.3.2    Cell Culture and Encapsulation/Coating 
  Stable C2C12 cells, previously transfected with furin-cleavable, B10-modified 
human insulin [21], were cultured in DMEM (Mediatech, Manassas, VA) with 10% FBS 
(Gemini Bioproducts, West Sacramento, CA), 1% penicillin/streptomycin (P/S) 
(Mediatech) and 1 μg/ml puromycin (Sigma) in order to maintain constant selective 
pressure on the cells. Cells were plated at approximately 300-350,000 cells per T-175 
flask and cultured under subconfluent conditions in order to prevent cell differentiation 
[99] in a 37oC humidified incubator with 95% air/5% CO2. All salt solutions used for 
encapsulation/coating were adjusted to 300 mOsm by adjusting the amount of the major 
salt component in the solution. For encapsulation, cells were detached from flasks using 
0.25% trypsin (Mediatech) and cell number determined using trypan blue dye exclusion. 
The cell suspension was then centrifuged, and 3.5 % oxidized RGD or RGE-modified 
LVM, reconstituted in 0.85% NaCl (w/v), was added to the cell pellet in order obtain an 
encapsulation density of 3x106 cells/ml alginate. This low cell density was used to 
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promote cell-matrix interactions over cell-cell interactions. Beads of 300-600 µm 
diameter were formed using an electrostatic bead generator (Nisco Engineering AG, 
Zurich, Switzerland) and crosslinked in a 1.1% (w/v) CaCl2 bath. Beads were 
immediately coated according to the procedure of Sun [227], with modifications. Briefly, 
beads were placed in 0.1% (w/v) CHES in 1.1% (w/v) CaCl2 for 3 minutes, washed with 
1.1% (w/v) CaCl2, and then incubated in 0.1% poly-L-lysine (PLL) (MW 15,000-30,000, 
Sigma) in 0.85% (w/v) NaCl, with mixing, for 5 minutes. Beads were then exposed to 
successive washes in 0.1% (w/v) CHES in 1.1% (w/v) CaCl2, 1.1% (w/v) CaCl2, and 
0.85% (w/v) NaCl (two washes). Beads were then incubated in 0.2% w/v Pronova UP 
LVM (unmodified) alginate in 0.85% (w/v) NaCl for 4 minutes. After one additional 
wash in 0.85% (w/v) NaCl, beads were washed with culture medium and then placed in 
T-25 flasks. Beads were not exposed to sodium citrate as the last step. Flasks were placed 
on a platform rocker (Stovall, Greensboro, NC) in an incubator at 37oC. Encapsulated 
cells were cultured in the same type of medium as monolayers. 
 
6.3.3    Cryopreservation 
6.3.3.1 Vitrification 
  For vitrification, the cryoprotectant (CPA) cocktail solution DPS, consisting of 3 
M dimethylsulfoxide (DMSO), 3 M 1,2 propanediol, and 0.5 M sucrose in a modified 
version of the EuroCollins carrier solution, containing 34.95 g/l glucose, 0.84 g/l 
NaHCO3 (Fisher Chemical, Fisher Scientific, Pittsburgh, PA), 1.12 g/l KCl and 1.68 g/l 
NaCl was used. For CPA addition, approximately 0.7 ml beads were placed in 40 µm cell 
strainers (BD Biosciences, Bedford, MA), and sequentially transferred through CPA 
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solutions of increasing concentration at 4oC in a six-well plate (BD Biosciences) (Table 
5.1). After incubation in the last CPA addition solution, beads and solution were 
transferred to pre-siliconized 20 ml borosilicate glass vials (Fisherbrand/Fisher Scientific) 
and a layer of isopentane (EMD Chemicals, Gibbstown, NJ) was placed on top of the 
CPA and beads. Vials were then placed on ice until transferred to a pre-chilled rack. The 
rack was then placed in an isopentane bath in a -135oC freezer for fast cooling to 
approximately -100oC (~64oC/min) prior to transfer to a rack in the freezer for slow 
cooling (~2oC/min) to -130oC. Temperature was tracked during the cooling process using 
a thermocouple placed in a sample vial containing only CPA solution and isopentane. 
Vitrification was verified by visual observation after cooling and immediately prior to 
warming of vials [206]. After overnight storage, vials were warmed rapidly in a 30% 
(v/v) DMSO in water bath at room temperature. Additionally, there was no 
crystallization/devitrification visible upon warming in the DMSO/water bath. 
Subsequently, vials were placed on ice and transferred to cell strainers for subsequent 
CPA removal in a stepwise fashion of decreasing CPA concentration at room 
temperature. Beads were then placed in T-12.5 flasks in fully supplemented DMEM at 
37oC or aliquoted out for immediate assay. 
Table 6.1 Cryoprotectant addition/removal protocol for DPS vitrification. A: addition; R: 
removal; RT: room temperature; PD; 1,2 propanediol 
Step DMSO (M) PD (M) Sucrose (M) Time (min) Temperature 
(oC) 
A1 1 1 0.15 2 4 
A2 2 2 0.3 2 4 
A3 3 3 0.5 2 4 
R1 2.25 2.25 0.3 2 RT 
R2 1.5 1.5 0.2 2 RT 
R3 0.75 0.75 0.1 2 RT 
R4 0 0 0 4 RT  
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6.3.3.2 Conventional Freezing 
  For conventional freezing, beads were added to 10% DMSO in fully 
supplemented DMEM at 4oC incubated for 10 minutes. Beads and solution were 
subsequently transferred to 2.0 ml cryogenic vials (Corning Inc., Corning, NY) which 
were placed in a Mr. Frosty isopropyl alcohol bath (Nalgene/Thermo Fisher Scientific, 
Rochester, NY) in a -80oC freezer (VWR International, Radnor, PA) for 1.5 hours. 
Subsequently, vials were plunged into liquid nitrogen. After overnight storage, beads 
were warmed rapidly in a 37oC water bath until no ice was visible. Beads were then 
placed in fully supplemented DMEM at 37oC for 10 minutes, followed by one wash in 
fully supplemented DMEM. Beads were subsequently transferred to T-12.5 flasks with 
fully supplemented DMEM and placed in the incubator at 37oC or aliquoted out for 
immediate assay. 
 
6.3.4    Metabolic Activity and Insulin Secretion                                   
  Metabolic activity from encapsulated cells was measured using alamarBlue® (Life 
Technologies, Carlsbad, CA). For the study comparing metabolic activity for the Fresh 
RGD/RGE/No peptide alginate encapsulated cells, 0.1 ml beads were added to 1 ml 
DMEM and 100 µl alamarBlue stock solution in a 12-well plate. After incubation for four 
hours at 37oC, samples of supernatant from each well were placed in a black 96-well 
plate (Nalgene/Nunc) and fluorescence was measured using a Synergy H4 Multimode 
microplate reader (Biotek Instruments, Winooski, VT) using excitation and emission 
wavelengths of 544 nm and 590 nm, respectively. For cryopreservation studies, 50 µl of 
beads were placed in 1 ml DMEM and 100 µl alamarBlue® stock solution and incubated 
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at 37oC for 4 hours. Medium was sampled at the beginning and end of the alamarBlue® 
assay period for insulin as well as for measuring fluorescence, as mentioned above. 
Insulin concentrations in samples were measured using an ultrasensitive human insulin 
radioimmunoassay kit (Millipore, St. Louis, MO), according to manufacturer’s 
instructions.  
 
6.3.5    LIVE/DEAD® Staining of Beads and Image Analysis 
  At one day post-warming, beads were stained with the LIVE/DEAD® viability kit 
(Life Technologies). Briefly, beads were washed 3 times in 0 mM glucose, phenol-free 
DMEM and then incubated in the same type of DMEM for 30 minutes with 2 µM calcein 
AM and 4 µM ethidium homodimer. Subsequently, beads were imaged using an LSM 
510 NLO confocal microscope with the following excitation/emission settings: calcein 
AM (excitation: 488 nm/emission: 500-530 nm) and ethidium homodimer (excitation: 
543 nm/emission: 560 nm) (Carl Zeiss, Thornwood, NY). A number of 10-20 beads were 
imaged per group, with Z-stacks taken every 10-20 µm.  
  For image analysis, Image J (NIH) was used to determine circularity of the cells 
in the beads. One Z-stack was taken per bead. For each image in the Z-stack, the green 
channel was isolated, a channel intensity threshold value of 30 was chosen, and particles 
with a size greater than 30 pixels squared were analyzed. For each bead, the average 
circularity from each slice was calculated and circularity values from each slice were 




6.3.6    Actin/Nuclei Staining  
Fresh RGE and RGD-modified beads were fixed and cells stained with rhodamine 
phalloidin (Life Technologies) and DAPI (Life Technologies) to qualitatively assess cell 
morphology on the day of cryopreservation. Beads were washed with phenol-free DMEM 
and fixed in 3.7% methanol-free formaldehyde (Thermofisher Scientific) for 20 minutes, 
followed by 2 washes in DMEM. Subsequently, beads were incubated in 0.5% triton-X 
100 (Acros Organics, Geel, Belgium) for 15 minutes, rinsed twice with DMEM, and 
blocked with 1% BSA in DMEM for 20 minutes. Beads were then incubated in 
rhodamine phalloidin for 20 minutes, washed once in DMEM, and then stained with 
DAPI for 15 minutes. Subsequently, beads were washed twice in DMEM and mounted 
onto glass slides using Prolong Antifade Gold Reagent (Life Technologies) and a cover 
slip. Each cover slip was sealed at the edges with clear nail polish. Cells in beads were 
imaged using an LSM 510 NLO confocal microscope (Carl Zeiss) with a 63x objective 
and excitation and emission settings of 543 and 554-707 nm, respectively. DAPI was 
imaged using a multiphoton laser at 750 nm.  
 
6.3.7    Statistical Analysis 
Data are represented as mean ± standard deviation. If necessary, data were 
normalized using the Box-Cox transformation [228] prior to statistical analysis. Data 
were analyzed using a One-way ANOVA and Tukey’s post-hoc analysis in the General 
Linear Model in Minitab (Minitab Inc., State College, PA). When comparing cell 
circularity per bead among different groups, individual beads were nested within 
encapsulations. Values of p<0.05 were considered statistically significant. 
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6.4       Results 
6.4.1    Characterization of Stable C2C12 Cells Encapsulated in RGD and Non-   
            Adhesive Alginate  Hydrogels 
In order to determine the appropriate RGD-alginate matrix to allow for cell 
spreading in 3-D while maintaining bead integrity during culture and post-preservation, 
various bead preparations were tested (refer to Appendix D). Following these tests, it was 
determined that 3.5% oxidized, RGD-modified LVM (cross-linked with calcium) coated 
with 0.1% PLL was the appropriate matrix. Encapsulated Stable C2C12 cells were then 
evaluated in adhesive (RGD) vs. non-adhesive matrices (RGE/no peptide) to establish the 
importance of cell-matrix interactions for these cells in alginate and to determine the 
appropriate non-adhesive matrix for subsequent studies. Stable C2C12 cells were 
encapsulated in beads containing RGD, RGE or no peptide alginate and assessed over 4 
days for cell morphology, bead integrity, and metabolic activity. As indicated in Figure 
6.1, bead integrity was maintained over 4 days in culture. In addition, spreading was 
apparent in RGD but not RGE/no peptide groups on Days 1 and 4. Viable cells were 





Figure 6.1 Representative light microscopy images (10x) of encapsulated Stable C2C12 
cells cultured 1 and 4 days post-encapsulation in RGD/RGE/no peptide alginate 
hydrogels (10x). Arrows indicate spread cells. Scale bars represent 500 µm. 
 
 
Figure 6.2 shows the metabolic activity over time for Stable C2C12 cells 
encapsulated in the different alginate hydrogels. Metabolic activity was maintained in 
cells encapsulated in RGD-modified alginate hydrogels from Day 1 to Day 4 (p>0.05), 
although there was a decline in metabolic activity for Stable C2C12 cells encapsulated in 
non-adhesive (RGE-modified and no peptide) alginates from Day 1 to Day 4 (p<0.05). 
Also, there was a decline in metabolic activity from Day 2 to Day 3 and from Day 2 to 
Day 4 for the RGE group (p<0.05). However, there was no difference between RGE and 
no peptide alginate groups at any given time point (p>0.05). On the basis of these results 
and the fact that an RGE-alginate matrix more closely resembles a RGD-matrix, RGE 
was selected as the appropriate non-adhesive control. The Stable C2C12 cells 
encapsulated in RGD-alginate had a higher metabolic activity compared to non-adhesive 
alginates from Day 2 onward (p<0.05). 
Day 1 
Day 4 
RGD RGE No Peptide 
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Figure 6.2 Metabolic activity over time for cells encapsulated in 3.5% RGD (white bars), 
RGE (light gray bars), and no peptide (dark gray bars) LVM alginate, and normalized to 
respective groups on Day 1. #p<0.05 compared to RGD group at same time point, 




6.4.2 Cryopreservation Effects on Stable C2C12 Cells Encapsulated in RGD vs. 
RGE-Alginate Hydrogels 
In order to evaluate the effects of cell-matrix interactions on cellular response 
after cryopreservation, Stable C2C12 cells encapsulated in RGD and RGE-alginate, 
cryopreserved one day post-encapsulation, were compared up to one day post-warming. 
As shown in Figures 6.3A and 6.3B, there was no difference in metabolic activity 
(normalized to respective Fresh controls) for Stable C2C12 cells encapsulated in RGD or 
RGE-alginate hydrogels up to one day post-warming after either DPS-vitrification or 
conventional freezing, respectively. Similarly, Figures 6.3C and 6.3D indicate no 
difference in insulin secretion (normalized to Fresh controls) for Stable C2C12 cells 
encapsulated in RGD or RGE alginate-hydrogels, after cryopreservation. The average 
































































beads*hr) at t0 and t1, respectively. The average ISR values for the Fresh RGE group 
were 4.79 ± 0.89 and 2.38 ± 0.67 µU/(0.05 ml beads*hr) at t0 and t1, respectively.  
 
Figure 6.3 Cellular response to cryopreservation in adhesive (RGD, white bars) vs. non-
adhesive (RGE, gray bars) alginate hydrogels in terms of A). metabolic activity-DPS-
vitrified; B).metabolic activity-Frozen, C). insulin secretion rate (ISR)-DPS vitrified, and 
D). ISR-Frozen. Groups were normalized to their respective Fresh controls. n=3-4 
 
6.4.3    Metabolic Activity in RGD-Alginate Hydrogels after 1 or 4 Days of Pre- 
            Cryopreservation Culture 
 To determine the effect of cryopreservation and culture time pre-preservation on 
metabolic activity post-warming in RGD-alginate encapsulated Stable C2C12 cells, 
encapsulated cells were cryopreserved either 1 or 4 days post-encapsulation and assessed 
































































































































































subsequently cryopreserved are referred to as the “RGD C1” group, and beads cultured 
for 4 days prior to cryopreservation are referred to as the “RGD C4” group. As indicated 
in Figure 6.4A, there was no difference in metabolic activity between the Frozen group 
and the respective Fresh control at any time point assayed (p>0.05). However, the DPS-
vitirifed group exhibited lower metabolic activity than the Fresh control immediately 
post-warming (p<0.05). Metabolic activity was maintained within the Cryopreserved 
groups and the Fresh control up to 3 days post-warming. With respect to the cells 
encapsulated and cultured 4 days prior to cryopreservation (RGD C4), Figure 6.4B 
indicates the DPS-vitrified group had lower metabolic activity compared to the respective 
Fresh control and the Frozen group immediately post-warming (p<0.05). There was no 
difference in metabolic activity between the Frozen and Fresh groups at any time point 
assayed for the RGD C4 group. Additionally, all groups exhibited an increase in 
metabolic activity from 0 to 3 days post-warming (p<0.05). 
Figure 6.4 Metabolic activity in Fresh and Cryopreserved Stable C2C12 cells 
encapsulated in RGD-alginate hydrogels and cultured A).1 or B). 4 days post-
encapsulation, prior to cryopreservation. All groups were normalized to the Fresh group 
at t0. The Fresh group is represented by the white bars, the Frozen group by the dark gray 
bars, and the DPS-vitrified group by the striped bars. *p<0.05 compared to same group at 
t0, ^p<0.05 compared to same group at one day post-warming, #p<0.05 compared to 














































































6.4.4 Insulin Secretory Function Over Time After 1 or 4 Days of Pre-      
            Cryopreservation Culture 
To determine the effect of cryopreservation and culture time pre-preservation on 
insulin secretion post-warming in RGD-alginate encapsulated cells, encapsulated Stable 
C2C12 cells were cryopreserved either 1 (RGD C1) or 4 (RGD C4) days post-
encapsulation and assessed up to 3 days post-warming. Figure 6.5A shows insulin 
secretory function from Fresh and Cryopreserved beads over time for the RGD C1 group 
(normalized to the Fresh t0 group) over time. There were no differences between the 
Fresh and Frozen group and Fresh and DPS-vitrified group at any time point assayed for 
the RGD C1 group (p>0.05). Additionally, insulin secretion decreased from immediately 
post-warming to one day post-warming for the Fresh control, with a  slight increase from 
time 1 to 3 days post-warming (p<0.05). Figure 6.5B shows insulin secretion from the 
beads cryopreserved 4 days post-encapsulation (RGD C4), normalized to the Fresh t0 
group. Overall, all groups exhibited an increase in normalized insulin secretion rate from 
immediately post-warming to 3 days post-warming and from one day post-warming to 3 
days post-warming (p<0.05). The DPS group transiently had higher insulin secretion than 
the Fresh group immediately post-warming (p<0.05). Similar to the RGD C1 group, there 
were no differences in insulin secretion between the Fresh and Frozen groups at any time 
point analyzed. The average ISR values for the Fresh groups at t0 were 5.82 ± 0.80 and 
4.26 ± 0.85 µU/(0.05 ml beads*hr) for RGD C1 and RGD C4, respectively. 
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Figure 6.5 Cryopreservation effects on insulin secretory function of Stable C2C12 cells 
encapsulated in RGD-alginate hydrogels cultured A).1 or B). 4 days post-encapsulation, 
prior to cryopreservation. Cryopreserved groups and Fresh controls were assessed up to 3 
days post-warming. All groups were normalized to the Fresh group at t0. The Fresh group 
is represented by the white bars, the Frozen group by the dark gray bars, and the DPS-
vitrified group by the striped bars *p<0.05 compared to same group at t0, ^p<0.05 
compared to same group at one day post-warming, #p<0.05 compared to Fresh group at 
same time point, @p<0.05 compared to Frozen group at same time point. n=3 
 
 
6.4.5 Direct Comparison of Pre-Cryopreservation Culture Time on Metabolic  
            Activity and Insulin Secretion Post-Warming From RGD-Alginate Hydrogels  
In order to more directly assess the effect of pre-culture time on cryopreservation 
response, the same data used in Figures 6.4 and 6.5 were re-analyzed with Cryopreserved 
groups normalized to the same day Fresh control, and cryopreservation responses from 
RGD C1 and RGD C4 groups at each respective time point were directly compared. 
Figures 6.6A and 6.6B show metabolic activity in DPS-vitrified and Frozen beads, 
respectively, up to three days post-warming (normalized to their respective, same day 
Fresh controls). Figures 6.6A and 6.6B show that there was no difference in 
cryopreservation response for the RGD C1 or RGD C4 group in terms of metabolic 




























































and 6.6D show insulin secretory response post-warming for DPS-vitrified and Frozen 
beads cultured 1 day (RGD C1) or four days (RGD C4) prior to cryopreservation. 
Overall, beads cultured for 1 day or 4 days prior to cryopreservation had similar insulin 
secretion rates (normalized to respective Fresh controls). However, at one day post-
warming, Frozen beads from the RGD C1 group exhibited higher normalized insulin 
secretion rates compared to the beads from the RGD C4 group (p<0.05).  
 
Figure 6.6 Effect of culture time prior to cryopreservation on Stable C2C12 cells 
encapsulated in RGD-alginate hydrogels and cultured for 1 (RGD C1-white bars) or 4 
(RGD C4-gray bars) days prior to cryopreservation A). metabolic activity-DPS vitrified, 
B). metabolic activity-Frozen and C). ISR-DPS-vitrified and D). ISR-Frozen.*p<0.05 


































































































































































6.4.6 LIVE/DEAD® Staining/Confocal Imaging and Image Analysis From Fresh 
and Cryopreserved Beads 
To assess cell morphology and viability within the beads, LIVE/DEAD® staining 
and confocal imaging were performed one day post-warming for the RGD C1, RGD C4, 
and RGE groups. As indicated by representative images in Figure 6.7A, there was no 
extensive cell death present one day post-warming for the RGD C1 Cryopreserved beads 
when compared to the Fresh control. Additionally, some spreading was present in the 
beads. Figure 6.7B indicates that there was also no extensive cell death one day post-
warming for the cryopreserved beads in the RGD C4 group. Although spreading was 
apparent in the RGD C4 group, there was some heterogeneity in cell morphology among 
beads. Figure 6.7C indicates that viable cells were present one day post-warming for all 
RGE groups. Overall, the cell morphology appeared rounded in the RGE-alginate beads.  
Figure 6.8A shows the average and distribution of circularity values per bead 
from Fresh RGE, RGD C1, and RGD C4 beads. Cells encapsulated in the non-adhesive 
matrix, RGE, exhibited a higher cell circularity per bead (more rounded shape) compared 
to the cells in both RGD groups (RGD C1 and RGD C4) (p<0.05). In addition, cells in 
the RGD C4 beads exhibited a lower cell circularity per bead (more elongated shape) 
compared to both the RGE and the RGD C1 beads. 
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Figure 6.7 Representative LIVE/DEAD® images (10x) from 3-D projections of beads 
one day post-warming for Cryopreserved groups and respective Fresh controls for A). 
RGD C1, B). RGD C4, and C). RGE groups. Scale bar represents 100 µm. 
 
Figures 6.8B and 6.8C indicate that for each of the RGD C1 and RGD C4 groups 
there was no difference in cell circularity per bead between the Cryopreserved groups and 
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no difference between the cell circularity per bead in the Fresh control and either Frozen 
or Vitrified groups (p>0.05). However, the DPS-vitrified group exhibited a higher cell 
circularity per bead compared to the Frozen group (p<0.05). In addition, when directly 
comparing cell circularity per bead in the Cryopreserved RGD C1 or RGD C4 groups, the 
beads in the RGD C4 group exhibited lower cell circularity per bead (p<0.05), indicating 
cells in those beads were more spread than cells in the cryopreserved beads from the 
RGD C1 group one day post-warming (data not shown).  
 
 
Figure 6.8 Box plots displaying circularity per bead for A). Fresh RGE, RGD C1 and 
RGD C4, B). RGD C1 Fresh and Cryopreserved, C). RGD C4 Fresh and Cryopreserved, 
and D). RGE Fresh and Cryopreserved groups. •average bead circularity for each group, 
and whiskers on each plot extend from minimum to maximum values of bead circularity 
within a given group. The red line represents the median and the bottom and top of each 
box represent the 25th and 75th percentile, respectively. n=3 for 3 independent 
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6.4.7    Bead Integrity Immediately Post-Warming 
In order to assess bead integrity after cryopreservation, phase contrast light 
microscopy images were taken of Fresh and Cryopreserved beads. As indicated in Figure 
6.9, overall bead integrity was maintained immediately post-warming in the 
Cryopreserved groups with respect to the Fresh controls. On average, fewer than 10% of 
the beads were broken for RGD C1, RGD C4, and RGE groups for both cryopreservation 
treatments and the Fresh control immediately post-warming. The percentage of broken 
beads was determined by counting beads in 6 independent fields of view for each group, 
and averages were taken from 2-3 independent experiments. 
  
Figure 6.9. Representative phase contrast light micrographs (4x) of Cryopreserved beads 
and Fresh controls immediately post-warming. Arrows point to damaged beads. The scale 










6.4.8 Actin/Nuclei Staining of Fresh RGD and RGE Beads at the Time of   
            Cryopreservation 
In order to assess cell morphology at the time of cryopreservation, Fresh beads 
from RGD C1, RGD C4, and RGE groups were stained for actin and counterstained with 
DAPI. Figure 6.10 shows representative confocal microscopy images of stained cells, and 
indicates that cells were overall rounded at the time of cryopreservation in the Fresh RGE 
group (Figure 6.10 E-F). Both adhesive groups (RGD C1 and RGD C4) exhibited more 
heterogeneity in cell morphology compared to the RGE group, with some spread cells as 
well as more rounded cells. Thus, elongated cells were present at the time of 
cryopreservation in the RGD-alginate groups, but not the RGE groups.  
 
Figure 6.10 Representative confocal microscopy images (63x) of actin/nuclei stained 
encapsulated cells in Fresh RGD and RGE beads at the time of cryopreservation: A)-B). 
RGD C1, C)-D). RGD C4, E)-F). RGE. White arrows point to spread cells. Scale bar 




6.5       Discussion 
Cryopreservation is important for clinical realization of tissue engineered 
constructs [5, 213]. Specifically, it is important to study cellular responses after exposure 
to different cryopreservation methods in a 3-D adhesive hydrogel environment, as 
cryopreservation with the added complexity of adhesion in 3-D may affect cellular 
response, but has not been extensively investigated. Indeed, studies have indicated that 
adhesion in 3-D may be beneficial for encapsulated insulin-secreting cells or islets [11, 
12, 96], and may become necessary as different cell types are microencapsulated for a 
pancreatic substitute. Hydrogels containing the RGD adhesive peptide motif in particular 
have been used for encapsulation of a variety of cell types, including myoblasts [20, 103], 
bone marrow stromal cells [101], pre-osteoblasts [103], and human embryonic stem cells 
[104].  
In this study, we have characterized cellular responses to cryopreservation in a 3-
D adhesive RGD-alginate system, where cell-matrix interactions have been shown to be 
important for cell survival, as indicated by the comparison of metabolic activity over time 
for Stable C2C12 cells encapsulated in RGD vs. non-adhesive alginates. Specifically, the 
decline in metabolic activity for Stable C2C12 cells encapsulated in non-adhesive (RGE-
modified and no peptide) alginate from Day 1 to Day 4, the higher metabolic activity in 
the RGD vs. non-adhesive hydrogels from Day 2 onward, and the maintenance of 
metabolic activity in the RGD-alginate beads from Day 1 to Day 4, all indicate that the 
encapsulated Stable C2C12 cells perform better in an adhesive environment at the given 
cell density used. Additionally, as there was no difference in metabolic activity between 
Stable C2C12 cells encapsulated in RGE and no peptide alginate hydrogels at any time 
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point assayed, there was likely no additional negative effect of incorporation of RGE into 
the alginate matrix. Due to the similarity in metabolic activity between RGE and no 
peptide alginates as well as RGE-alginate being a non-adhesive control closer in 
composition to an RGD-matrix, RGE-alginate was chosen as the non-adhesive control for 
subsequent cryopreservation experiments. 
Although the Stable C2C12 cells used in this study perform better in an adhesive 
RGD-alginate matrix, as mentioned above, it is still important to understand how the 
presence of cell-matrix interactions affects cell response to cryopreservation in a 3-D 
hydrogel environment, as this information may be significant in helping to design 
strategies for cryopreservation of cells in 3-D hydrogels. Although recent evidence 
suggests that encapsulation in an adhesive matrix may result in higher viability compared 
to encapsulation in a non-adhesive matrix after freezing-warming [16], not all studies 
showing benefits of cryopreservation in adhesive matrices include a non-adhesive control 
to compare the effects of cryopreservation in non-adhesive vs. adhesive matrices [17]. A 
non-adhesive control would help in understanding if there is indeed an additional benefit 
to adhesion over encapsulation alone for cells, especially as encapsulation in a non-
adhesive matrix has been shown to result in higher cell viability and reduction of 
apoptosis compared to cryopreservation of cells in suspension [229]. Additionally, no 
studies have simultaneously compared effects of both cryopreservation methods (i.e. 
vitrification and conventional freezing) in the context of adhesive vs. non-adhesive 3-D 
hydrogel environments. In the current study, early time points were chosen to assess the 
effect of cell-matrix interactions in 3-D, as the metabolic activity declined for cells 
encapsulated in non-adhesive alginates over time (Figure 6.2). As no differences in 
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insulin secretory response or metabolic activity (normalized to respective Fresh controls, 
Figure 6.3), were found after either freezing or vitrification up to one day post-warming, 
this indicated that the encapsulated cells responded similarly to both cryopreservation 
methods at early time points post-warming regardless of the presence of cell-matrix 
interactions. This is in contrast to Sambu et al.[16], who found that mouse embryonic 
stem cells encapsulated in RGD-functionalized alginate and subsequently frozen 
performed better in terms of viability and expression of the Oct-4 stem cell maker 
compared to cells encapsulated and frozen in non-adhesive alginate. However, the 
addition of adhesion in 3-D did not significantly improve all factors examined, as not all 
stem cell markers studied exhibited different expression levels after cryopreservation in 
unmodified alginate compared to RGD-functionalized alginate. Additionally, the authors 
did not include data from non-preserved controls, and thus were unable to account for 
possible differences in initial cell viability or physiological status prior to 
cryopreservation. Including data from the Fresh non-adhesive control is key, as we have 
shown that metabolic activity from cells in Fresh non-adhesive alginate beads is lower 
than that from cells in RGD-alginates (Figure 6.2). 
Cell morphology was quantitatively assessed, via circularity measurements, after 
cryopreservation, as cell spreading of myoblasts encapsulated in partially oxidized, RGD-
modified hydrogels has been associated with differentiation of and fusion of myoblasts 
into multinucleated myotubes [20]. For a model pancreatic substitute containing 
myoblasts, terminal differentiation of myoblasts and fusion into myotubes would be 
important prior to use in vivo, as this would prevent excessive cell growth after 
implantation. As expected, the circularity per bead for the Fresh RGE group was higher 
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than that for both the Fresh RGD-encapsulated groups. This is likely due to the inability 
of the cells to attach and subsequently spread in the RGE-functionalized matrix, as 
opposed to their ability to bind to the RGD-alginate. Soluble RGD peptide competition 
studies have indicated that C2C12 cells can bind in an RGD-specific manner to RGD-
conjugated alginate [98, 99]. Additionally, the ability of C2C12 cells to bind to RGD-
alginate is in accordance with the literature showing that myoblasts express integrins such 
as αvβ3[230-232] and αvβ1[231] that can bind to the RGD sequence [222]. 
Additionally, the cell circularity per bead was similar between the cryopreserved 
groups and the Fresh control for either the RGD groups or the RGE group one day post-
warming. Although a quantitative measure of cell shape after cryopreservation in 3-D 
hydrogels is lacking in the literature, some studies have qualitatively assessed cell 
morphology after freezing and warming in collagen gels [225, 233]. Koebe et al. [225] 
reported that only approximately 30% of hepatocytes cultured in a collagen sandwich 
configuration and conventionally frozen had a morphology similar to CPA-treated, non-
frozen controls 2 and 11 days post-warming. Teo et al. [233], showed that immediately 
after freezing-thawing, in addition to changes to the microstructure of the matrix, 
fibroblasts encapsulated in collagen matrices experienced damage to cellular extensions 
as well as cell detachment, indicating damage to cell-matrix adhesions. Differences in 
cell morphology may not have been seen in the current study, as we examined 
morphology one day post-warming, allowing for possible recovery of changes present 
immediately post-warming. Additionally, cell morphology may have been better 
maintained in the RGD-alginate as opposed to previous studies with cells encapsulated 
and cryopreserved in collagen gels, as stresses formed during the cryopreservation 
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procedure, such as ice formation and mechanical deformation during freezing, may have 
affected the RGD peptides to a smaller extent than collagen fibrils in the collagen matrix. 
Freezing has been shown to affect the matrix structure of collagen gels, specifically by 
increasing the mean void area, or porosity, of the matrix [233]. Similarly, the structure of 
collagen fibers from heart valve tissue has also been shown to be damaged after freezing 
and to a smaller extent by vitrification [234, 235]. Since we did not use a gel consisting 
of a structural protein, but rather a polysaccharide conjugated with a small peptide, the 
damage to the peptide itself after freezing or vitrification may be less than that to a gel 
containing a dense extracellular matrix protein structure. Another plausible reason for the 
maintenance in cell morphology in the current study, especially after freezing, is the 
possible decrease in ice formation. Indeed, polysaccharide gels such as dextran [236] and 
alginate [237] have been shown to reduce ice crystallization during cryopreservation. As 
such, encapsulation in alginate has been shown to better maintain morphology of cell 
clusters including islets [37] and neurospheres [42] after conventional freezing compared 
to non-encapsulated controls. The maintenance of cell morphology and bead integrity 
may have also been an important factor in preserving metabolic activity and insulin 
secretion from the Cryopreserved encapsulated Stable C2C12 cells in this study. 
It is important to note that developing a 3-D hydrogel system that allowed for cell 
spreading in 3-D, while maintaining bead integrity in culture and after cryopreservation, 
was challenging. This was due to the requirement for cell spreading (likely due to less 
hydrogel resistance and/or decreased stiffness) in the matrix, while still having the beads 
robust enough to survive both methods of cryopreservation. After various preparations 
were tested (refer to Appendix D), it was determined that 3.5% oxidized RGD-LVM, 
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cross-linked with Ca2+ and coated with 0.1% PLL and unmodified alginate was the 
appropriate matrix to allow for both cell spreading and maintenance of bead integrity 
during culture and cryopreservation. Although there were some broken beads present 
immediately post-warming in the current experiments (less than 10%), the cause of the 
bead breakage is currently unclear. One possibility may be due in part to the agitation of 
the beads in the cell strainer during the CPA addition and removal procedure. 
Importantly, we examined cryopreservation response in RGD-alginate hydrogels 
up to 3 days post-warming, to account for recovery over time and because results 
immediately post-thaw may give overestimates of cell viability due to delayed-onset cell 
death after cryopreservation [238]. As the metabolic activity for the DPS-vitrified group 
was lower than Fresh immediately post-warming (p<0.05), and there were no differences 
in metabolic activity between Fresh and Frozen constructs, metabolic activity was 
maintained throughout the study specifically in Frozen constructs. Overall, insulin 
secretion rate was also maintained in Frozen constructs. Additionally, we saw no 
difference in ISR between Fresh and Cryopreserved groups from the RGE-alginate 
encapsulated cells immediately post-warming (data not shown). This is in contrast to 
Murua et al. [44], who saw a 42% decrease in erythropoietin secretion, compared to the 
Fresh control, after freezing stably transfected C2C12 cells encapsulated in alginate-poly-
L-lysine-alginate beads. However, the alginate type and freezing protocol used were 
different than those used in the current procedure, which may have contributed to the 
reduced secretion.  
Interestingly, when directly comparing cryopreservation response for RGD-
containing beads cultured one day (RGD C1) vs. four days (RGD C4) post-encapsulation 
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prior to cryopreservation (Figure 6.6), no differences were seen in metabolic activity or 
insulin secretion, except for a small difference in insulin secretion between RGD C1 and 
RGD C4 groups for the Frozen beads one day post-warming. Although the cell circularity 
per bead was lower for the cryopreserved RGD C4 groups compared to the cryopreserved 
RGD C1 groups one day post-warming (data not shown), they overall responded 
similarly to both cryopreservation methods in terms of metabolic activity, with a slight 
difference in insulin secretion for the Frozen group. Koebe et al. found a higher survival 
rate, better recovery, and greater albumin secretion for encapsulated rat hepatocytes 
cultured 7 or 11 days prior to freezing compared to constructs cultured only 3 days prior 
to cryopreservation. Additionally, Ji et al. [17] found that cryopreserving adherent human 
embryonic stem cell colonies 24 hours after placement of a top matrigel layer led to a 
higher viability compared to colonies that were cryopreserved only one hour after 
placement of the matrigel layer. However, no differences in viability were seen between 
the groups that were cryopreserved 24 hours after matrigel layer placement on top of cells 
and those that were cryopreserved 48 hours after matrigel layer placement [17]. Although 
we possibly may have seen a difference in cryopreservation response if we had waited 
longer than 4 days post-encapsulation to cryopreserve the RGD-alginate beads, large cell 
clusters were seen in beads at later time points (data not shown), leading to increased 
cell-cell interactions. This was undesirable in the current study, as the overall focus was 
on the effect of cell-matrix interactions more than cell-cell interactions on 




6.6       Conclusions 
In summary, at early time points post-warming, the presence of cell-matrix 
interactions did not affect cryopreservation response with respect to metabolic activity or 
insulin secretion after vitrification or freezing. Furthermore, when directly comparing the 
effect of pre-preservation culture period on RGD-alginate encapsulated Stable C2C12 
cell response post-warming, there was no difference in metabolic activity or ISR, except 
for slightly higher ISR one day post-warming from the Frozen group cultured one day 
pre-preservation. Up to 3 days post-warming, metabolic activity and ISR from Frozen 
RGD-alginate encapsulated cells were maintained relative to Fresh controls, irrespective 
of one or four-day pre-preservation culture period.  In spite of a transient decrease 
immediately post-warming, metabolic activity in DPS-vitrified RGD-alginate 
encapsulated cells was similar to Fresh controls up to 3 days post-warming, regardless of 
pre-preservation culture period.  Insulin secretion rate from DPS-vitrified encapsulated 
Stable C2C12 cells was also similar to Fresh controls, except for a transient increase 
immediately post-warming in 4-day pre-preservation cultured encapsulated cells. 
Although differences were seen between Fresh RGD C1, RGD C4, and RGE groups, cell 
circularity per bead was maintained one day post-warming, respective to Fresh controls, 
after both freezing and vitrification in each type of alginate matrix. Except for differences 
immediately post-warming in metabolic activity and insulin secretion rate relative to 
Fresh controls for the DPS-vitrified group, overall, conventional freezing and DPS-
vitrification maintain metabolic activity, insulin secretion rate, and cell morphology for 
Stable C2C12 cells encapsulated in RGD-alginate hydrogels. Due to simplicity of 
procedure and slightly superior results compared to vitrification, freezing appears 
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appropriate for cryopreservation of Stable C2C12 cells encapsulated in a partially 
oxidized, adhesive RGD-alginate matrix. 
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CHAPTER 7 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
7.1       Conclusions 
A tissue engineered pancreatic substitute consisting of insulin-secreting cells 
encapsulated in alginate hydrogels may provide more physiologic control of blood 
glucose levels compared to exogenous insulin therapy. For clinical translation of such a 
pancreatic substitute, long-term storage is critical, and cryopreservation is the most 
promising means of preservation. In particular, the two main cryopreservation methods 
that may be employed are conventional freezing and vitrification (ice-free 
cryopreservation). Although not necessarily damaging to single cells in suspension, ice 
formation during conventional freezing may be detrimental to a 3-D construct. 
Additionally, the high concentrations of cryoprotectants necessary for vitrification may 
lead to cell osmotic excursions as well as cytotoxicity. Thus, both cryopreservation 
methods must be carefully evaluated in determining the appropriate method of 
preservation for a pancreatic substitute consisting of insulin-secreting cells encapsulated 
in alginate hydrogels.   
As different cell types are being explored for use in pancreatic substitutes, 
different requirements for anchorage-dependence in 3-D may become necessary upon 
encapsulation. Cell-matrix interactions are important for various processes, including cell 
survival, proliferation, and differentiation [221]. Indeed, recent studies have indicated the 
importance of adhesion in 3-D for encapsulated insulin-secreting cells [11, 12, 96]. Thus, 
it is important to study the effect of cryopreservation on cells encapsulated in non-
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adhesive vs. adhesive alginate hydrogel environments. Therefore, we investigated the 
effects of both conventional freezing and vitrification on βTC-tet cells encapsulated in 
unmodified alginate, a model pancreatic substitute containing cells that have been shown 
to proliferate and function in a non-adhesive environment [18, 19]. Additionally, we 
investigated the effects of conventional freezing and vitrification on C2C12 cells, stably 
transfected to secrete insulin, encapsulated in RGD-modified, partially oxidized alginate. 
Stable C2C12 cells were encapsulated in an adhesive matrix, as C2C12 cells have been 
shown to proliferate and differentiate in an adhesive 3-D RGD-alginate environment [20].  
In CHAPTER 4 of this thesis, the appropriate parameters and procedures for 13C 
labeling, extraction, and isotopomer analysis from Fresh and Cryopreserved encapsulated 
βTC-tet cells were established. A volume of 6 ml of Fresh beads encapsulated at 7x107 
cells/ml was found to be appropriate for obtaining sufficient SNR in the NMR spectrum. 
Additionally, a pseudo isotopomer steady state was achieved at the 6 hour incubation 
period in the labeling medium. To interpret 13C NMR-derived isotopomer patterns, a 
previously published model with a second non-pyruvate carboxylase anaplerotic entrance 
to the TCA cycle was found to represent the experimental data well. Using these 
established parameters and procedures, relative metabolic fluxes were determined in 
CHAPTER 5. 
In CHAPTER 5 of this thesis, cryopreservation effects on intermediary 
metabolism in encapsulated βTC-tet cells were investigated using 13C NMR and 
isotopomer analysis. Post-warming, secretory function after glucose and high K+ induced 
secretion was studied from Frozen and DPS-vitrified beads. Relative carbon flow through 
the TCA cycle-associated pathways studied was found to be maintained after both 
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conventional freezing and vitrification. Although insulin secretory function was 
maintained in Conventionally Frozen constructs during the extraction experiments, it was 
impaired in the DPS-vitrified constructs. As a similar trend in decreased insulin secretion 
compared to Fresh controls was found in DPS-vitrified beads upon performing a small-
scale GSIS test, with beads from a single cryopreservation batch, the scale-up of the 
vitrification procedure necessary for the extractions did not cause the decrease in insulin 
secretion. Upon exposure to high K+, DPS-vitrified constructs secreted significantly less 
insulin compared to Fresh controls, although secretion from Frozen constructs was 
comparable to Fresh. Intracellular insulin content measured prior to depolarization was 
similar in Cryopreserved groups compared to Fresh controls. As DPS-vitrified beads 
exhibited reduced insulin secretion upon depolarization with high K+ compared to Fresh 
controls, similar stimulation indices for glucose and high K+ -induced insulin secretion, 
and similar intracellular insulin content to Fresh controls prior to depolarization, this 
indicates a possible defect in the late-stage insulin secretion/exocytosis machinery in 
these encapsulated cells.  
In CHAPTER 6 of this thesis, Stable C2C12 cells were encapsulated in RGD and 
RGE-alginate hydrogels, cryopreserved, and assessed up to one day post-warming to 
examine the effect of cell-matrix interactions on cryopreservation response in terms of 
metabolic activity and insulin secretion. To address the longer-term response of Stable 
C2C12 cells encapsulated in an adhesive alginate environment, Stable C2C12 cells were 
encapsulated in RGD-alginate hydrogels, cultured either 1 or 4 days post-encapsulation, 
cryopreserved, and assessed up to 3 days post-warming. As myoblast spreading in 
partially oxidized, RGD-modified hydrogels has been associated with myoblast 
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differentiation and fusion into myotubes [20], and myoblast differentiation would be 
optimal for a pancreatic substitute prior to in vivo implantation, cell circularity in beads 
was also assessed after cryopreservation. Regardless of cryopreservation method, the 
presence of cell-matrix interactions did not affect the cellular response with respect to 
metabolic activity or insulin secretion at early time points post-warming. Direct 
comparison of pre-preservation culture time on cellular response post-warming indicated 
similar insulin secretion and metabolic activity for RGD-alginate encapsulated Stable 
C2C12 cells, except for a difference in ISR one day post-warming from the Frozen group 
cultured one day prior to preservation. Irrespective of one or four-day pre-preservation 
culture period, metabolic activity and ISR from Frozen RGD-alginate encapsulated 
Stable C2C12 cells were maintained relative to Fresh controls, up to 3 days post-
warming. Except for a decrease immediately post-warming, metabolic activity in DPS-
vitrified RGD-alginate encapsulated Stable C2C12 cells was maintained relative to Fresh 
controls up to 3 days post-warming, regardless of pre-preservation culture period.  In 
addition, the insulin secretion rate from DPS-vitrified Stable C2C12 cells encapsulated in 
RGD-alginate was maintained relative to Fresh controls, except for an increase 
immediately post-warming in encapsulated cells that were cultured 4 days prior to 
cryopreservation. In terms of cell morphology, cell circularity per bead was maintained 
one day post-warming for cells cryopreserved  in RGD-alginate hydrogels cultured either 
1 or 4 days pre-preservation as well as RGE-encapsulated and Cryopreserved Stable 
C2C12 cells, relative to Fresh controls.  Overall, both methods preserved metabolic 
activity, secretory function, and bead integrity, with freezing producing slightly superior 
outcomes. 
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 In summary, the work in this thesis indicates that conventional freezing can be 
used to successfully cryopreserve and maintain intermediary metabolism and secretory 
function post-warming in βTC-tet cells encapsulated in unmodified alginate. Although 
intermediary metabolism is maintained in vitrified encapsulated βTC-tet cells, insulin 
secretory function in response to glucose and K+-induced secretion is impaired. In 
addition, conventional freezing maintains metabolic activity, insulin secretory function, 
and cell morphology in Stable C2C12 cells encapsulated in partially oxidized, RGD-
modified alginate. Although vitrification results in differences immediately post-warming 
in metabolic activity and insulin secretion, overall, metabolic activity, insulin secretory 
function, and cell morphology are maintained post-warming after vitrification for Stable 
C2C12 cells encapsulated in RGD-modified alginate hydrogels.  
 
7.2   Future Directions 
7.2.1    Cryopreservation Effects on Insulin Secretion from Vitrified Encapsulated   
            βTC-tet Cells  
Although results from CHAPTER 5 indicate that conventional freezing 
successfully maintains intermediary metabolism, as measured by 13C NMR and 
isotopomer analysis, as well as glucose-stimulated and depolarization-induced insulin 
secretion from encapsulated βTC-tet cells, further investigation into the effects of 
vitrification on insulin secretion is still warranted, as vitrification may be beneficial for 
more complex systems such as encapsulated islets. Additionally, vitrification may be 
important for encapsulated insulin-secreting cell systems where the biomaterial 
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component may be damaged by conventional freezing, as has been shown previously for 
encapsulated islets [25] and beta cells [22].  
Although glucose-stimulated as well as depolarization-induced insulin secretory 
function were affected immediately post-warming in the Vitrified beads, it is not clear if 
incubation for a longer time at 37oC post-warming would allow for recovery of secretory 
function from the encapsulated cells. Indeed, the insulin secretory response 24 hours 
post-warming has been shown to be different than that obtained within 2 hours post-
warming for Frozen and Vitrified islets in culture [239]. Thus, the Vitrified beads could 
be incubated for various periods immediately post-warming, such as 4-24 hours, prior to 
performing a glucose-stimulated or K+ induced depolarization/exocytosis test. If even 
after extended incubation at 37oC the depolarization/exocytosis response is still impaired, 
further investigation into the mechanism responsible for the impaired secretion would be 
warranted.  
As cryoprotectants alone have been shown to exhibit toxicity towards cells [163] 
and higher cryoprotectant concentrations are used in vitrification compared to freezing, 
an important test would be to see if the CPA addition/removal process itself affects 
insulin secretion from encapsulated βTC-tet cells. Cryoprotectants alone, for example, 
have been shown to cause reduced enzyme activity possibly due to denaturing of proteins 
[240] in addition to affecting the cytoskeletal network [241, 242].  Thus, it may be 
possible that affecting protein structure or activity may lead to problems with proper ion 
transport in channels and/or that cytoskeletal disruption may affect processes such as 
secretory granule transport. If CPA addition/removal does not impair secretion, then the 
cooling and warming steps of vitrification should be added and subsequent tests, as 
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described below, should be performed. If, however, secretion is impaired after just adding 
and removing CPAs, then areas in the insulin secretion pathway as well as their 
respective tests, as described below, should be examined after only CPA 
addition/removal. 
One of the first steps in elucidating vitrification-induced secretion defects would 
involve determining if there is indeed an increase in intracellular calcium concentration 
after membrane depolarization by exposure to high K+. A previous study has indicated 
impaired response to depolarization after high K+ exposure in cryopreserved cells, where 
the rise in intracellular calcium was three times lower compared to fresh cells [209].  One 
method that could be used to assess this would be by loading vitrified beads post-
warming with a fluorescent calcium indicator, such as fluo-4 AM, and then exposing the 
beads to a high concentration of K+ to artificially induced membrane depolarization. 
Subsequently the change in intracellular calcium would be monitored by imaging the 
beads over time after K+ exposure with confocal microscopy [209]. If there is impairment 
in the rise of intracellular calcium subsequent to addition of a high concentration of K+, 
then steps upstream of the increase in intracellular calcium concentration should be 
investigated, such as the ability of the plasma membrane to depolarize or the opening of 
the voltage-gated calcium channels.  The change in membrane potential after 
depolarization in the vitrified beta cells can be measured to see if membrane 
depolarization is actually occurring. Although exocytosis studies have been performed on 
beta cells from Conventionally Frozen free islets [243, 244], information from Vitrified 
islets is lacking in the literature.  
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If indeed the intracellular calcium concentration does increase, in spite of the 
reduced insulin secretion after high K+ exposure, a further area of investigation could be 
the movement of the secretory granules to the plasma membrane or the process of fusion 
of secretory granules with the plasma membrane. The cellular cytoskeletal organization is 
important for glucose-stimulated insulin secretion in the beta cell [245, 246], and 
cryoprotectants have been shown to affect the cytoskeleton [241, 242]. For example, 
evidence in the literature suggests that cryoprotectants can affect the integrity of the 
microtubule network [242, 247, 248], and in the beta cell this could potentially affect 
recruitment of secretory granules from the various pools within the cytosol to the plasma 
membrane prior to fusion and exocytosis. This would be applicable for longer-term 
secretion from encapsulated beta cells as initial insulin release is likely due to fusion of 
secretory vesicles that are near the plasma membrane and likely not those that are located 
in the reserve pool that may need to be transported to the plasma membrane. Cytoskeletal 
integrity would likely be more affected by vitrification as opposed to conventional 
freezing, as higher concentrations of cryoprotectants are used for vitrification.  
 
7.2.2    Cryopreservation Effects on Intermediary Metabolism in Encapsulated Islets 
In addition, future metabolic studies can be performed on encapsulated islets as 
opposed to encapsulated insulinoma cells, as encapsulated islets represent a more 
clinically relevant system. As previous studies of freezing and vitrification of 
encapsulated islets have indicated impaired insulin secretion post-warming [24, 25, 53], 
determining the effect of cryopreservation on the metabolism of the viable cells in the 
islets would be beneficial in understanding how cryopreservation affects fundamental 
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processes in GSIS in encapsulated islets. However, obtaining a sufficient signal-to-noise 
ratio may be challenging, as a previous 13C NMR and isotopomer analysis study indicated 
lower SNR in the 13C NMR spectrum obtained from porcine islets compared to spectra 
obtained from insulinoma cells [36]. Possible methods to increase signal-to-noise ratio in 
the NMR spectrum include using a higher field strength NMR magnet than that used in 
CHAPTER 5 (11.7 T) or a cryoprobe.   
 
7.2.3    Examination of First and Second Phases of Insulin Secretion to Measure   
            Dynamic Insulin Secretory Response Post-Preservation 
Although the static insulin secretory response from encapsulated βTC-tet cells 
was evaluated in CHAPTER 4 of this thesis, the dynamic response would provide real-
time insulin secretory kinetics and better provide a response that mimics in vivo 
conditions. A single-pass perfusion system could be used to determine the effect of 
cryopreservation on different phases of the insulin secretory response [249]. This could 
be especially useful in elucidating if any particular phase of the insulin secretory response 
is affected post-vitrification. 
 
7.2.4 Effects of Longer-Term Culture of Encapsulated βTC-tet cells on the   
            Cryopreservation Outcome 
As evidence in the literature has suggested differences in cell survival and 
function depending on culture period pre-cryopreservation for cells encapsulated under 
[17] or within hydrogels [225], it would be beneficial to understand how cell response is 
affected by culture time of encapsulated βTC-tet cells prior to cryopreservation. Although 
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in CHAPTER 5 freezing was found to be appropriate for cryopreservation of 
encapsulated βTC-tet cells cultured overnight prior to cryopreservation, changes such as 
the formation of cell clusters and deposition of a more dense extracellular matrix may 
render cells more susceptible to ice formation. In a broader application sense, it is also 
important to study cryopreservation response at different time points after encapsulation 
to find the ideal time of culture prior to cryopreservation for long-term storage at an 
industrial facility.  
 
7.2.5    Cryopreservation of Encapsulated Islets 
Although encapsulated βTC-tet cells represent an appropriate model pancreatic 
substitute for animal studies, encapsulated islets would represent a more clinically 
relevant system. Although studies with Conventionally Frozen alginate-poly-L-lysine-
alginate (APA) encapsulated islets have indicated glucose responsiveness in vitro and in 
vivo with reversal of hyperglycemia in rodent models [37, 53], the presence of the PLL 
layer may elicit an inflammatory response [82], leading to possible failure of the implant. 
Thus, islets encapsulated in barium alginate may represent a more biocompatible system, 
compared to APA-encapsulated islets.  Although implantation of Conventionally Frozen 
barium alginate encapsulated rat islets resulted in restoration of normoglycemia in a 
diabetic rat model [52], investigation into other islet species, such as porcine, 
encapsulated in barium alginate, is still warranted. Encapsulated porcine islets are 
promising as potential pancreatic substitutes, as porcine insulin is similar to human 
insulin, and the porcine islet supply is ample.  Evidence suggests that APA-encapsulated 
porcine islets may be more prone to damage after freezing compared to APA-
 125
encapsulated rat islets [37, 53], in spite of using the same freezing procedure, indicating 
that encapsulated islet response to cryopreservation protocols can be species-specific [37, 
53]. This would also warrant investigations of vitrification of encapsulated porcine islets.  
 
7.2.6    Long-Term Storage of Encapsulated Insulin-Secreting Cells 
The studies in this thesis have evaluated cryopreservation effects on encapsulated 
cells stored overnight prior to warming. Although metabolic processes should be halted 
below temperatures of -130oC, it would be important to see how long-term storage (i.e. 
weeks, months, years) affects cellular response, as not many studies have compared the 
effect of storage time from different cryopreservation methods. This is particularly 
important for the Vitrified samples, as maintaining glass stability is important for long-
term storage. Reports in the literature vary from days, months, and even up to a year in 
long-term storage, but often only examine one type of cryopreservation method. Studies 
examining insulin secretion and viability from encapsulated insulin-secreting cells for 
time scales of days to a year would help in understanding how long microencapsulated 
cells can be stored without any major effects on cell viability or function.  
 
7.2.7    Effects of Cryopreservation on Encapsulated Differentiated Myoblasts 
In order to use the encapsulated myoblasts in vivo, it would be beneficial to 
differentiate them prior to implantation to prevent excessive cell growth. Thus, it would 
be important to investigate the effects of cryopreservation on insulin secretion from 
myotubes derived from differentiation of myoblasts in RGD-alginate hydrogels; indeed, 
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myotubes may respond differently to cryopreservation as compared to undifferentiated 
myoblasts.  




PRELIMINARY CRYOPROTECTANT (CPA) 
ADDITION/REMOVAL AND VITRIFICATION STUDIES FROM 
ENCAPSULATED βTC-TET CELLS 
In order to determine the appropriate cryopreservation solution for vitrification, 
various pre-formulated cryoprotectant (CPA) solutions were tested on encapsulated βTC-
tet cells. Baseline protocols for addition and removal of CPAs were created using a 
previously developed math model [28] . CPAs were added and removed in a stepwise 
fashion at 4oC and 22oC, respectively, from βTC-tet cells encapsulated at 3x107 cells/ml 
in 500-600 μm calcium alginate beads. The following solutions were tested: 7 M 1,2 
propanediol (PD), VS55 (3.1 M dimethylsulfoxide (DMSO), 3.1 M formamide, 2.2 M 
PD), PEG 400 (5 M PD, 1 M DMSO, 12% PEG 400), DP6 (3 M DMSO, 3 M PD) + 0.3 
M sucrose, 5.5 M PD + 1 M sucrose. The CPA-treated groups were compared to the 
carrier solution 1X EuroCollins and the Fresh control.                                                                                  
Post-treatment, beads were cultured for 3 days and assayed immediately post-
treatment (day 0) and at days 1 and 3 for metabolic activity using alamarBlue® at each 
time point. For the alamarBlue® incubation, 100 µl of alamarBlue® stock solution was 
added to 0.1 ml beads and 1 ml fully supplemented DMEM. Beads were subsequently 
incubated at 37oC for 3 hours prior to reading fluorescence (Excitation: 544 
nm/Emission: 590 nm). As indicated in Figure A.1, the DP6+0.3 M sucrose group was 
comparable to Fresh and 1X EC at every time point (p>0.05). The PEG400 group was 
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similar to 1X EC at all time points (p>0.05). Recovery was apparent, and all groups 
exhibited an increase in metabolic activity and were comparable to Fresh on Day 3 
(p>0.05). Based on these results, two solutions, PEG400 and DP6 + 0.3 M sucrose, were 





















































Figure A.1 CPA addition/removal from encapsulated βTC-tet cells. *no statistical 
difference vs. 1X EC on same day; (p>0.05); #no statistical difference vs. Fresh on same 
day (p>0.05); ≠indicates a statistically significant increase in metabolic activity relative to 
the same group on Day 0 (p <0.05). n=3-12 
 
Initial vitrification studies were performed using a benchtop apparatus. However, 
to allow for overnight storage as well as allow for scale-up of the vitrification process, 
subsequent vitrification studies were performed in a mechanical freezer. However, upon 
performing vitrification studies in the mechanical freezer, DP6 + 0.3 M sucrose 
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devitrified upon warming. Thus, the sucrose concentration was increased to 0.5 M to 
prevent devitrification, and the new vitrification solution was named DPS. Subsequent 
vitrification studies indicated that although DPS and PEG400-vitrified groups gave lower 
metabolic activity compared to Fresh controls (Figure A.2), there was no difference in 
normalized ISR between DPS-vitrified and the Fresh control (Figure A.3). Thus, DPS 
was chosen as the vitrification solution for the studies in this thesis. 
 
Figure A.2 Metabolic activity (normalized to Fresh Controls) after vitrification of 
encapsulated βTC-tet cells. Note: for the DPS group, cells were encapsulated in alginate-
poly-L-lysine-alginate (APA) beads. βTC insulinomas encapsulated in alginate coated 
with poly-L-lysine (PLL) have been shown to exhibit similar metabolic activity and 











































Figure A.3 ISR (normalized to Fresh Controls) after vitrification of encapsulated βTC-tet 
cells. Note: For the DPS group, cells were encapsulated in alginate-poly-L-lysine-alginate 














































METAL VS. PLASTIC GENERATOR PROBE: POTENTIAL 
PARAMAGNETIC ION EFFECTS ON 13C NMR SPECTRA 
 
 
As paramagnetic ions can lead to severe line broadening in the NMR spectrum, 
thus reducing resolution and potentially making it difficult to distinguish isotopomer 
patters, special precautions were taken during the development of the perchloric acid 
extraction procedure to minimize potential contamination. Specifically, the standard 
metal homogenizer probe used initially was replaced with a plastic Omni Tip™ generator 
probe to help minimize potential paramagnetic ion contamination. Switching to the 
plastic probe led to better resolution in the NMR spectrum, as indicated below in Figure 
B.1. Although it is not entirely clear if paramagnetic ions were the cause of the line 
broadening, it is a plausible explanation, as these ions are known to lead to line 






Figure B.1 Glutamate resonances from 13C NMR spectra obtained from extractions using 
A). metal generator probe and B). a plastic Omin Tip™ generator probe. Prior to each 
extraction, a 6 ml bead volume of Fresh beads was incubated in 0 mM glucose DMEM 
for 1 hour followed by 12 hour incubation in 13C-glucose medium. 
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APPENDIX C 
PRELIMINARY STUDIES WITH ALGINATE MODIFICATION 
 
 
In order to allow for cell attachment and spreading in 3-D, various alginates were 
modified with the RGD peptide at a density of 10 mg/g alginate, using aqueous 
carbodiimide chemistry [98]. Stable C2C12 cells were then encapsulated on Day 0 in 
RGD-modified and unmodified alginates (controls) at a low cell density of 1x106 cells/ml 
in order to promote cell-matrix interactions and cultured for 10 days. Metabolically active 
cell number was assessed with alamarBlue™. An increase in cell number was apparent 
only in the RGD-modified LVM group (Figure C.1). Cells encapsulated in other alginates 
experienced a decrease in cell number over time. Although light microscopy pictures 
indicated that cell proliferation was likely occurring in the 2% RGD-LVM group, 











































Figure C.1 Metabolic activity of Stable C2C12 cells encapsulated in different alginates 
at a density of 1x106 cells/ml on Day 0. Beads were cultured for 10 days and sampled for 
metabolic activity via alamarBlue® and normalized to Day 1 values. Data shown 





Figure C.2 Stable C2C12 cells encapsulated at 1x106 cells/ml in 2% LVM or 2% RGD-
LVM. A)., C)., and E). represent 2% unmodified LVM on days 1, 5, and 10, respectively. 
B)., D)., and F). represent 2% RGD-LVM on days 1,5, and 10, respectively. All pictures 
were taken with a 10x objective on an Olympus IX71 inverted microscope. 
 
 
In order to produce weaker gels that may allow for cell spreading in 3-D, 
alginates were oxidized prior to RGD modification. Partial oxidation was performed as 
previously described [111]. After oxidation, alginates were modified with RGD peptide 
at a density of 10 mg/g alginate as before. Stable C2C12 cells were encapsulated in RGD-
modified oxidized alginates at a density of 1x106 cells/ml on Day 0 and beads were 
assessed with alamarBlue™ over five days (Figure C.3).  The highest metabolic activity 
(Figure C.4) and cell spreading were observed in the 2% RGD-modified oxidized LVM 
group. However, in order to increase the cell density for assay purposes to 3x106 cells/ml, 
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and still maintain bead integrity immediately post-encapsulation, the concentration of 
alginate was increased from 2% to 3%. A control of 3% oxidized LVM without RGD was 
also included to assess the effect of the softer gels on the encapsulated cells. Initial results 
indicate cells encapsulated at the higher density in 3% RGD-modified oxidized LVM also 
experienced an increase in the alamarBlue® reading with cell spreading apparent by 3 
days post-encapsulation (Figures C.3 and C.4). It is unclear if the alamarBlue® increase 
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Figure C.3 Metabolic activity measured by alamarBlue® of Stable C2C12 cells 
encapsulated in different types of RGD-modified oxidized alginates at 1x106 cells/ml 
(3% alginate groups were encapsulated at 3x106 cells/ml) and normalized to Day 1 
values. The blend represents 2% RGD-modified oxidized LVM and 2% RGD-modified 
oxidized LVG in a 1:1 ratio. Data shown represent one independent encapsulation from 




























Figure C.4 Light microscopy pictures of Stable C2C12 cells encapsulated in 3% RGD-
modified oxidized LVM at 3x106 cells/ml. A). Day 1, 10x; B). Day 3, 10x; C). Day 3, 















Various bead formulations were tested in order to determine the best system to 
allow for spreading in 3-D RGD-alginate while still being robust enough for surviving 
time in culture and the cryopreservation procedure. Although various preparations were 
tried, this section highlights some of the key preparations tried to determine the 
appropriate 3-D adhesive matrix.  Figure D.1 summarizes the different approaches taken 



















Figure D.1 Flow chart summarizing approaches and results obtained after trying different 
preparations of Stable C2C12 cells encapsulated in partially oxidized, RGD-modified 
alginate hydrgels. 
 
Stable C2C12 cells encapsulated in 3.5% oxidized RGD-LVM and crossinked in 
Ca2+ resulted in broken beads after culture in T-flasks. Thus, various approaches were 
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of inhomogeneous calcium alginate beads, barium alginate beads, and poly-L-lysine 
coated calcium alginate beads. 
 
D.1      Inhomogeneous Calcium Alginate Beads 
  Inhomogeneous calcium alginate beads were tested, as they are known to result in 
a higher concentration of alginate at the periphery of the bead compared to the center, 
possibly creating a more stable bead. To form inhomogeneous beads, alginate was 
dissolved in mannitol and subsequently crosslinked in 100 mM CaCl2 adjusted to 300 
mOsm. Although the inhomogeneous calcium alginate beads exhibited nice, spherical 
geometry post-encapsulation, and overall bead integrity during 4 days in culture (Figure 













Figure D.3  Fresh inhomogeneous calcium alginate beads after LIVE/DEAD® staining. 
Beads are damaged after the LIVE/DEAD® staining and imaging procedure. 
 
D.2      Inhomogeneous Barium Alginate Beads 
Additionally, inhomogeneous barium-alginate beads were also formed to see if 
stiffer beads could be formed compared to using calcium alginate beads. Concentrations 
of 20-50 mM Ba2+ were tried, but led to no spreading in beads. As indicated in Figure 
D.4, crosslinking beads in 20 mM BaCl2 led to maintenance of bead integrity up to 4 days 
in culture, but did not result in cell spreading. This may have been due to the stiffness of 
the beads, but it is unclear.  Beads crosslinked using lower concentrations of barium (i.e. 
10 mM Ba2+) resulted in irregular bead formation. Additionally, homogeneous barium 
alginate beads were also tested, and led to similar results of maintenance of bead integrity 











Figure D.4 Fresh Stable C2C12 cells encapsulated in 3.5% oxidized RGD-modified 
LVM and crosslinked in 20 mM BaCl2 in mannitol (inhomogeneous bead formation). 
Beads were cultured up to 4 days post-encapsulation. 
 
D.3      Poly-L-lysine-Alginate Coating of Standard Calcium Alginate Beads 
Another approach was to coat beads with poly-L-lysine (PLL) (and a final coating 
of unmodified alginate) in order to help mechanically stabilize the beads. It was thought 
that the PLL would form a thin shell at the periphery of the beads to help stabilize them. 
Standard beads, using alginate dissolved in 0.85% NaCl for encapsulation, and 
crosslinked in 300 mOsm CaCl2 (without NaCl), were formed. However, the base coating 
protocol, of incubating beads in 0.05% PLL in 0.85% NaCl for 6 minutes [227], resulted 
in broken beads. Thus, various modifications, as described in Table D.1, were performed.  
 
Table D.1 Modifications made to base protocol for coating standard calcium alginate 
beads and subsequent results. The base protocol involved coating 3.5% oxidized RGD-
modified LVM beads in 0.05% PLL in 0.85% NaCl for 6 minutes. Alginate was 
dissolved in 0.85% NaCl.  
Modification Result
Increase [alginate] to 3.8% Majority Beads Broken
Increase [PLL] to 0.1% for 10 min Intact beads, appear very coated
Increase [PLL] to 0.1% for 5 min Intact beads, appear very coated
Increase [PLL] to 0.1% for 5 min with one less 0.85% wash Intact beads, cell spreading  
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The best option was found to be increasing the PLL concentration to 0.1% for 5 
minutes with one less 0.85% NaCl wash. It was desirable to reduce the number of washes 
in 0.85% NaCl in order to reduce the likelihood of bead destabilization from sodium ions. 
These beads were able to maintain integrity in culture over 4 days and exhibited cell 
spreading (Figure D.5). After 4 days in culture, bead integrity was maintained after 







Figure D.5 Fresh Stable C2C12 cells encapsulated in 3.5% oxidized RGD-LVM and 









Figure D.6 Stable C2C12 cells encapsulated in 3.5% oxidized RGD-LVM and coated 
with 0.1% PLL and alginate, before and after cryopreservation. Beads were cultured for 4 
days prior to cryopreservation. Light micrographs represent images from beads 
immediately post-warming (Day 5) as well as the respective Fresh control (Day 4) 
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D.4      Poly-L-lysine-Alginate Coating of Inhomogeneous Calcium Alginate Beads 
 
Inhomogeneous, PLL-alginate-coated calcium alginate beads were also tested, as 
they did not require 0.85% NaCl washes, and the exclusion of these washes was thought 
to possibly help stabilize the alginate matrix. Additionally, inhomogenous beads may be 
more stable than standard coated beads due to the higher concentration of alginate at the 
periphery. The alginate was dissolved in 300 mOsm mannitol as opposed to 0.85% NaCl. 
The base protocol described in Table D.2 resulted in 30-40% broken beads. Thus, the 
modifications listed in Table D.2 were performed. As none of the modifications were 
deemed appropriate, inhomogeneous beads were not used for subsequent studies. 
 
Table D.2 Modifications made to base protocol for coating inhomogeneous calcium 
alginate beads and subsequent results. The base protocol involved coating beads in 0.1% 
PLL in 300 mOsm mannitol for 6 minutes. The alginate was dissolved in mannitol.  
Modification Result
Coat in 50/50 0.85% NaCl and 300 mOsm mannitol Majority of beads broken
Remove CHES and CaCl2 washes Majority of beads broken
Coat in 0.85% NaCl for 5 minutes Beads intact, but no spreading
Coat in 0.85% NaCl for 2.5 minutes Majority of beads broken
Decrease [PLL] to 0.05% in 0.85% NaCl Majority of beads broken










Figure D.7  Fresh inhomogeneous coated beads maintained bead integrity in culture but 
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